0001193125-22-219950.txt : 20220812 0001193125-22-219950.hdr.sgml : 20220812 20220812161220 ACCESSION NUMBER: 0001193125-22-219950 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220812 DATE AS OF CHANGE: 20220812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ascendant Digital Acquisition Corp. III CENTRAL INDEX KEY: 0001850316 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 981585828 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41036 FILM NUMBER: 221160203 BUSINESS ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: (212) 209-6126 MAIL ADDRESS: STREET 1: 667 MADISON AVENUE STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 10-Q 1 d324890d10q.htm 10-Q 10-Q
falseQ2000185031600-0000000--12-31NY 0001850316 2022-01-01 2022-06-30 0001850316 2022-06-30 0001850316 2021-12-31 0001850316 2021-04-01 2021-06-30 0001850316 2022-04-01 2022-06-30 0001850316 2021-02-19 2021-06-30 0001850316 2021-02-19 2021-03-31 0001850316 2022-01-01 2022-03-31 0001850316 2021-11-15 0001850316 2021-11-15 2021-11-15 0001850316 2021-02-19 2021-12-31 0001850316 2021-02-18 0001850316 2022-03-31 0001850316 2021-03-31 0001850316 2021-06-30 0001850316 acdi:PublicSharesMember 2022-06-30 0001850316 us-gaap:IPOMember 2022-06-30 0001850316 srt:MinimumMember 2022-06-30 0001850316 srt:MinimumMember acdi:PostTransactionMember 2022-06-30 0001850316 us-gaap:CommonClassBMember 2022-06-30 0001850316 us-gaap:CommonClassAMember 2022-06-30 0001850316 acdi:SponsorMember acdi:PromissoryNoteMember acdi:RelatedPartyLoansMember 2022-06-30 0001850316 acdi:WorkingCapitalLoanMember 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember 2022-06-30 0001850316 acdi:PublicWarrantsMember 2022-06-30 0001850316 acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsEighteenDollarsMember acdi:PublicWarrantsMember us-gaap:CommonClassAMember 2022-06-30 0001850316 acdi:PublicWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember us-gaap:CommonClassAMember 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember us-gaap:CommonClassAMember 2022-06-30 0001850316 us-gaap:CommonClassAMember acdi:RedemptionOfWarrantsMember 2022-06-30 0001850316 acdi:PublicWarrantsMember us-gaap:CommonClassAMember 2022-06-30 0001850316 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-06-30 0001850316 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-06-30 0001850316 us-gaap:CommonClassBMember acdi:ConversionOfClassBToClassACommonStockMember 2022-06-30 0001850316 acdi:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2022-06-30 0001850316 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-06-30 0001850316 acdi:PublicWarrantsMember acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001850316 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member acdi:WarrantLiabilitiesMember acdi:PublicWarrantsMember 2022-06-30 0001850316 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember acdi:WarrantLiabilitiesMember acdi:PublicWarrantsMember 2022-06-30 0001850316 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001850316 us-gaap:CashMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsEighteenDollarsMember acdi:PublicWarrantsMember 2022-06-30 0001850316 acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember acdi:PublicWarrantsMember 2022-06-30 0001850316 us-gaap:CommonClassBMember 2021-12-31 0001850316 us-gaap:CommonClassAMember 2021-12-31 0001850316 acdi:WorkingCapitalLoanMember 2021-12-31 0001850316 acdi:PublicWarrantsMember 2021-12-31 0001850316 acdi:PrivatePlacementWarrantsMember 2021-12-31 0001850316 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-12-31 0001850316 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001850316 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001850316 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001850316 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001850316 us-gaap:FairValueMeasurementsRecurringMember acdi:WarrantLiabilitiesMember acdi:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001850316 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember acdi:WarrantLiabilitiesMember acdi:PrivatePlacementWarrantsMember 2021-12-31 0001850316 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember acdi:WarrantLiabilitiesMember acdi:PrivatePlacementWarrantsMember 2021-12-31 0001850316 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember acdi:WarrantLiabilitiesMember acdi:PrivatePlacementWarrantsMember 2021-12-31 0001850316 acdi:PublicWarrantsMember acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001850316 acdi:PublicWarrantsMember acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001850316 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001850316 us-gaap:CashMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001850316 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001850316 us-gaap:FairValueInputsLevel3Member 2022-04-01 2022-06-30 0001850316 acdi:AdministrativeServicesMember 2022-04-01 2022-06-30 0001850316 us-gaap:CommonClassBMember 2022-04-01 2022-06-30 0001850316 us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001850316 us-gaap:CommonClassBMember 2021-04-01 2021-06-30 0001850316 us-gaap:CommonClassAMember 2021-04-01 2021-06-30 0001850316 us-gaap:CapitalUnitsMember 2022-01-01 2022-06-30 0001850316 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001850316 acdi:SponsorMember acdi:FounderSharesMember 2022-01-01 2022-06-30 0001850316 us-gaap:IPOMember 2022-01-01 2022-06-30 0001850316 us-gaap:CommonClassAMember acdi:InitialPublicOfferAndPrivatePlacementMember 2022-01-01 2022-06-30 0001850316 acdi:PublicWarrantsMember 2022-01-01 2022-06-30 0001850316 acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsEighteenDollarsMember acdi:PublicWarrantsMember 2022-01-01 2022-06-30 0001850316 acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember acdi:PublicWarrantsMember 2022-01-01 2022-06-30 0001850316 us-gaap:CommonClassAMember acdi:PublicWarrantsMember 2022-01-01 2022-06-30 0001850316 acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsEighteenDollarsMember acdi:PublicWarrantsMember us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001850316 us-gaap:CommonClassAMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember acdi:PublicWarrantsMember 2022-01-01 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001850316 us-gaap:CommonClassAMember acdi:RedemptionOfWarrantsMember 2022-01-01 2022-06-30 0001850316 us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001850316 acdi:ConversionOfClassBToClassACommonStockMember us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001850316 us-gaap:OverAllotmentOptionMember acdi:UnderwritingAgreementMember 2022-01-01 2022-06-30 0001850316 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-06-30 0001850316 acdi:AdministrativeServicesMember 2022-01-01 2022-06-30 0001850316 acdi:SponsorMember 2022-01-01 2022-06-30 0001850316 us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001850316 us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001850316 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001850316 us-gaap:CommonClassBMember 2021-02-19 2021-06-30 0001850316 us-gaap:OverAllotmentOptionMember 2021-11-15 2021-11-15 0001850316 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-11-15 2021-11-15 0001850316 us-gaap:OverAllotmentOptionMember acdi:PrivatePlacementWarrantsMember 2021-11-15 2021-11-15 0001850316 us-gaap:IPOMember acdi:PrivatePlacementWarrantsMember 2021-11-15 2021-11-15 0001850316 us-gaap:IPOMember 2021-11-15 2021-11-15 0001850316 us-gaap:CommonClassAMember 2021-11-15 2021-11-15 0001850316 acdi:PrivatePlacementWarrantsMember 2021-11-15 2021-11-15 0001850316 acdi:SponsorMember acdi:FounderSharesMember 2021-11-15 2021-11-15 0001850316 acdi:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2021-11-15 2021-11-15 0001850316 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-11-15 0001850316 us-gaap:IPOMember 2021-11-15 0001850316 acdi:PublicWarrantsMember 2021-11-15 0001850316 us-gaap:CommonClassAMember 2021-11-15 0001850316 acdi:PrivatePlacementWarrantsMember 2021-11-15 0001850316 us-gaap:IPOMember acdi:UnderwritingAgreementMember 2021-11-15 0001850316 us-gaap:OverAllotmentOptionMember 2021-11-15 0001850316 us-gaap:CommonClassBMember acdi:FounderSharesMember acdi:SponsorMember 2021-02-24 2021-02-24 0001850316 srt:MaximumMember us-gaap:CommonClassBMember acdi:FounderSharesMember acdi:SponsorMember 2021-02-24 0001850316 acdi:RelatedPartyLoansMember acdi:PromissoryNoteMember acdi:SponsorMember 2021-02-24 0001850316 us-gaap:CommonClassBMember acdi:FounderSharesMember acdi:SponsorMember 2021-03-23 2021-03-23 0001850316 us-gaap:CommonClassBMember acdi:FounderSharesMember acdi:SponsorMember 2021-03-23 0001850316 srt:DirectorMember acdi:FounderSharesMember acdi:SponsorMember 2021-03-31 2021-03-31 0001850316 acdi:FounderSharesMember 2021-11-09 2021-11-09 0001850316 acdi:SponsorMember acdi:OfficeSpaceAdministrativeAndSupportServicesMember 2021-11-09 2021-11-09 0001850316 srt:MaximumMember acdi:FounderSharesMember 2021-11-09 0001850316 srt:MinimumMember acdi:SponsorMember 2021-11-09 0001850316 us-gaap:CommonClassAMember acdi:RedemptionOfWarrantsMember 2021-02-19 2021-12-31 0001850316 us-gaap:FairValueInputsLevel3Member 2021-02-19 2021-12-31 0001850316 us-gaap:CommonClassAMember 2021-02-19 2021-12-31 0001850316 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001850316 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-03-31 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-02-19 2021-03-31 0001850316 us-gaap:AdditionalPaidInCapitalMember 2021-02-19 2021-03-31 0001850316 us-gaap:RetainedEarningsMember 2021-02-19 2021-03-31 0001850316 us-gaap:CommonClassAMember 2022-08-12 0001850316 us-gaap:CommonClassBMember 2022-08-12 0001850316 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001850316 us-gaap:RetainedEarningsMember 2022-06-30 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001850316 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001850316 us-gaap:RetainedEarningsMember 2021-06-30 0001850316 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001850316 us-gaap:RetainedEarningsMember 2021-12-31 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001850316 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001850316 us-gaap:RetainedEarningsMember 2022-03-31 0001850316 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-02-18 0001850316 us-gaap:AdditionalPaidInCapitalMember 2021-02-18 0001850316 us-gaap:RetainedEarningsMember 2021-02-18 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001850316 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001850316 us-gaap:RetainedEarningsMember 2021-03-31 xbrli:shares iso4217:USD utr:Day xbrli:pure utr:Month utr:Year iso4217:USD xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 10-Q
 
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2022
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
to
                    
Commission File No. 001-41036
 
 
ASCENDANT DIGITAL ACQUISITION CORP. III
(Exact name of registrant as specified in its charter)
 
 
 
Cayman Islands
 
N/A
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S.
Em
ployer
Identification Number)
667 Madison Avenue5th Floor
New YorkNY
 
10065
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code:
(212209-6126
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbols
 
Name of each exchange
on which registered
Units, each consisting of one Class A ordinary share, $0.0001 par value, and
one-half
of one redeemable warrant
 
ACDI.U
 
The New York Stock Exchange
Class A ordinary shares, par value $0.0001 per share
 
ACDI
 
The New York Stock Exchange
Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share
 
ACDI WS
 
The New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405
of Regulation S-T (§232.405 of
this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer,
a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company”
in Rule 12b-2 of
the Exchange Act.
 
Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant is a shell company (as
defined
in Rule 12b-2 of the
Exchange Act):    Yes      No  ☐
As of August 12, 2022, the Registrant had 30,000,000 Class A ordinary shares, $0.0001 par value per share, and 7,500,000 Class B ordinary shares, $0.0001 par value per share, outstanding.
 
 
 

ASCENDANT DIGITAL ACQUISITION CORP. III
Quarterly Report on Form
10-Q
TABLE OF CONTENTS
 
        
Page
 
PART 1 – FINANCIAL INFORMATION
  
Item 1.
       1  
       1  
       2  
       3  
       4  
       5  
Item 2.
       19  
Item 3.
       22  
Item 4.
       22  
PART II – OTHER INFORMATION
  
Item 1.
       23  
Item 1A.
       23  
Item 2.
       23  
Item 3.
       24  
Item 4.
       24  
Item 5.
       24  
Item 6.
       24  
     25  

PART I – FINANCIAL INFORMATION
 
Item 1.
Interim Financial Statements (unaudited)
ASCENDANT DIGITAL ACQUISITION CORP. III
CONDENSED BALANCE SHEETS
 
 
  
June 30, 2022
 
 
December 31, 2021
 
 
  
(Unaudited)
 
 
 
 
Assets
  
 
Current assets:
  
 
Cash
   $ 516,095     $ 831,432  
Prepaid expenses
     746,106       970,696  
    
 
 
   
 
 
 
Total current assets
     1,262,201       1,802,128  
Investments held in Trust Account
     306,566,918       306,016,692  
    
 
 
   
 
 
 
Total Assets
  
$
307,829,119
 
 
$
307,818,820
 
    
 
 
   
 
 
 
     
Liabilities, Redeemable Class A Ordinary Shares and Shareholders’ Deficit:
                
Current liabilities:
                
Accounts payable
   $ 195,612     $ 27,416  
Accounts payable - related party
     —         18,898  
Accrued expenses
     2,586       119,732  
    
 
 
   
 
 
 
Total current liabilities
     198,198       166,046  
Derivative warrant liabilities
     3,445,000       18,285,000  
Deferred underwriting commissions
     10,500,000       10,500,000  
    
 
 
   
 
 
 
Total liabilities
     14,143,198       28,951,046  
     
Commitments and Contingencies
                
     
Class A ordinary shares subject to possible redemption, $0.0001 par value, 30,000,000
shares at redemption value of approximately $10.22 and $10.20 per share as of June 30, 2022 and December 31, 2021, respectively
     306,466,918       306,000,000  
     
Shareholders’ Deficit:
                
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
                  
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; no
non-redeemable
shares issued and outstanding
                  
Class B ordinary shares; $0.0001 par value; 50,000,000 shares authorized; 7,500,000 shares issued and outstanding
     750       750  
Additional
paid-in
capital
                  
Accumulated deficit
     (12,781,747     (27,132,976
    
 
 
   
 
 
 
Total shareholders’ deficit
     (12,780,997     (27,132,226
    
 
 
   
 
 
 
Total Liabilities, Redeemable Class A Ordinary Shares and Shareholders’ Deficit
  
$
307,829,119
 
 
$
307,818,820
 
    
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
1

ASCENDANT DIGITAL ACQUISITION CORP. III
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS
 
 
  
For the Three Months Ended June 30,
 
 
For the Six Months
Ended

June 30, 2022
 
 
For the Period From

February 19, 2021 (Inception)

Through June 30, 2021
 
 
  
2022
 
 
2021
 
General and administrative expenses
   $ 240,825     $ 10,243     $ 512,116     $ 10,243  
Administrative expenses - related party
     30,000       —         60,000       —    
    
 
 
   
 
 
   
 
 
   
 
 
 
Loss from operations
     (270,825     (10,243     (572,116     (10,243
         
Other income:
                                
Change in fair value of derivative warrant liabilities
     7,155,000       —         14,840,000       —    
Interest income from operating account
     16       —         37       —    
Income from investments held in Trust Account
     342,480       —         550,226       —    
    
 
 
   
 
 
   
 
 
   
 
 
 
Total other income
     7,497,496       —         15,390,263       —    
    
 
 
   
 
 
   
 
 
   
 
 
 
Net income (loss)
  
$
7,226,671
 
 
$
(10,243
 
$
14,818,147
 
 
$
(10,243
    
 
 
   
 
 
   
 
 
   
 
 
 
         
Basic and diluted weighted average shares outstanding of Class A ordinary shares
     30,000,000       —         30,000,000       —    
    
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net income per ordinary share, Class A ordinary shares
   $ 0.19     $ —       $ 0.40     $ —    
    
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted weighted average shares outstanding of Class B ordinary shares
     7,500,000       6,525,000       7,500,000       6,277,841  
    
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net income (loss) per ordinary share, Class B ordinary shares
   $ 0.19     $ (0.00   $ 0.40     $ (0.00
    
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
2

ASCENDANT DIGITAL ACQUISITION CORP. III
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT
 
 
  
For the Three and Six Months Ended June 30, 2022
 
 
  
Class B Ordinary Shares
 
  
Additional
Paid-in Capital
 
  
Accumulated
Deficit
 
 
Total
Shareholders’
Deficit
 
 
  
Shares
 
  
Amount
 
Balance - December 31, 2021
  
 
7,500,000
 
  
$
750
 
  
$
  
 
  
$
(27,132,976
 
$
(27,132,226
Net income
     —          —          —          7,591,476       7,591,476  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance - March 31, 2022 (unaudited)
  
 
7,500,000
 
  
$
750
 
  
$
  
 
  
$
(19,541,500
 
$
(19,540,750
Accretion of Class A ordinary shares subject to possible redemption amount
     —          —          —          (466,918     (466,918
Net income
     —          —          —          7,226,671       7,226,671  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance - June 30, 2022 (unaudited)
  
 
7,500,000
 
  
$
750
 
  
$
  
 
  
$
(12,781,747
 
$
(12,780,997
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 

 
  
For the Period From February 19, 2021 (Inception) Through June 30, 2021
 
    
Class B Ordinary Shares
    
Additional
Paid-in
Capital
    
Accumulated
Deficit
   
Total
Shareholders’
Equity
 
    
Shares
    
Amount
 
Balance - February 19, 2021 (inception)
  
 
  
 
  
$
  
 
  
$
  
 
  
$
  
 
 
$
  
 
Issuance of Class B ordinary shares to Sponsor
     7,503,750        750        24,250        —         25,000  
Net loss
     —          —          —          (10,243     (10,243
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance - March 31, 2021 (unaudited)
  
 
7,503,750
 
  
$
750
 
  
$
24,250
 
  
$
(10,243
 
$
14,757
 
Net loss
     —          —          —          —         —    
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance - June 30, 2021 (unaudited)
  
 
7,503,750
 
  
$
750
 
  
$
24,250
 
  
$
(10,243
 
$
14,757
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
3

ASCENDANT DIGITAL ACQUISITION CORP. III
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
 
    
For the Six Months Ended

June 30, 2022
   
For the Period From
February 19, 2021 (Inception)

Through June 30, 2021
 
Cash Flows from Operating Activities:
                
Net income (loss)
   $ 14,818,147     $ (10,243
Adjustments to reconcile net income (loss) to net cash used in operating activities:
                
General and administrative expenses paid by related party in exchange for issuance of Class B ordinary shares
              10,243  
Income from investments held in Trust Account
     (550,226         
Change in fair value of derivative warrant liabilities
     (14,840,000         
Changes in operating assets and liabilities:
                
Prepaid expenses
     224,590           
Accounts payable
     168,196           
Accounts payable - related party
     (18,898         
Accrued expenses
     (117,146         
    
 
 
   
 
 
 
Net cash used in operating activities
     (315,337         
    
 
 
   
 
 
 
     
Net change in cash
     (315,337         
     
Cash - beginning of the period
     831,432          
    
 
 
   
 
 
 
Cash - end of the period
  
$
516,095
 
 
$
  
 
    
 
 
   
 
 
 
     
Supplemental disclosure of noncash investing and financing activities:
                
Payment of deferred offering costs by note payable - related party
   $        $ 103,546  
Deferred offering costs included in accrued expenses
   $        $ 130,420  
Payment of deferred offering costs by the Sponsor in exchange for the issuance of Class B ordinary shares
   $        $ 14,757  
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
4

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Note 1 — Description of Organization and Business Operations and Liquidity
Ascendant Digital Acquisition Corp. III (the “Company”) was incorporated in the Cayman Islands on February 19, 2021. The Company is a blank check company formed for the purpose of entering into a business combination.
The Company is not limited to a particular industry or geographic region for purposes of consummating a business combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of June 30, 2022, the Company had not commenced any operations. All activity through June 30, 2022 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below and since the offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business combination, at the earliest. The Company
generates non-operating
interest income from the proceeds held in the Trust Account (as defined below).
The registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective on November 10, 2021. On November 15, 2021, the Company consummated the sale of 26,100,000 units (“Units”) with respect to the Class A ordinary shares included in the Units being offered (the “Public Shares”) at $10.00 per Unit generating gross proceeds of $261,000,000, which is discussed in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 10,330,000 warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to the Company’s sponsor, Ascendant Sponsor LP III (the “Sponsor”) generating gross proceeds of $10,330,000.
Additionally with the closing of the Initial Public Offering, the Company consummated the closing of the sale of 3,900,000 additional Units upon receiving notice of the underwriter’s election to partially exercise its overallotment option (“Overallotment Units”), generating additional gross proceeds of $39,000,000. Since the underwriters only partially exercised their over-allotment option, on November 15, 2021 the Sponsor forfeited 3,750 shares for no consideration. Simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional 1,170,000 Private Placement Warrants to the Sponsor, generating gross proceeds of $1,170,000.
Offering costs for the Initial Public Offering and the exercise of the underwriters’ over-allotment option amounted to $14,172,182, consisting of $3,000,000 of underwriting fees, $10,500,000 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $672,182 of other costs. As described in Note 6, the $10,500,000 of deferred underwriting fee payable is contingent upon the consummation of a business combination by February 15, 2023, subject to the terms of the underwriting agreement.
Following the closing of the Initial Public Offering and partial exercise of the over-allotment, $306,000,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Warrants was placed in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and
(d)(4) of Rule 2a-7 of the Investment
Company Act, as determined by the Company, until the earlier of (i) the completion of a business combination and (ii) the distribution of the Trust Account, as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a business combination. There is no assurance that the Company will be able to complete a business combination successfully. The Company must complete one or more initial business combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting
 
5

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able to successfully effect a Business Combination.
The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially at $10.20 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights with respect to the Company’s warrants.
The per-share amount
to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”).
Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s business combination. If the Company seeks shareholder approval of the business combination, the Company will proceed with a business combination if a majority of the shares voted are voted in favor of the business combination, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of incorporation (the “Charter”), conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a business combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a business combination, the Sponsor agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a business combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.
Notwithstanding the foregoing, the Charter provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.
The Company’s Sponsor, officers, directors and advisory board members (collectively, “Initial Shareholders”) agreed not to propose an amendment to the Charter that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a business combination, unless the Company provides the Public Shareholders with the opportunity to redeem their shares of Class A ordinary shares in conjunction with any such amendment.
If the Company is unable to complete a business combination by February 15, 2023, 15 months from the closing of the Initial Public Offering (“Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public
Shares, at a per-share price, payable in
cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay for its franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
 
6

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a business combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a business combination within the Combination Period. The underwriters agreed to waive their rights to its deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a business combination within the Combination Period, and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.20 per shares held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Going Concern Consideration
As of June 30, 2022, the Company had cash of approximately $516,000 and working capital surplus of approximately $1.0 million.
The Company’s liquidity needs up prior to the consummation of the Initial Public Offering had been satisfied through the cash receipt of $25,000 from the Sponsor to cover for certain expenses on behalf of the Company in exchange for issuance of Founder Shares (as defined in Note 5), and loan from the related party of approximately $153,396 under the Note (as defined in Note 5). The Company repaid the Note in full on November 11, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering, over-allotment, and the Private Placement held outside of the Trust Account.
In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of June 30, 2022, there were no amounts outstanding under Working Capital Loan.
In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after February 15, 2023. The unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.
 
7

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Note 2 — Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to
Form 10-Q and
Article 8 of
Regulation S-X and
pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022 or any future period.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on
Form 10-K filed
by the Company with the SEC on March 25, 2022.
Use of Estimates
The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements.
Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.
Emerging Growth Company
The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but
any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2022 and December 31, 2021, the Company had no cash equivalents.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000.
The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such accounts.
 
8

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Investments Held in the Trust Account
The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income from investments held in the Trust Account in the accompanyin
g unaudited
 
condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 9).
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as
equity, is re-assessed at the end
of each reporting period.
The Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are
classified as non-current liabilities as
their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
 
9

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares sold in the Initial Public Offering and over-allotment feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of June 30, 2022 and December 31, 2021, 30,000,000 Class A ordinary shares subject to possible redemption were presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges
against additional paid-in capital (to
the extent available) and accumulated deficit.
As of June 30, 2022 and December 31, 2021, the shares of Class A ordinary shares reflected on the balance sheet are reconciled on the following table:
 
Gross proceeds from Initial Public Offering
  
$
300,000,000
 
Less:
  
     
Fair value of Public Warrants at issuance
  
 
(9,180,180
Offering costs allocated to Class A ordinary shares subject to possible redemption
  
 
(13,723,591
Plus:
  
     
Accretion on Class A ordinary shares subject to possible redemption amount
  
 
28,903,771
 
 
  
 
 
 
Class A ordinary share subject to possible redemption - December 31, 2021
  
 
306,000,000
 
Plus:
  
     
Increase in redemption value of Class A ordinary shares subject to redemption
  
 
466,918
 
 
  
 
 
 
Class A ordinary shares subject to possible redemption - June 30, 2022
  
$
306,466,918
 
 
  
 
 
 
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of FASB
ASC 340-10-S99-1. Offering
costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to derivative warrant liabilities were expensed as incurred and presented
as non-operating expenses
in th
e unaudited
c
ondensed statements of operations. Offering costs allocated to the Class A ordinary shares issued were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Income Taxes
The Company follows the guidance for accounting for income taxes under FASB ASC 740, “Income Taxes.” FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net loss by the weighted average number of ordinary shares outstanding for the respective period.
 
10

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase an aggregate of 26,500,000 Class A ordinary shares in the calculation of diluted income (loss) per ordinary share since their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the three and six months ended June 30, 2022, for the six months ended June 30, 2021 and for the period from February 19, 2021 (inception) through June 30, 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per ordinary share for each class of ordinary shares:
 
    
For the Three Months Ended June 30, 2022
    
For the Six Months Ended June 30, 2022
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net income per ordinary share:
                                   
Numerator:
                                   
Allocation of net income
   $ 5,781,337      $ 1,445,334      $ 11,854,518      $ 2,963,629  
         
Denominator:
                                   
Basic and diluted weighted average ordinary shares outstanding
     30,000,000        7,500,000        30,000,000        7,500,000  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $ 0.19      $ 0.19      $ 0.40      $ 0.40  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
For the Three Months Ended June 30, 2021
    
For the Six Months Ended June 30, 2021
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net loss per ordinary share:
                                   
Numerator:
                                   
Allocation of net loss
   $         $ (10,243    $         $ (10,243
         
Denominator:
                                   
Basic and diluted weighted average ordinary shares outstanding
               6,525,000                  6,277,841  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net loss per ordinary share
   $         $ (0.00    $         $ (0.00
    
 
 
    
 
 
    
 
 
    
 
 
 
Recent Accounting Pronouncements
The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.
 
11

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Note 3 — Initial Public Offering
On November 15, 2021, the Company consummated its Initial Public Offering of 30,000,000 Units, including 3,900,000 units as a result of the partial exercise by the underwriters of their over-allotment option, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $14.2 million, of which approximately $10.5 million was for deferred underwriting commissions.
Each Unit consists of one Class A ordinary
share, and 
one-half
of one redeemable warrant
 (the “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7).
Note 4 — Private Placement Warrants
On November 15, 2021, simultaneously with the consummation of the Initial Public Offering and the underwriters’ partial exercise of their over-allotment option, the Company consummated the issuance and sale (“Private Placement”) of 11,500,000 Private Placement Warrants in a private placement transaction at a price of $10.00 per Placement Unit, generating gross proceeds of $11,500,000. Each whole Private Placement Warrant will be exercisable to purchase one share of Class A ordinary shares at a price of $11.50 per share. A portion of the proceeds from the Private Placement Units will be added to the proceeds from the Proposed Public Offering to be held in the Trust Account. If the Company does not complete a business combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants and all underlying securities will be worthless.
Note 5 — Related Party Transactions
Founder Shares
On February 24, 2021, the Sponsor purchased an aggregate of 8,625,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.003 per share. On March 23, 2021, the Sponsor surrendered 1,437,500 founder shares to the Company for cancellation for no consideration creating a total of 7,187,500 founder shares to be outstanding. In March 2021, the Sponsor transferred an aggregate of 230,000 founder shares to members of the Company’s board of directors and the Company’s advisory board, resulting in the Sponsor holding 6,957,500 founder shares. On November 9, 2021, the Company effected a share capitalization of 316,250 founder shares, resulting in the Sponsor holding 7,273,750 founder shares (for an aggregate of 7,503,750 founder shares of which up to 978,750 of which were subject to forfeiture if the underwriters’ over-allotment option is not exercised in full). Since the underwriters only partially exercised their over-allotment option, on November 15, 2021 the Sponsor forfeited 3,750 shares for no consideration.
The Founder Shares will automatically convert into shares of Class A ordinary shares at the time of the Company’s initial business combination and are subject to certain transfer restrictions, as described in Note 6. Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal number of shares of Class A ordinary shares, subject to adjustment, at any time.
Related Party Loans
On February 24, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”).
This loan was non-interest bearing and payable
on the earlier of December 31, 2021, or the completion of the Initial Public Offering. The outstanding balance under the Note was repaid at the closing of the Initial Public Offering on November 15, 2021, and the Note was terminated.
In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a business combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a
 
12

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
business combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a business combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into units of the post business combination entity at a price of $1.00 per warrant. The units would be identical to the Private Placement Units. As of June 30, 2022 and December 31, 2021, there were no Working Capital Loans outstanding.
Administrative Services Agreement
On November 9, 2021, the Company entered into an agreement with the Sponsor, pursuant to which the Company agreed to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative services provided to the Company until the earlier of the consummation of a Business Combination or liquidation. The Company incurred $30,000 and $60,000 in connection with such fees during the three and six months ended June 30, 2022, respectively, included within the general and administrative fees in the accompanying unaudited condensed statements of operations.
In addition, the Sponsor, officers and directors, and any of their respective affiliates will be reimbursed for
any out-of-pocket expenses
incurred in connection with activities on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable business combinations. The audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, officers or directors, or the Company’s or their affiliates. Any such payments prior to an initial business combination will be made from funds held outside the Trust Account.
Due to Related Party
During the period from February 19, 2021 (inception) through December 31, 2021, the Company’s Sponsor paid approximately $19,000 of expenses on behalf of the Company. As of December 31, 2021, outstanding balance for such expenses was approximately $19,000, included in due to related party in current liabilities, on the accompanying condensed balance sheet. Such fees were settled during in March 2022.
Note 6 — Commitments and Contingencies
Registration Rights
The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A ordinary shares) pursuant to a registration rights agreement to be signed on or before the date of the prospectus for the Initial Public Offering. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination
of the applicable lock-up period for the
securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters
45-day option
from the final prospectus relating to the Initial Public Offering to purchase up to 3,915,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On November 15, 2021, the underwriters elected to partially exercise the over-allotment option purchasing 3,900,000 units and forfeited the option for the remaining 15,000 Units.
The underwriters were paid a cash underwriting discount of $0.10 per unit on the offering not including the Units issued with the underwriter’s exercise of their over-allotment option, or $3,000,000 in the aggregate at the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred underwriting commissions of $0.35 per unit, or $10,500,000 from the closing of the Initial Public Offering. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes a business combination, subject to the terms of the underwriting agreement.
 
13

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Risks and Uncertainties
Management continues to evaluate the
impact of the COVID-19 pandemic and has
concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.
Note 7 — Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit
Preference Shares
 —The Company is authorized to issue 5,000,000 shares of preference shares with a par value of $0.0001 per shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2022 and December 31, 2021, there were no preference shares issued or outstanding.
Class
 A Ordinary Shares
The Company is authorized to issue 500,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. As of June 30, 2022 and December 31, 2021, there were 30,000,000 shares of Class A ordinary shares outstanding, all of which were classified as temporary equity in the accompanying unaudited condensed balance sheets.
Class
 B Ordinary Shares
The Company is authorized to issue 50,000,000 shares of Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of June 30, 2022 and December 31, 2021, there were 7,500,000 shares of Class B ordinary shares outstanding.
Shareholders of the ordinary shares of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class B ordinary shares will have the right to appoint all of the Company’s directors prior to the consummation of the initial business combination. On any other matter submitted to a vote of the Company’s shareholders, holders of Class B ordinary shares and holders of Class A ordinary shares will vote together as a single class, except as required by applicable law or stock exchange rule.
The shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the initial business
combination on a one-for-one basis, subject to
adjustment. In the case that additional shares of Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Proposed Public Offering and related to the closing of the initial business combination, the ratio at which shares of Class B ordinary shares shall convert into shares of Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding shares of Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A ordinary shares issuable upon conversion of all shares of Class B ordinary shares will equal, in the aggregate, on
an as-converted basis,
approximately 26.0% of the sum of the total number of all shares of ordinary shares outstanding upon the completion of the Proposed Public Offering plus all shares of Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial business combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial business combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal number of shares of Class A ordinary shares, subject to adjustment as provided above, at any time.
 
14

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Note 8 — Warrants
As of June 30, 2022 and December 31, 2021, the Company has 15,000,000 Public Warrants and 11,500,000 Private Placement Warrants outstanding.
Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) the completion of a business combination and (b) 12 months from the closing of the Proposed Public Offering. The Public Warrants will expire five years from the completion of a business combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any shares of ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.
Redemption of warrants when the price per Class A ordinary shares equals or exceeds $18.00:
Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):
 
   
in whole and not in part;
 
   
at a price of $0.01 per warrant;
 
   
upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the
“30-day
redemption period”; and
 
   
if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants— Public Shareholders’ Warrants—Anti-Dilution Adjustments”) for any 20 trading days within a
30-trading day
period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the
30-day redemption
period. If and when the warrants become redeemable by the Company, the Company may exercise their redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Except as set forth below, none of the private placement warrants will be redeemable by the Company so long as they are held by the Company’s sponsor or its permitted transferees.
Redemption of warrants when the price per Class
 A ordinary shares equals or exceeds $10.00:
Once the warrants become exercisable, the Company may call redeem the outstanding warrants:
 
   
in whole and not in part;
 
   
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities— Warrants—Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of Class A ordinary shares (as defined below) except as otherwise described in “Description of Securities—Warrants—Public Shareholders’ Warrants”;
 
15

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
   
if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-dilution Adjustments”) for any 20 trading days within the
30-trading day period
ending three trading days before the Company sends the notice of redemption to the warrant holders; and
 
   
if the closing price of the Class A ordinary shares for any 20 trading days within a
30-trading day
period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. The Company will provide warrant holders with the final fair market value no later than one business day after the 10 trading day period described above ends. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). Any redemption of the warrants for Class A ordinary shares will apply to both the public warrants and the Private Placement Warrants.
No fractional Class A ordinary shares will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder.
If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the shares of ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable for cash or on a cashless basis, at the holder’s
option, and be non-redeemable so long as
they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The exercise price and number of ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or the Company’s recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of shares of ordinary shares at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
In addition, if the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the
 
16

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) 
the
price at which the Company issues the additional shares of ordinary shares or equity-linked securities.
Note 9 — Fair Value Measurements
The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.
As of June 30, 2022
 
Description
  
Quoted Prices in
Active Markets
(Level 1)
    
Significant Other
Observable Inputs
(Level 2)
    
Significant Other
Unobservable Inputs
(Level 3)
 
Assets:
                          
Investments held in Trust Account
   $ 306,566,918      $         $     
Liabilities:
                          
Derivative warrant liabilities - Public Warrant
   $ 1,950,000      $         $     
Derivative warrant liabilities - Private Placement Warrant
   $         $         $ 1,495,000  
As of December 31, 2021
 
Description
  
Quoted Prices in
Active Markets
(Level 1)
    
Significant
Other
Observable
Inputs
(Level 2)
    
Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:
                          
Investments held in Trust Account
   $ 306,016,692      $         $     
       
Liabilities:
                          
Derivative warrant liabilities—Public warrant
   $         $         $ 10,350,000  
Derivative warrant liabilities—Private warrant
   $         $         $ 7,935,000  
 
(1)
Includes $1,577 and $933 in cash as of June 30, 2022 and December 31, 2021, respectively.
Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in January 2022, as the Public Warrants were separately listed and traded in in January 2022.
Level 1 assets include investments in money market funds that invest solely in U.S. government securities and U.S. Treasury Bills. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
The Company utilizes a Monte Carlo simulation model to value the Private Placement Warrants and the Public Warrants prior to being separately listed and traded, with changes in fair value recognized in the accompanying unaudited condensed statements of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares
 
17

ASCENDANT DIGITAL ACQUISITION CORP. III
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the
U.S. Treasury zero-coupon yield curve
on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.
The following table provides quantitative information regarding Level 3 fair value measurements inputs as of June 30, 2022 and December 31, 2021:
 
    
June 30, 2022
   
December 31, 2021
 
Exercise price
   $ 11.50     $ 11.50  
Volatility
     12.80     10.80
Stock price
   $ 10.01     $ 9.81  
Expected term (years)
     5.51       5.86  
Risk-free rate
     2.97     1.33
Dividend yield
     0.00     0.00
Probability of business combination
     10.00     90.00
The change in the fair value of the Level 3 warrant liabilities for the three and six months ended June 30, 2022 is summarized as follow:
 
Derivative warrant liabilities at December 31, 2021 - Level 3
   $ 18,285,000  
Transfer of Public Warrants from Level 3 to level 1
     (10,350,000
Change in fair value of derivative warrant liabilities
     (3,335,000
    
 
 
 
Derivative warrant liabilities at March 31, 2022 - Level 3
   $ 4,600,000  
Change in fair value of derivative warrant liabilities
     (3,105,000
    
 
 
 
Derivative warrant liabilities at June 30, 2022 - Level 3
   $ 1,495,000  
    
 
 
 
Note 10 — Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that th
e un
audited
 
c
ondensed financial statements were issued. Based on this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.
 
18

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References in this Quarterly Report on Form
10-Q
(this “Quarterly Report”) to “we,” “us” or the “Company” refer to Ascendant Digital Acquisition Corp. III References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Ascendant Sponsor LP III. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in
this Form 10-Q including, without
limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
Ascendant Digital Acquisition Corp. III was incorporated in the Cayman Islands on February 19, 2021. We were formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, reorganization or other similar business transaction with one or more businesses that we have not yet identified (a “Business Combination”).
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
As of June 30, 2022, we had not commenced any operations. All activity through June 30, 2022 relates to our formation and the initial public offering (the “IPO”), and since the offering, the search for a prospective initial Business Combination. We will not generate any operating revenues until after the completion of a Business Combination, at the earliest. We
will generate non-operating interest income
from the proceeds held in the Trust Account.
For the three months ended June 30, 2022, we had net income of approximately $7.2 million, which consisted of a gain of approximately $7.2 million from the change in fair value of derivative warrant liabilities, approximately $342,000 in income from investments held in Trust Account and interest income from operating account, which were partially offset by approximately $241,000 in general and administrative expenses and $30,000 of related party administrative fees.
For the six months ended June 30, 2022, we had net income of approximately $14.8 million, which consisted of a gain of approximately $14.8 million from the change in fair value of derivative warrant liabilities, approximately $550,000
 
19

in income from investments held in Trust Account and interest income from operating account, which were partially offset by approximately $512,000 in general and administrative expenses and $60,000 of related party administrative fees.
For the six months ended June 30, 2021 and for the period February 19, 2021 (inception) through to June 30, 2021, we had a net loss of approximately $10,000, which consisted solely of general and administrative expenses.
Capital Resources and Going Concern Consideration
The registration statement for our IPO (the “Registration Statement”) was declared effective on November 10, 2021. On November 15, 2021, we consummated the sale of 26,100,000 units (“Units”) with respect to the Class A ordinary shares included in the Units being offered (the “Public Shares”) at $10.00 per Unit generating gross proceeds of $261,000,000.
Simultaneously with the closing of the IPO, we consummated the sale of 10,330,000 warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to our sponsor, Ascendant Sponsor LP III (the “Sponsor”) generating gross proceeds of $10,330,000.
Additionally with the closing of the IPO, we consummated the closing of the sale of 3,900,000 additional Units upon receiving notice of the underwriter’s election to partially exercise its overallotment option (“Overallotment Units”), generating additional gross proceeds of $39,000,000. Simultaneously with the exercise of the overallotment, we consummated the Private Placement of an additional 1,170,000 Private Placement Warrants to the Sponsor, generating gross proceeds of $1,170,000.
Offering costs for the IPO and the exercise of the underwriters’ over-allotment option amounted to $14,026,631, consisting of $3,000,000 of underwriting fees, $10,500,000 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $526,631 of other costs. The deferred underwriting fee is contingent upon the consummation of a Business Combination by February 15, 2023, subject to the terms of the underwriting agreement. Following the closing of the IPO and partial exercise of the over-allotment, $306,000,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement Warrants was placed in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by us meeting the conditions of paragraphs (d)(2), (d)(3) and
(d)(4) of Rule 2a-7 of the Investment
Company Act, as determined by us, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account.
We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes payable), to complete our Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
In order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors may, but are not obligated to, loan us funds as may be required (“Working Capital Loans”). If we complete a Business Combination, we will repay the Working Capital Loans out of the proceeds of the Trust Account released to us. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, we may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of June 30, 2022 and December 31, 2021, there were no Working Capital Loans outstanding. As of June 30, 2022, we had cash of $665,569 and working capital surplus of $1,334,812. In connection with our assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15,
 
20

“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” our management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after February 15, 2023. The unaudited condensed financial statements do not include any adjustment that might be necessary if we are unable to continue as a going concern.
Off-Balance Sheet
Arrangements
We have no obligations, assets or liabilities, which would
be considered off-balance sheet arrangements
as of June 30, 2022. We do not participate in transactions that create relationships with entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose
of facilitating off-balance sheet arrangements.
We have not entered
into any off-balance sheet financing
arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or
purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities. The underwriters are entitled to a deferred underwriting commissions of $0.35 per unit, or $10,500,000 from the closing of the IPO. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes a Business Combination, subject to the terms of the underwriting agreement.
JOBS Act
On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is
required for non-emerging growth companies.
As such, our unaudited condensed financial statements may not be comparable to companies that comply with public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be
required of non-emerging growth public
companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of executive compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our IPO or until we are no longer an “emerging growth company,” whichever is earlier.
Critical Accounting Policies
The preparation of unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
 
21

Ordinary Shares Subject to Possible Redemption
We account for our ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of our condensed balance sheets. We recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional
paid-in
capital and accumulated deficit.
Net Income (Loss) Per Ordinary Share
We comply with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” We have two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net loss by the weighted average number of ordinary shares outstanding for the respective period.
The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase an aggregate of 26,500,000 Class A ordinary shares in the calculation of diluted income (loss) per ordinary share since their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the three and six months ended June 30, 2022, for the six months ended June 30, 2021 and for the period from February 19, 2021 (inception) through June 30, 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
Recent Accounting Pronouncements
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
As of June 30, 2022, we were not subject to any market or interest rate risk. The net proceeds held in the Trust Account have been invested in U.S. government treasury bills, notes or bonds with a maturity of 185 days or less, or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
Item 4. Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Operating Officer, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As required
by Rules 13a-15 and 15d-15 under the
Exchange Act, our Chief Executive Officer and Chief Operating Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2022. Based upon their evaluation, our Chief Executive Officer and Chief Operating Officer concluded that our disclosure controls and procedures (as defined
in Rules 13a-15 (e)
and 15d-15 (e) under
the Exchange Act) were effective.
 
22

Changes in Internal Control Over Financial Reporting
During the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II-OTHER INFORMATION
 
ITEM 1.
LEGAL PROCEEDINGS
None.
 
ITEM 1A.
RISK FACTORS
Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our Annual Report on Form
10-K
(the “Annual Report”) for the year ended December 31, 2021, filed with the SEC on March 25, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in the Annual Report.
 
ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The securities in the IPO were registered under the Securities Act on a registration statement
on Form S-1 (Registration No. 333-255349). The Registration
Statement
on Form S-1, as amended
(the “Registration Statement”), for the Company’s IPO was declared effective on November 10, 2021. On November 15, 2021, the Company consummated the sale of 26,100,000 units (“Units”) with respect to the Class A ordinary shares included in the Units being offered (the “Public Shares”) at $10.00 per Unit generating gross proceeds of $261,000,000, which is discussed in Note 3.
Simultaneously with the closing of the IPO, the Company consummated the sale of 10,330,000 warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to the Company’s sponsor, Ascendant Sponsor LP III (the “Sponsor”) generating gross proceeds of $10,330,000.
Offering costs for the IPO and the exercise of the underwriters’ over-allotment option amounted to $14,026,631, consisting of $3,000,000 of underwriting fees, $10,500,000 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $526,631 of other costs. As described in Note 6, the $10,500,000 of deferred underwriting fee payable is contingent upon the consummation of a Business Combination by February 15, 2023, subject to the terms of the underwriting agreement.
Additionally with the closing of the IPO, the Company consummated the closing of the sale of 3,900,000 additional Units upon receiving notice of the underwriter’s election to partially exercise its overallotment option (“Overallotment Units”), generating additional gross proceeds of $39,000,000. Simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional 1,170,000 Private Placement Warrants to the Sponsor, generating gross proceeds of $1,170,000.
Following the closing of the IPO and partial exercise of the over-allotment, $306,000,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement Warrants was placed in a trust account (“Trust Account”) and will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and
(d)(4) of Rule 2a-7 of the Investment
Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account.
 
23

For a description of the use of the proceeds generated in our IPO, see Part I, Item 2 of this Quarterly Report.
 
ITEM 3.
DEFAULTS UPON SENIOR SECURITIES
None.
 
ITEM 4.
MINE SAFETY DISCLOSURES
Not applicable.
 
ITEM 5.
OTHER INFORMATION
None.
 
ITEM 6.
EXHIBITS
 
Exhibit
Number
  
Description
  31.1*    Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d) to 14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31.2*    Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d) to 14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32.1**    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  32.2**    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*    Inline XBRL Instance Document
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*    Inline XBRL Taxonomy Extension Extension Labels Linkbase Document
101.PRE*    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104    The cover page from the
Company’s Form 10-Q
for the quarterly period ended June 30, 2022, formatted in Inline XBRL and contained in Exhibit 101
 
*
Filed herewith.
**
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
 
24

SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this
report
to be signed on its behalf by the undersigned, thereunto duly authorized.
August 12, 2022
 
ASCENDANT DIGITAL ACQUISITION CORP. III
By:  
/s/ Mark Gerhard
  Name: Mark Gerhard
  Title: Chief Executive Officer and Director (Principal Executive Officer)
By:  
/s/ Riaan Hodgson
  Name: Riaan Hodgson
  Title: Chief Operating Officer and Director (Principal Financial and Accounting Officer)
 
25
EX-31.1 2 d324890dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark Gerhard, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Ascendant Digital Acquisition Corp. III;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

 

  b)

(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

 

  c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 12, 2022

 

/s/ Mark Gerhard

Mark Gerhard

Chief Executive Officer and Director

(Principal Executive Officer)

EX-31.2 3 d324890dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Riaan Hodgson, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Ascendant Digital Acquisition Corp. III;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

 

  b)

(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

 

  c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 12, 2022

 

/s/ Riaan Hodgson

Riaan Hodgson
Chief Operating Officer and Director
(Principal Financial Officer and Principal Accounting Officer)
EX-32.1 4 d324890dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Ascendant Digital Acquisition Corp. III (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Mark Gerhard, Chief Executive Officer and Director of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

 

  1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2.

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: August 12, 2022

 

/s/ Mark Gerhard

Mark Gerhard
Chief Executive Officer and Director
(Principal Executive Officer)
EX-32.2 5 d324890dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Ascendant Digital Acquisition Corp. III (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Riaan Hodgson, Chief Operating Officer and Director of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

 

  1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2.

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: August 12, 2022

 

/s/ Riaan Hodgson

Riaan Hodgson
Chief Operating Officer and Director
(Principal Financial Officer and Principal Accounting Officer)
EX-101.SCH 6 acdi-20220630.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Description of Organization and Business Operations and Liquidity link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Private Placement Warrants link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Warrants link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Description of Organization and Business Operations and Liquidity - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Summary of Significant Accounting Policies - Summary Of Reconciled Balance Sheet Class A Ordinary Shares (Detail) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Summary of Significant Accounting Policies - Summary Of Basic and Diluted Net Loss Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Initial Public Offering - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Private Placement Warrants - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Warrants - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Fair Value Measurements - Summary of Fair Value Assets and Liabilities Measured on Recurring Basis (Details) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Fair Value Measurements - Summary of Fair Value of the Level 3 Warrant Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 acdi-20220630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 acdi-20220630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 acdi-20220630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 acdi-20220630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover Page - shares
6 Months Ended
Jun. 30, 2022
Aug. 12, 2022
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Amendment Flag false  
Document Period End Date Jun. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q2  
Entity Registrant Name ASCENDANT DIGITAL ACQUISITION CORP. III  
Entity Central Index Key 0001850316  
Entity File Number 001-41036  
Entity Filer Category Non-accelerated Filer  
Entity Tax Identification Number 00-0000000  
Entity Incorporation, State or Country Code E9  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Shell Company true  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Address, Address Line One 667 Madison Avenue  
Entity Address, Address Line Two 5th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10065  
City Area Code 212  
Local Phone Number 209-6126  
Title of 12(b) Security Class A ordinary shares, par value $0.0001 per share  
Trading Symbol ACDI  
Security Exchange Name NYSE  
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant [Member]    
Document Information [Line Items]    
Title of 12(b) Security Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant  
Trading Symbol ACDI.U  
Security Exchange Name NYSE  
Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share [Member]    
Document Information [Line Items]    
Title of 12(b) Security Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share  
Trading Symbol ACDI WS  
Security Exchange Name NYSE  
Common Class A [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   30,000,000
Common Class B [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   7,500,000
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED BALANCE SHEETS - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash $ 516,095 $ 831,432
Prepaid expenses 746,106 970,696
Total current assets 1,262,201 1,802,128
Investments held in Trust Account 306,566,918 306,016,692
Total Assets 307,829,119 307,818,820
Current liabilities:    
Accounts payable 195,612 27,416
Accounts payable - related party   18,898
Accrued expenses 2,586 119,732
Total current liabilities 198,198 166,046
Derivative warrant liabilities 3,445,000 18,285,000
Deferred underwriting commissions 10,500,000 10,500,000
Total liabilities 14,143,198 28,951,046
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value, 30,000,000 shares at redemption value of approximately $10.22 and $10.20 per share as of June 30, 2022 and December 31, 2021, respectively 306,466,918 306,000,000
Shareholders' Deficit:    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding 0 0
Additional paid-in capital 0 0
Accumulated deficit (12,781,747) (27,132,976)
Total shareholders' deficit (12,780,997) (27,132,226)
Total Liabilities, Redeemable Class A Ordinary Shares and Shareholders' Deficit 307,829,119 307,818,820
Common Class A [Member]    
Current liabilities:    
Class A ordinary shares subject to possible redemption, $0.0001 par value, 30,000,000 shares at redemption value of approximately $10.22 and $10.20 per share as of June 30, 2022 and December 31, 2021, respectively 306,466,918 306,000,000
Shareholders' Deficit:    
Common Stock, Value, Issued 0 0
Common Class B [Member]    
Shareholders' Deficit:    
Common Stock, Value, Issued $ 750 $ 750
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares
Jun. 30, 2022
Dec. 31, 2021
Preferred stock par or stated value per share $ 0.0001 $ 0.0001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common Class A [Member]    
Common stock par or stated value per share $ 0.0001 $ 0.0001
Common stock shares authorized 500,000,000 500,000,000
Common stock shares issued 0 0
Common stock shares outstanding 0 0
Temporary equity, par or stated value per share $ 0.0001 $ 0.0001
Temporary equity, shares issued 30,000,000 30,000,000
Temporary equity, redemption price per share $ 10.22 $ 10.2
Common Class B [Member]    
Common stock par or stated value per share $ 0.0001 $ 0.0001
Common stock shares authorized 50,000,000 50,000,000
Common stock shares issued 7,500,000 7,500,000
Common stock shares outstanding 7,500,000 7,500,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 4 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2021
Jun. 30, 2022
General and administrative expenses $ 240,825 $ 10,243 $ 10,243 $ 512,116
Administrative expenses - related party 30,000     60,000
Loss from operations (270,825) (10,243) (10,243) (572,116)
Other income:        
Change in fair value of derivative warrant liabilities 7,155,000   0 14,840,000
Interest income from operating account 16     37
Income from investments held in Trust Account 342,480   0 550,226
Total other income 7,497,496     15,390,263
Net income (loss) 7,226,671 (10,243) $ (10,243) 14,818,147
Common Class A [Member]        
Other income:        
Net income (loss) $ 5,781,337 $ 0   $ 11,854,518
Basic weighted average shares outstanding 30,000,000 0   30,000,000
Diluted weighted average shares outstanding 30,000,000 0   30,000,000
Basic net income per ordinary share $ 0.19 $ 0   $ 0.4
Diluted net income per ordinary share $ 0.19 $ 0   $ 0.4
Common Class B [Member]        
Other income:        
Net income (loss) $ 1,445,334 $ (10,243)   $ 2,963,629
Basic weighted average shares outstanding 7,500,000 6,525,000 6,277,841 7,500,000
Diluted weighted average shares outstanding 7,500,000 6,525,000 6,277,841 7,500,000
Basic net income per ordinary share $ 0.19 $ 0 $ 0 $ 0.4
Diluted net income per ordinary share $ 0.19 $ 0 $ 0 $ 0.4
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)
Total
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Common Class B [Member]
Common Class B [Member]
Common Stock [Member]
Beginning Balance at Feb. 18, 2021 $ 0 $ 0 $ 0   $ 0
Beginning Balance, shares at Feb. 18, 2021         0
Issuance of Class B ordinary shares to Sponsor 25,000 24,250     $ 750
Issuance of Class B ordinary shares to Sponsor, shares         7,503,750
Net income (loss) (10,243)   (10,243)    
Balance Ending at Mar. 31, 2021 14,757 24,250 (10,243)   $ 750
Balance Ending, shares at Mar. 31, 2021         7,503,750
Beginning Balance at Feb. 18, 2021 0 0 0   $ 0
Beginning Balance, shares at Feb. 18, 2021         0
Net income (loss) (10,243)        
Balance Ending at Jun. 30, 2021 14,757 24,250 (10,243)   $ 750
Balance Ending, shares at Jun. 30, 2021         7,503,750
Beginning Balance at Feb. 18, 2021 0 0 0   $ 0
Beginning Balance, shares at Feb. 18, 2021         0
Balance Ending at Dec. 31, 2021 (27,132,226) 0 (27,132,976)   $ 750
Balance Ending, shares at Dec. 31, 2021         7,500,000
Beginning Balance at Mar. 31, 2021 14,757 24,250 (10,243)   $ 750
Beginning Balance, shares at Mar. 31, 2021         7,503,750
Net income (loss) (10,243)     $ (10,243)  
Balance Ending at Jun. 30, 2021 14,757 24,250 (10,243)   $ 750
Balance Ending, shares at Jun. 30, 2021         7,503,750
Beginning Balance at Dec. 31, 2021 (27,132,226) 0 (27,132,976)   $ 750
Beginning Balance, shares at Dec. 31, 2021         7,500,000
Net income (loss) 7,591,476   7,591,476    
Balance Ending at Mar. 31, 2022 (19,540,750) 0 (19,541,500)   $ 750
Balance Ending, shares at Mar. 31, 2022         7,500,000
Beginning Balance at Dec. 31, 2021 (27,132,226) 0 (27,132,976)   $ 750
Beginning Balance, shares at Dec. 31, 2021         7,500,000
Net income (loss) 14,818,147     2,963,629  
Balance Ending at Jun. 30, 2022 (12,780,997) 0 (12,781,747)   $ 750
Balance Ending, shares at Jun. 30, 2022         7,500,000
Beginning Balance at Mar. 31, 2022 (19,540,750) 0 (19,541,500)   $ 750
Beginning Balance, shares at Mar. 31, 2022         7,500,000
Accretion of Class A ordinary shares subject to possible redemption amount (466,918)   (466,918)    
Net income (loss) 7,226,671   7,226,671 $ 1,445,334  
Balance Ending at Jun. 30, 2022 $ (12,780,997) $ 0 $ (12,781,747)   $ 750
Balance Ending, shares at Jun. 30, 2022         7,500,000
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 4 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Cash Flows from Operating Activities:      
Net income (loss) $ 7,226,671 $ (10,243) $ 14,818,147
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
General and administrative expenses paid by related party in exchange for issuance of Class B ordinary shares   10,243 0
Income from investments held in Trust Account (342,480) 0 (550,226)
Change in fair value of derivative warrant liabilities (7,155,000) 0 (14,840,000)
Changes in operating assets and liabilities:      
Prepaid expenses   0 224,590
Accounts payable   0 168,196
Accounts payable - related party   0 (18,898)
Accrued expenses   0 (117,146)
Net cash used in operating activities   0 (315,337)
Net change in cash   0 (315,337)
Cash - beginning of the period     831,432
Cash - end of the period $ 516,095 0 516,095
Supplemental disclosure of noncash investing and financing activities:      
Payment of deferred offering costs by note payable - related party   103,546 0
Deferred offering costs included in accrued expenses   130,420 0
Payment of deferred offering costs by the Sponsor in exchange for the issuance of Class B ordinary shares   $ 14,757 $ 0
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Description of Organization and Business Operations and Liquidity
6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Organization and Business Operations and Liquidity
Note 1 — Description of Organization and Business Operations and Liquidity
Ascendant Digital Acquisition Corp. III (the “Company”) was incorporated in the Cayman Islands on February 19, 2021. The Company is a blank check company formed for the purpose of entering into a business combination.
The Company is not limited to a particular industry or geographic region for purposes of consummating a business combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of June 30, 2022, the Company had not commenced any operations. All activity through June 30, 2022 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below and since the offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business combination, at the earliest. The Company
generates non-operating
interest income from the proceeds held in the Trust Account (as defined below).
The registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective on November 10, 2021. On November 15, 2021, the Company consummated the sale of 26,100,000 units (“Units”) with respect to the Class A ordinary shares included in the Units being offered (the “Public Shares”) at $10.00 per Unit generating gross proceeds of $261,000,000, which is discussed in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 10,330,000 warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to the Company’s sponsor, Ascendant Sponsor LP III (the “Sponsor”) generating gross proceeds of $10,330,000.
Additionally with the closing of the Initial Public Offering, the Company consummated the closing of the sale of 3,900,000 additional Units upon receiving notice of the underwriter’s election to partially exercise its overallotment option (“Overallotment Units”), generating additional gross proceeds of $39,000,000. Since the underwriters only partially exercised their over-allotment option, on November 15, 2021 the Sponsor forfeited 3,750 shares for no consideration. Simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional 1,170,000 Private Placement Warrants to the Sponsor, generating gross proceeds of $1,170,000.
Offering costs for the Initial Public Offering and the exercise of the underwriters’ over-allotment option amounted to $14,172,182, consisting of $3,000,000 of underwriting fees, $10,500,000 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $672,182 of other costs. As described in Note 6, the $10,500,000 of deferred underwriting fee payable is contingent upon the consummation of a business combination by February 15, 2023, subject to the terms of the underwriting agreement.
Following the closing of the Initial Public Offering and partial exercise of the over-allotment, $306,000,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Warrants was placed in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and
(d)(4) of Rule 2a-7 of the Investment
Company Act, as determined by the Company, until the earlier of (i) the completion of a business combination and (ii) the distribution of the Trust Account, as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a business combination. There is no assurance that the Company will be able to complete a business combination successfully. The Company must complete one or more initial business combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting
securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able to successfully effect a Business Combination.
The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially at $10.20 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights with respect to the Company’s warrants.
The per-share amount
to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”).
Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s business combination. If the Company seeks shareholder approval of the business combination, the Company will proceed with a business combination if a majority of the shares voted are voted in favor of the business combination, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of incorporation (the “Charter”), conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a business combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a business combination, the Sponsor agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a business combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.
Notwithstanding the foregoing, the Charter provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.
The Company’s Sponsor, officers, directors and advisory board members (collectively, “Initial Shareholders”) agreed not to propose an amendment to the Charter that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a business combination, unless the Company provides the Public Shareholders with the opportunity to redeem their shares of Class A ordinary shares in conjunction with any such amendment.
If the Company is unable to complete a business combination by February 15, 2023, 15 months from the closing of the Initial Public Offering (“Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public
Shares, at a per-share price, payable in
cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay for its franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
 
The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a business combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a business combination within the Combination Period. The underwriters agreed to waive their rights to its deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a business combination within the Combination Period, and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.20 per shares held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Going Concern Consideration
As of June 30, 2022, the Company had cash of approximately $516,000 and working capital surplus of approximately $1.0 million.
The Company’s liquidity needs up prior to the consummation of the Initial Public Offering had been satisfied through the cash receipt of $25,000 from the Sponsor to cover for certain expenses on behalf of the Company in exchange for issuance of Founder Shares (as defined in Note 5), and loan from the related party of approximately $153,396 under the Note (as defined in Note 5). The Company repaid the Note in full on November 11, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering, over-allotment, and the Private Placement held outside of the Trust Account.
In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of June 30, 2022, there were no amounts outstanding under Working Capital Loan.
In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after February 15, 2023. The unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 2 — Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to
Form 10-Q and
Article 8 of
Regulation S-X and
pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022 or any future period.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on
Form 10-K filed
by the Company with the SEC on March 25, 2022.
Use of Estimates
The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements.
Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.
Emerging Growth Company
The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but
any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2022 and December 31, 2021, the Company had no cash equivalents.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000.
The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such accounts.
Investments Held in the Trust Account
The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income from investments held in the Trust Account in the accompanyin
g unaudited
 
condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 9).
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as
equity, is re-assessed at the end
of each reporting period.
The Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are
classified as non-current liabilities as
their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares sold in the Initial Public Offering and over-allotment feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of June 30, 2022 and December 31, 2021, 30,000,000 Class A ordinary shares subject to possible redemption were presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges
against additional paid-in capital (to
the extent available) and accumulated deficit.
As of June 30, 2022 and December 31, 2021, the shares of Class A ordinary shares reflected on the balance sheet are reconciled on the following table:
 
Gross proceeds from Initial Public Offering
  
$
300,000,000
 
Less:
  
     
Fair value of Public Warrants at issuance
  
 
(9,180,180
Offering costs allocated to Class A ordinary shares subject to possible redemption
  
 
(13,723,591
Plus:
  
     
Accretion on Class A ordinary shares subject to possible redemption amount
  
 
28,903,771
 
 
  
 
 
 
Class A ordinary share subject to possible redemption - December 31, 2021
  
 
306,000,000
 
Plus:
  
     
Increase in redemption value of Class A ordinary shares subject to redemption
  
 
466,918
 
 
  
 
 
 
Class A ordinary shares subject to possible redemption - June 30, 2022
  
$
306,466,918
 
 
  
 
 
 
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of FASB
ASC 340-10-S99-1. Offering
costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to derivative warrant liabilities were expensed as incurred and presented
as non-operating expenses
in th
e unaudited
c
ondensed statements of operations. Offering costs allocated to the Class A ordinary shares issued were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Income Taxes
The Company follows the guidance for accounting for income taxes under FASB ASC 740, “Income Taxes.” FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net loss by the weighted average number of ordinary shares outstanding for the respective period.
The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase an aggregate of 26,500,000 Class A ordinary shares in the calculation of diluted income (loss) per ordinary share since their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the three and six months ended June 30, 2022, for the six months ended June 30, 2021 and for the period from February 19, 2021 (inception) through June 30, 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per ordinary share for each class of ordinary shares:
 
    
For the Three Months Ended June 30, 2022
    
For the Six Months Ended June 30, 2022
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net income per ordinary share:
                                   
Numerator:
                                   
Allocation of net income
   $ 5,781,337      $ 1,445,334      $ 11,854,518      $ 2,963,629  
         
Denominator:
                                   
Basic and diluted weighted average ordinary shares outstanding
     30,000,000        7,500,000        30,000,000        7,500,000  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $ 0.19      $ 0.19      $ 0.40      $ 0.40  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
For the Three Months Ended June 30, 2021
    
For the Six Months Ended June 30, 2021
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net loss per ordinary share:
                                   
Numerator:
                                   
Allocation of net loss
   $ —        $ (10,243    $ —        $ (10,243
         
Denominator:
                                   
Basic and diluted weighted average ordinary shares outstanding
     —          6,525,000        —          6,277,841  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net loss per ordinary share
   $ —        $ (0.00    $ —        $ (0.00
    
 
 
    
 
 
    
 
 
    
 
 
 
Recent Accounting Pronouncements
The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2
Initial Public Offering
6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]  
Initial Public Offering
Note 3 — Initial Public Offering
On November 15, 2021, the Company consummated its Initial Public Offering of 30,000,000 Units, including 3,900,000 units as a result of the partial exercise by the underwriters of their over-allotment option, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $14.2 million, of which approximately $10.5 million was for deferred underwriting commissions.
Each Unit consists of one Class A ordinary
share, and 
one-half
of one redeemable warrant (the “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7).
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Private Placement Warrants
6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]  
Private Placement Warrants
Note 4 — Private Placement Warrants
On November 15, 2021, simultaneously with the consummation of the Initial Public Offering and the underwriters’ partial exercise of their over-allotment option, the Company consummated the issuance and sale (“Private Placement”) of 11,500,000 Private Placement Warrants in a private placement transaction at a price of $10.00 per Placement Unit, generating gross proceeds of $11,500,000. Each whole Private Placement Warrant will be exercisable to purchase one share of Class A ordinary shares at a price of $11.50 per share. A portion of the proceeds from the Private Placement Units will be added to the proceeds from the Proposed Public Offering to be held in the Trust Account. If the Company does not complete a business combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants and all underlying securities will be worthless.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2
Related Party Transactions
6 Months Ended
Jun. 30, 2022
Related Party Transactions [Abstract]  
Related Party Transactions
Note 5 — Related Party Transactions
Founder Shares
On February 24, 2021, the Sponsor purchased an aggregate of 8,625,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.003 per share. On March 23, 2021, the Sponsor surrendered 1,437,500 founder shares to the Company for cancellation for no consideration creating a total of 7,187,500 founder shares to be outstanding. In March 2021, the Sponsor transferred an aggregate of 230,000 founder shares to members of the Company’s board of directors and the Company’s advisory board, resulting in the Sponsor holding 6,957,500 founder shares. On November 9, 2021, the Company effected a share capitalization of 316,250 founder shares, resulting in the Sponsor holding 7,273,750 founder shares (for an aggregate of 7,503,750 founder shares of which up to 978,750 of which were subject to forfeiture if the underwriters’ over-allotment option is not exercised in full). Since the underwriters only partially exercised their over-allotment option, on November 15, 2021 the Sponsor forfeited 3,750 shares for no consideration.
The Founder Shares will automatically convert into shares of Class A ordinary shares at the time of the Company’s initial business combination and are subject to certain transfer restrictions, as described in Note 6. Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal number of shares of Class A ordinary shares, subject to adjustment, at any time.
Related Party Loans
On February 24, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”).
This loan was non-interest bearing and payable
on the earlier of December 31, 2021, or the completion of the Initial Public Offering. The outstanding balance under the Note was repaid at the closing of the Initial Public Offering on November 15, 2021, and the Note was terminated.
In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a business combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a
business combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a business combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into units of the post business combination entity at a price of $1.00 per warrant. The units would be identical to the Private Placement Units. As of June 30, 2022 and December 31, 2021, there were no Working Capital Loans outstanding.
Administrative Services Agreement
On November 9, 2021, the Company entered into an agreement with the Sponsor, pursuant to which the Company agreed to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative services provided to the Company until the earlier of the consummation of a Business Combination or liquidation. The Company incurred $30,000 and $60,000 in connection with such fees during the three and six months ended June 30, 2022, respectively, included within the general and administrative fees in the accompanying unaudited condensed statements of operations.
In addition, the Sponsor, officers and directors, and any of their respective affiliates will be reimbursed for
any out-of-pocket expenses
incurred in connection with activities on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable business combinations. The audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, officers or directors, or the Company’s or their affiliates. Any such payments prior to an initial business combination will be made from funds held outside the Trust Account.
Due to Related Party
During the period from February 19, 2021 (inception) through December 31, 2021, the Company’s Sponsor paid approximately $19,000 of expenses on behalf of the Company. As of December 31, 2021, outstanding balance for such expenses was approximately $19,000, included in due to related party in current liabilities, on the accompanying condensed balance sheet. Such fees were settled during in March 2022.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 6 — Commitments and Contingencies
Registration Rights
The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A ordinary shares) pursuant to a registration rights agreement to be signed on or before the date of the prospectus for the Initial Public Offering. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination
of the applicable lock-up period for the
securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters
a 45-day option
from the final prospectus relating to the Initial Public Offering to purchase up to 3,915,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On November 15, 2021, the underwriters elected to partially exercise the over-allotment option purchasing 3,900,000 units and forfeited the option for the remaining 15,000 Units.
The underwriters were paid a cash underwriting discount of $0.10 per unit on the offering not including the Units issued with the underwriter’s exercise of their over-allotment option, or $3,000,000 in the aggregate at the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred underwriting commissions of $0.35 per unit, or $10,500,000 from the closing of the Initial Public Offering. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes a business combination, subject to the terms of the underwriting agreement.
 
Risks and Uncertainties
Management continues to evaluate the
impact of the COVID-19 pandemic and has
concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2
Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit
6 Months Ended
Jun. 30, 2022
Temporary Equity And Stockholders Equity Note [Abstract]  
Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit
Note 7 — Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit
Preference Shares
 —The Company is authorized to issue 5,000,000 shares of preference shares with a par value of $0.0001 per shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2022 and December 31, 2021, there were no preference shares issued or outstanding.
Class
 A Ordinary Shares
The Company is authorized to issue 500,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. As of June 30, 2022 and December 31, 2021, there were 30,000,000 shares of Class A ordinary shares outstanding, all of which were classified as temporary equity in the accompanying unaudited condensed balance sheets.
Class
 B Ordinary Shares
The Company is authorized to issue 50,000,000 shares of Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of June 30, 2022 and December 31, 2021, there were 7,500,000 shares of Class B ordinary shares outstanding.
Shareholders of the ordinary shares of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class B ordinary shares will have the right to appoint all of the Company’s directors prior to the consummation of the initial business combination. On any other matter submitted to a vote of the Company’s shareholders, holders of Class B ordinary shares and holders of Class A ordinary shares will vote together as a single class, except as required by applicable law or stock exchange rule.
The shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the initial business
combination on a one-for-one basis, subject to
adjustment. In the case that additional shares of Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Proposed Public Offering and related to the closing of the initial business combination, the ratio at which shares of Class B ordinary shares shall convert into shares of Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding shares of Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A ordinary shares issuable upon conversion of all shares of Class B ordinary shares will equal, in the aggregate, on
an as-converted basis,
approximately 26.0% of the sum of the total number of all shares of ordinary shares outstanding upon the completion of the Proposed Public Offering plus all shares of Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial business combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial business combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal number of shares of Class A ordinary shares, subject to adjustment as provided above, at any time.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2
Warrants
6 Months Ended
Jun. 30, 2022
Warrants and Rights Note Disclosure [Abstract]  
Warrants
Note 8 — Warrants
As of June 30, 2022 and December 31, 2021, the Company has 15,000,000 Public Warrants and 11,500,000 Private Placement Warrants outstanding.
Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) the completion of a business combination and (b) 12 months from the closing of the Proposed Public Offering. The Public Warrants will expire five years from the completion of a business combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any shares of ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.
Redemption of warrants when the price per Class A ordinary shares equals or exceeds $18.00:
Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):
 
   
in whole and not in part;
 
   
at a price of $0.01 per warrant;
 
   
upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the
“30-day
redemption period”; and
 
   
if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants— Public Shareholders’ Warrants—Anti-Dilution Adjustments”) for any 20 trading days within a
30-trading day
period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the
30-day redemption
period. If and when the warrants become redeemable by the Company, the Company may exercise their redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Except as set forth below, none of the private placement warrants will be redeemable by the Company so long as they are held by the Company’s sponsor or its permitted transferees.
Redemption of warrants when the price per Class
 A ordinary shares equals or exceeds $10.00:
Once the warrants become exercisable, the Company may call redeem the outstanding warrants:
 
   
in whole and not in part;
 
   
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities— Warrants—Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of Class A ordinary shares (as defined below) except as otherwise described in “Description of Securities—Warrants—Public Shareholders’ Warrants”;
 
   
if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-dilution Adjustments”) for any 20 trading days within the
30-trading day period
ending three trading days before the Company sends the notice of redemption to the warrant holders; and
 
   
if the closing price of the Class A ordinary shares for any 20 trading days within a
30-trading day
period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. The Company will provide warrant holders with the final fair market value no later than one business day after the 10 trading day period described above ends. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). Any redemption of the warrants for Class A ordinary shares will apply to both the public warrants and the Private Placement Warrants.
No fractional Class A ordinary shares will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder.
If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the shares of ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable for cash or on a cashless basis, at the holder’s
option, and be non-redeemable so long as
they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
The exercise price and number of ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or the Company’s recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of shares of ordinary shares at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
In addition, if the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the
volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) 
the
price at which the Company issues the additional shares of ordinary shares or equity-linked securities.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
Note 9 — Fair Value Measurements
The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.
As of June 30, 2022
 
Description
  
Quoted Prices in
Active Markets
(Level 1)
    
Significant Other
Observable Inputs
(Level 2)
    
Significant Other
Unobservable Inputs
(Level 3)
 
Assets:
                          
Investments held in Trust Account
   $ 306,566,918      $ —        $ —    
Liabilities:
                          
Derivative warrant liabilities - Public Warrant
   $ 1,950,000      $ —        $ —    
Derivative warrant liabilities - Private Placement Warrant
   $ —        $ —        $ 1,495,000  
As of December 31, 2021
 
Description
  
Quoted Prices in
Active Markets
(Level 1)
    
Significant
Other
Observable
Inputs
(Level 2)
    
Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:
                          
Investments held in Trust Account
   $ 306,016,692      $ —        $ —    
       
Liabilities:
                          
Derivative warrant liabilities—Public warrant
   $ —        $ —        $ 10,350,000  
Derivative warrant liabilities—Private warrant
   $ —        $ —        $ 7,935,000  
 
(1)
Includes $1,577 and $933 in cash as of June 30, 2022 and December 31, 2021, respectively.
Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in January 2022, as the Public Warrants were separately listed and traded in in January 2022.
Level 1 assets include investments in money market funds that invest solely in U.S. government securities and U.S. Treasury Bills. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.
The Company utilizes a Monte Carlo simulation model to value the Private Placement Warrants and the Public Warrants prior to being separately listed and traded, with changes in fair value recognized in the accompanying unaudited condensed statements of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares
 
 
based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the
U.S. Treasury zero-coupon yield curve
on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.
The following table provides quantitative information regarding Level 3 fair value measurements inputs as of June 30, 2022 and December 31, 2021:
 
    
June 30, 2022
   
December 31, 2021
 
Exercise price
   $ 11.50     $ 11.50  
Volatility
     12.80     10.80
Stock price
   $ 10.01     $ 9.81  
Expected term (years)
     5.51       5.86  
Risk-free rate
     2.97     1.33
Dividend yield
     0.00     0.00
Probability of business combination
     10.00     90.00
The change in the fair value of the Level 3 warrant liabilities for the three and six months ended June 30, 2022 is summarized as follow:
 
Derivative warrant liabilities at December 31, 2021 - Level 3
   $ 18,285,000  
Transfer of Public Warrants from Level 3 to level 1
     (10,350,000
Change in fair value of derivative warrant liabilities
     (3,335,000
    
 
 
 
Derivative warrant liabilities at March 31, 2022 - Level 3
   $ 4,600,000  
Change in fair value of derivative warrant liabilities
     (3,105,000
    
 
 
 
Derivative warrant liabilities at June 30, 2022 - Level 3
   $ 1,495,000  
    
 
 
 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2
Subsequent Events
6 Months Ended
Jun. 30, 2022
Subsequent Events [Abstract]  
Subsequent Events
Note 10 — Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that th
e un
audited
 
c
ondensed financial statements were issued. Based on this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to
Form 10-Q and
Article 8 of
Regulation S-X and
pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022 or any future period.
The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on
Form 10-K filed
by the Company with the SEC on March 25, 2022.
Use of Estimates
Use of Estimates
The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements.
Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.
Emerging Growth Company
Emerging Growth Company
The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but
any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2022 and December 31, 2021, the Company had no cash equivalents.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000.
The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such accounts.
Investments Held in the Trust Account
Investments Held in the Trust Account
The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income from investments held in the Trust Account in the accompanyin
g unaudited
 
condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 9).
Fair Value Measurements
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
   
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
   
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
   
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments
Derivative Financial Instruments
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as
equity, is re-assessed at the end
of each reporting period.
The Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are
classified as non-current liabilities as
their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Class A Ordinary shares subject to Possible Redemption
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares sold in the Initial Public Offering and over-allotment feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of June 30, 2022 and December 31, 2021, 30,000,000 Class A ordinary shares subject to possible redemption were presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges
against additional paid-in capital (to
the extent available) and accumulated deficit.
As of June 30, 2022 and December 31, 2021, the shares of Class A ordinary shares reflected on the balance sheet are reconciled on the following table:
 
Gross proceeds from Initial Public Offering
  
$
300,000,000
 
Less:
  
     
Fair value of Public Warrants at issuance
  
 
(9,180,180
Offering costs allocated to Class A ordinary shares subject to possible redemption
  
 
(13,723,591
Plus:
  
     
Accretion on Class A ordinary shares subject to possible redemption amount
  
 
28,903,771
 
 
  
 
 
 
Class A ordinary share subject to possible redemption - December 31, 2021
  
 
306,000,000
 
Plus:
  
     
Increase in redemption value of Class A ordinary shares subject to redemption
  
 
466,918
 
 
  
 
 
 
Class A ordinary shares subject to possible redemption - June 30, 2022
  
$
306,466,918
 
 
  
 
 
 
Offering Costs Associated with the Initial Public Offering
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of FASB
ASC 340-10-S99-1. Offering
costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to derivative warrant liabilities were expensed as incurred and presented
as non-operating expenses
in th
e unaudited
c
ondensed statements of operations. Offering costs allocated to the Class A ordinary shares issued were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as
non-current
liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Income Taxes
Income Taxes
The Company follows the guidance for accounting for income taxes under FASB ASC 740, “Income Taxes.” FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) Per Ordinary Share
Net Income (Loss) Per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net loss by the weighted average number of ordinary shares outstanding for the respective period.
The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase an aggregate of 26,500,000 Class A ordinary shares in the calculation of diluted income (loss) per ordinary share since their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the three and six months ended June 30, 2022, for the six months ended June 30, 2021 and for the period from February 19, 2021 (inception) through June 30, 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per ordinary share for each class of ordinary shares:
 
    
For the Three Months Ended June 30, 2022
    
For the Six Months Ended June 30, 2022
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net income per ordinary share:
                                   
Numerator:
                                   
Allocation of net income
   $ 5,781,337      $ 1,445,334      $ 11,854,518      $ 2,963,629  
         
Denominator:
                                   
Basic and diluted weighted average ordinary shares outstanding
     30,000,000        7,500,000        30,000,000        7,500,000  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $ 0.19      $ 0.19      $ 0.40      $ 0.40  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
For the Three Months Ended June 30, 2021
    
For the Six Months Ended June 30, 2021
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net loss per ordinary share:
                                   
Numerator:
                                   
Allocation of net loss
   $ —        $ (10,243    $ —        $ (10,243
         
Denominator:
                                   
Basic and diluted weighted average ordinary shares outstanding
     —          6,525,000        —          6,277,841  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net loss per ordinary share
   $ —        $ (0.00    $ —        $ (0.00
    
 
 
    
 
 
    
 
 
    
 
 
 
Recent Accounting Pronouncements
Recent Accounting Pronouncements
The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2022
Temporary Equity Disclosure [Abstract]  
Summary Of Reconciled Balance Sheet Class A Ordinary Shares
As of June 30, 2022 and December 31, 2021, the shares of Class A ordinary shares reflected on the balance sheet are reconciled on the following table:
 
Gross proceeds from Initial Public Offering
  
$
300,000,000
 
Less:
  
     
Fair value of Public Warrants at issuance
  
 
(9,180,180
Offering costs allocated to Class A ordinary shares subject to possible redemption
  
 
(13,723,591
Plus:
  
     
Accretion on Class A ordinary shares subject to possible redemption amount
  
 
28,903,771
 
 
  
 
 
 
Class A ordinary share subject to possible redemption - December 31, 2021
  
 
306,000,000
 
Plus:
  
     
Increase in redemption value of Class A ordinary shares subject to redemption
  
 
466,918
 
 
  
 
 
 
Class A ordinary shares subject to possible redemption - June 30, 2022
  
$
306,466,918
 
 
  
 
 
 
Summary Of Basic and Diluted Net Loss Per Share
The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per ordinary share for each class of ordinary shares:
 
    
For the Three Months Ended June 30, 2022
    
For the Six Months Ended June 30, 2022
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net income per ordinary share:
                                   
Numerator:
                                   
Allocation of net income
   $ 5,781,337      $ 1,445,334      $ 11,854,518      $ 2,963,629  
         
Denominator:
                                   
Basic and diluted weighted average ordinary shares outstanding
     30,000,000        7,500,000        30,000,000        7,500,000  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net income per ordinary share
   $ 0.19      $ 0.19      $ 0.40      $ 0.40  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
For the Three Months Ended June 30, 2021
    
For the Six Months Ended June 30, 2021
 
    
Class A
    
Class B
    
Class A
    
Class B
 
Basic and diluted net loss per ordinary share:
                                   
Numerator:
                                   
Allocation of net loss
   $ —        $ (10,243    $ —        $ (10,243
         
Denominator:
                                   
Basic and diluted weighted average ordinary shares outstanding
     —          6,525,000        —          6,277,841  
    
 
 
    
 
 
    
 
 
    
 
 
 
Basic and diluted net loss per ordinary share
   $ —        $ (0.00    $ —        $ (0.00
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Summary of Fair Value Assets and Liabilities Measured on Recurring Basis
The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.
As of June 30, 2022
 
Description
  
Quoted Prices in
Active Markets
(Level 1)
    
Significant Other
Observable Inputs
(Level 2)
    
Significant Other
Unobservable Inputs
(Level 3)
 
Assets:
                          
Investments held in Trust Account
   $ 306,566,918      $ —        $ —    
Liabilities:
                          
Derivative warrant liabilities - Public Warrant
   $ 1,950,000      $ —        $ —    
Derivative warrant liabilities - Private Placement Warrant
   $ —        $ —        $ 1,495,000  
As of December 31, 2021
 
Description
  
Quoted Prices in
Active Markets
(Level 1)
    
Significant
Other
Observable
Inputs
(Level 2)
    
Significant
Other
Unobservable
Inputs
(Level 3)
 
Assets:
                          
Investments held in Trust Account
   $ 306,016,692      $ —        $ —    
       
Liabilities:
                          
Derivative warrant liabilities—Public warrant
   $ —        $ —        $ 10,350,000  
Derivative warrant liabilities—Private warrant
   $ —        $ —        $ 7,935,000  
(1)
Includes $1,577 and $933 in cash as of June 30, 2022 and December 31, 2021, respectively.
Summary of Quantitative Information Regarding Level 3 Fair Value Measurements
The following table provides quantitative information regarding Level 3 fair value measurements inputs as of June 30, 2022 and December 31, 2021:
 
    
June 30, 2022
   
December 31, 2021
 
Exercise price
   $ 11.50     $ 11.50  
Volatility
     12.80     10.80
Stock price
   $ 10.01     $ 9.81  
Expected term (years)
     5.51       5.86  
Risk-free rate
     2.97     1.33
Dividend yield
     0.00     0.00
Probability of business combination
     10.00     90.00
Summary of Fair Value of the Level 3 Warrant Liabilities
The change in the fair value of the Level 3 warrant liabilities for the three and six months ended June 30, 2022 is summarized as follow:
 
Derivative warrant liabilities at December 31, 2021 - Level 3
   $ 18,285,000  
Transfer of Public Warrants from Level 3 to level 1
     (10,350,000
Change in fair value of derivative warrant liabilities
     (3,335,000
    
 
 
 
Derivative warrant liabilities at March 31, 2022 - Level 3
   $ 4,600,000  
Change in fair value of derivative warrant liabilities
     (3,105,000
    
 
 
 
Derivative warrant liabilities at June 30, 2022 - Level 3
   $ 1,495,000  
    
 
 
 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2
Description of Organization and Business Operations and Liquidity - Additional Information (Detail) - USD ($)
1 Months Ended 6 Months Ended 10 Months Ended
Nov. 15, 2021
Nov. 09, 2021
Mar. 31, 2021
Jun. 30, 2022
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from issuance initial public offering $ 300,000,000        
Stock issued during period, value, new issues     $ 25,000    
Sale of stock, price per share       $ 10.2  
Restricted Investments Term       180 days  
Percentage of public shares to be redeemed on non completion of business combination       100.00%  
Dissolution expense       $ 100,000  
Minimum share price of the residual assets remaining available for distribution       $ 10.2  
Cash       $ 516,095 $ 831,432
Net Working Capital       1,000,000  
Due To Related Parties, Current         19,000
Working Capital Loan [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Due To Related Parties, Current       0 0
Founder Shares [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Shares issued, shares, share-based payment arrangement, forfeited   978,750      
Sponsor [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Repayments of Related Party Debt       153,396  
Sponsor [Member] | Founder Shares [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Stock issued during period, value, new issues       $ 25,000  
Shares issued, shares, share-based payment arrangement, forfeited 3,750        
Minimum [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Percentage of fair market value of target business to asset held in trust account       80.00%  
Percentage of redeeming shares of public shares without the companies prior written consent       15.00%  
Minimum [Member] | Post Transaction [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Percentage of voting interests acquired       50.00%  
Private Placement Warrants [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Class of warrants and rights issued during the period 11,500,000        
Class of warrants and rights issued, price per warrant $ 10        
Proceeds from issuance of private placement $ 11,500,000        
IPO [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Stock issued during period, shares, new issues 30,000,000        
Share price $ 10        
Offering costs       $ 14,172,182  
Underwriting expense paid | $       3,000,000  
Deferred underwriting fees payable       10,500,000  
Other offering costs       672,182  
Payments to acquire restricted investments       $ 306,000,000  
IPO [Member] | Private Placement Warrants [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Class of warrants and rights issued during the period 10,330,000        
Class of warrants and rights issued, price per warrant $ 1        
Proceeds from issuance of private placement $ 10,330,000        
Over-Allotment Option [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Stock issued during period, shares, new issues 3,900,000        
Stock issued during period, value, new issues $ 39,000,000        
Shares issued, shares, share-based payment arrangement, forfeited 3,750        
Over-Allotment Option [Member] | Private Placement Warrants [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Class of warrants and rights issued during the period 1,170,000        
Proceeds from issuance of private placement $ 1,170,000        
Common Class A [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from issuance initial public offering         $ 300,000,000
Common Class A [Member] | IPO [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Stock issued during period, shares, new issues 26,100,000        
Share price $ 10        
Proceeds from issuance initial public offering $ 261,000,000        
Public Shares [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Share price       $ 10.2  
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
6 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Cash equivalents $ 0 $ 0
FDIC Insured Amount 250,000  
Unrecognized tax benefits 0  
Accrued for interest and penalties $ 0  
Term of Restricted Investments 185 days  
Common Class A [Member]    
Temporary Equity, Shares Issued 30,000,000 30,000,000
Common Class A [Member] | Initial Public Offer And Private Placement [Member]    
Antidilutive securities excluded from computation of earnings per share, amount 26,500,000  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies - Summary Of Reconciled Balance Sheet Class A Ordinary Shares (Detail) - USD ($)
3 Months Ended 6 Months Ended 10 Months Ended
Nov. 15, 2021
Jun. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Redeemable Noncontrolling Interest [Line Items]        
Gross proceeds from Initial Public Offering $ 300,000,000      
Accretion on Class A ordinary shares subject to possible redemption amount   $ 466,918    
Class A ordinary share subject to possible redemption   306,466,918 $ 306,466,918 $ 306,000,000
Common Class A [Member]        
Redeemable Noncontrolling Interest [Line Items]        
Gross proceeds from Initial Public Offering       300,000,000
Fair value of Public Warrants at issuance       (9,180,180)
Offering costs allocated to Class A ordinary shares subject to possible redemption       (13,723,591)
Accretion on Class A ordinary shares subject to possible redemption amount       28,903,771
Increase in redemption value of Class A ordinary shares subject to redemption     466,918  
Class A ordinary share subject to possible redemption   $ 306,466,918 $ 306,466,918 $ 306,000,000
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies - Summary Of Basic and Diluted Net Loss Per Share (Details) - USD ($)
1 Months Ended 3 Months Ended 4 Months Ended 6 Months Ended
Mar. 31, 2021
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Numerator:              
Allocation of net income (loss) $ (10,243) $ 7,226,671 $ 7,591,476 $ (10,243) $ (10,243) $ 14,818,147  
Common Class A [Member]              
Numerator:              
Allocation of net income (loss)   $ 5,781,337   $ 0   $ 11,854,518 $ 0
Denominator:              
Basic weighted average shares outstanding   30,000,000   0   30,000,000 0
Diluted weighted average shares outstanding   30,000,000   0   30,000,000 0
Basic net income (loss) per ordinary share   $ 0.19   $ 0   $ 0.4 $ 0
Diluted net income (loss) per ordinary share   $ 0.19   $ 0   $ 0.4 $ 0
Common Class B [Member]              
Numerator:              
Allocation of net income (loss)   $ 1,445,334   $ (10,243)   $ 2,963,629 $ (10,243)
Denominator:              
Basic weighted average shares outstanding   7,500,000   6,525,000 6,277,841 7,500,000 6,277,841
Diluted weighted average shares outstanding   7,500,000   6,525,000 6,277,841 7,500,000 6,277,841
Basic net income (loss) per ordinary share   $ 0.19   $ 0 $ 0 $ 0.4 $ 0
Diluted net income (loss) per ordinary share   $ 0.19   $ 0 $ 0 $ 0.4 $ 0
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Initial Public Offering - Additional Information (Detail) - USD ($)
10 Months Ended
Nov. 15, 2021
Dec. 31, 2021
Jun. 30, 2022
Class of Stock [Line Items]      
Proceeds from issuance initial public offering $ 300,000,000    
Deferred underwriting commissions   $ 10,500,000 $ 10,500,000
Public Warrants [Member]      
Class of Stock [Line Items]      
Exercise price of warrant $ 11.5    
warrants issuable 1    
Common Class A [Member]      
Class of Stock [Line Items]      
Stock conversion basis one-half of one redeemable warrant    
Shares issued 1    
Proceeds from issuance initial public offering   $ 300,000,000  
IPO [Member]      
Class of Stock [Line Items]      
Stock issued during period, shares, new issues 30,000,000    
Share price $ 10    
IPO [Member] | Common Class A [Member]      
Class of Stock [Line Items]      
Stock issued during period, shares, new issues 26,100,000    
Share price $ 10    
Proceeds from issuance initial public offering $ 261,000,000    
Over-Allotment Option [Member]      
Class of Stock [Line Items]      
Stock issued during period, shares, new issues 3,900,000    
Expense Related to Distribution or Servicing and Underwriting Fees $ 14,200,000    
Deferred underwriting commissions $ 10,500,000    
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2
Private Placement Warrants - Additional Information (Detail) - Private Placement Warrants [Member]
Nov. 15, 2021
USD ($)
$ / shares
shares
Class of Stock [Line Items]  
Class of warrants and rights issued during the period | shares 11,500,000
Class of warrants and rights issued, price per warrant $ 10
Proceeds from issuance of private placement | $ $ 11,500,000
Exercise price of warrant $ 11.5
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2
Related Party Transactions - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 10 Months Ended
Nov. 15, 2021
Nov. 09, 2021
Mar. 31, 2021
Mar. 23, 2021
Feb. 24, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Related Party Transaction [Line Items]                  
Stock issued during period, value, new issues           $ 25,000      
Due to Related Parties Current                 $ 19,000
Related Party Transaction, Expenses from Transactions with Related Party                 19,000
Working Capital Loan [Member]                  
Related Party Transaction [Line Items]                  
Debt Instrument Convertible Into Warrants             $ 1,500,000 $ 1,500,000  
Debt Instrument Conversion Price             $ 1 $ 1  
Due to Related Parties Current             $ 0 $ 0 $ 0
Administrative Services [Member]                  
Related Party Transaction [Line Items]                  
RelatedPartyTransaction, SellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty             $ 30,000 $ 60,000  
Sponsor [Member] | Office Space, Administrative and Support Services [Member]                  
Related Party Transaction [Line Items]                  
Related Party Transaction, Amounts of Transaction   $ 10,000              
Sponsor [Member] | Promissory Note [Member] | Related Party Loans [Member]                  
Related Party Transaction [Line Items]                  
Debt Instrument, Face Amount         $ 300,000        
Debt Instrument Interest Rate             0.00% 0.00%  
Founder Shares [Member]                  
Related Party Transaction [Line Items]                  
Number of shares forfeited during the period.   978,750              
Capitalization of Shares   316,250              
Founder Shares [Member] | Sponsor [Member]                  
Related Party Transaction [Line Items]                  
Stock issued during period, value, new issues               $ 25,000  
Number of shares forfeited during the period. 3,750                
Founder Shares [Member] | Sponsor [Member] | Director [Member]                  
Related Party Transaction [Line Items]                  
Stock issued during period, shares, new issues     230,000            
Number of shares forfeited during the period.     6,957,500            
Common Class B [Member] | Founder Shares [Member] | Sponsor [Member]                  
Related Party Transaction [Line Items]                  
Stock issued during period, shares, new issues         8,625,000        
Stock issued during period, value, new issues         $ 25,000        
Stock Issued During Period, Shares, Other       1,437,500          
Temporary equity shares outstanding       7,187,500          
Minimum [Member] | Sponsor [Member]                  
Related Party Transaction [Line Items]                  
Temporary equity shares outstanding   7,273,750              
Maximum [Member] | Founder Shares [Member]                  
Related Party Transaction [Line Items]                  
Temporary equity shares outstanding   7,503,750              
Maximum [Member] | Common Class B [Member] | Founder Shares [Member] | Sponsor [Member]                  
Related Party Transaction [Line Items]                  
Shares Issued, Price Per Share         $ 0.003        
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2
Commitments and Contingencies - Additional Information (Detail) - USD ($)
6 Months Ended
Nov. 15, 2021
Jun. 30, 2022
Other Commitments [Line Items]    
Aggregate Cash Underwriting Discount $ 3,000,000  
Deferred Underwriting Commissions $ 10,500,000  
Over-Allotment Option [Member]    
Other Commitments [Line Items]    
Stock Issued During Period, Shares, New Issues 3,900,000  
Over-Allotment Option [Member] | Underwriting Agreement [Member]    
Other Commitments [Line Items]    
Number Of Days Granted For Exercising The Option   45 days
Common Stock, Shares Subscribed but Unissued   3,915,000
Stock Issued During Period, Shares, New Issues 3,900,000  
Stock Forfeited During The Period Shares 15,000  
IPO [Member]    
Other Commitments [Line Items]    
Stock Issued During Period, Shares, New Issues 30,000,000  
IPO [Member] | Underwriting Agreement [Member]    
Other Commitments [Line Items]    
Cash Underwriting Discount Per Unit $ 0.1  
Deferred Underwriting Commissions Per Unit $ 0.35  
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2
Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit - Additional Information (Detail) - $ / shares
6 Months Ended
Nov. 15, 2021
Jun. 30, 2022
Dec. 31, 2021
Class of Stock [Line Items]      
Preferred stock par or stated value per share   $ 0.0001 $ 0.0001
Preferred stock shares authorized   5,000,000 5,000,000
Preferred stock shares issued   0 0
Preferred stock shares outstanding   0 0
Common Class A [Member]      
Class of Stock [Line Items]      
Common stock par or stated value per share   $ 0.0001 $ 0.0001
Common stock shares authorized   500,000,000 500,000,000
Common stock shares outstanding   0 0
Common Stock, Conversion Basis one-half of one redeemable warrant    
Common Class A [Member] | Common Stock [Member]      
Class of Stock [Line Items]      
Common stock shares outstanding   30,000,000 30,000,000
Common Class B [Member]      
Class of Stock [Line Items]      
Common stock par or stated value per share   $ 0.0001 $ 0.0001
Common stock shares authorized   50,000,000 50,000,000
Common stock shares outstanding   7,500,000 7,500,000
Common stock shares voting rights   one vote  
Common Class B [Member] | Common Stock [Member]      
Class of Stock [Line Items]      
Common stock shares outstanding   7,500,000 7,500,000
Common Class B [Member] | Conversion of Class B to Class A Common Stock [Member]      
Class of Stock [Line Items]      
Common Stock, Conversion Basis   one-for-one  
Percentage Of Common Stock Issued And Outstanding   26.00%  
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2
Warrants - Additional Information (Detail) - $ / shares
6 Months Ended 10 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Nov. 15, 2021
Redemption of Warrants [Member] | Common Class A [Member]      
Class of Warrant or Right [Line Items]      
Trading day period to calculate volume weighted average trading price following notice of redemption 10 days 10 days  
Number of shares issued upon exercise of warrant 0.361    
Public Warrants [Member]      
Class of Warrant or Right [Line Items]      
Class of warrant or right, outstanding 15,000,000 15,000,000  
Period to exercise warrants after closing of proposed public offering 12 months    
Warrants and rights outstanding term 5 years    
Number of shares issued upon exercise of warrant     1
Public Warrants [Member] | Common Class A [Member]      
Class of Warrant or Right [Line Items]      
Threshold trading days 20 days    
Threshold issue price for capital raising purpose in connection with closing of business combination $ 9.2    
Percentage of gross proceeds on total equity proceeds 60.00%    
Volume weighted average price per share $ 9.2    
Adjusted exercise price of warrants percentage 115.00%    
Public Warrants [Member] | Redemption Of Warrants When Class A Equals or Exceeds Eighteen Dollars [Member]      
Class of Warrant or Right [Line Items]      
Notice period to redeem warrants 30 days    
Warrant redemption price (in dollars per share) $ 0.01    
Public Warrants [Member] | Redemption Of Warrants When Class A Equals or Exceeds Eighteen Dollars [Member] | Common Class A [Member]      
Class of Warrant or Right [Line Items]      
Share price (in dollars per share) $ 18    
Threshold trading days 20 days    
Threshold consecutive trading days 30 days    
Public Warrants [Member] | Redemption Of Warrants When Class A Equals or Exceeds Ten Dollars [Member]      
Class of Warrant or Right [Line Items]      
Notice period to redeem warrants 30 days    
Warrant redemption price (in dollars per share) $ 0.1    
Public Warrants [Member] | Redemption Of Warrants When Class A Equals or Exceeds Ten Dollars [Member] | Common Class A [Member]      
Class of Warrant or Right [Line Items]      
Share price (in dollars per share) $ 10    
Threshold trading days 20 days    
Threshold consecutive trading days 30 days    
Private Placement Warrants [Member]      
Class of Warrant or Right [Line Items]      
Class of warrant or right, outstanding 11,500,000 11,500,000  
Private Placement Warrants [Member] | Redemption Of Warrants When Class A Equals or Exceeds Ten Dollars [Member] | Common Class A [Member]      
Class of Warrant or Right [Line Items]      
Share price (in dollars per share) $ 18    
Threshold trading days 20 days    
Threshold consecutive trading days 30 days    
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements - Additional Information (Detail) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Cash [Member] | Level 1 [Member] | Fair Value Measurements Recurring [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Investments, Fair Value Disclosure $ 1,577 $ 933
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements - Summary of Fair Value Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value Measurements Recurring [Member] - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Level 1 [Member]    
Assets:    
Investments held in Trust Account $ 306,566,918 $ 306,016,692
Level 1 [Member] | Warrant Liabilities [Member] | Public Warrants [Member]    
Liabilities:    
Derivative warrant liabilities 1,950,000 0
Level 1 [Member] | Warrant Liabilities [Member] | Private warrant [Member]    
Liabilities:    
Derivative warrant liabilities 0 0
Level 2 [Member]    
Assets:    
Investments held in Trust Account 0 0
Level 2 [Member] | Warrant Liabilities [Member] | Public Warrants [Member]    
Liabilities:    
Derivative warrant liabilities 0 0
Level 2 [Member] | Warrant Liabilities [Member] | Private warrant [Member]    
Liabilities:    
Derivative warrant liabilities 0 0
Level 3 [Member]    
Assets:    
Investments held in Trust Account 0 0
Level 3 [Member] | Warrant Liabilities [Member] | Public Warrants [Member]    
Liabilities:    
Derivative warrant liabilities 0 10,350,000
Level 3 [Member] | Warrant Liabilities [Member] | Private warrant [Member]    
Liabilities:    
Derivative warrant liabilities $ 1,495,000 $ 7,935,000
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements (Details) - Fair Value, Inputs, Level 3 [Member]
6 Months Ended 10 Months Ended
Jun. 30, 2022
$ / shares
Dec. 31, 2021
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Exercise price $ 11.5 $ 11.5
Volatility 12.80% 10.80%
Stock price $ 10.01 $ 9.81
Expected team 5 years 6 months 3 days 5 years 10 months 9 days
Risk-free rate 2.97% 1.33%
Dividend yield 0.00% 0.00%
Probability of business combination 10 90
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements - Summary of Fair Value of the Level 3 Warrant Liabilities (Detail) - USD ($)
3 Months Ended 4 Months Ended 6 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Jun. 30, 2022
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]        
Beginning Balance   $ 18,285,000   $ 18,285,000
Change in fair value of derivative warrant liabilities $ (7,155,000)   $ 0 (14,840,000)
Ending balance 3,445,000     3,445,000
Fair Value, Inputs, Level 3 [Member]        
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]        
Beginning Balance 4,600,000 18,285,000   18,285,000
Transfer of Public Warrants   (10,350,000)    
Change in fair value of derivative warrant liabilities (3,105,000) (3,335,000)    
Ending balance $ 1,495,000 $ 4,600,000   $ 1,495,000
XML 44 d324890d10q_htm.xml IDEA: XBRL DOCUMENT 0001850316 2022-01-01 2022-06-30 0001850316 2022-06-30 0001850316 2021-12-31 0001850316 2021-04-01 2021-06-30 0001850316 2022-04-01 2022-06-30 0001850316 2021-02-19 2021-06-30 0001850316 2021-02-19 2021-03-31 0001850316 2022-01-01 2022-03-31 0001850316 2021-11-15 0001850316 2021-11-15 2021-11-15 0001850316 2021-02-19 2021-12-31 0001850316 2021-02-18 0001850316 2022-03-31 0001850316 2021-03-31 0001850316 2021-06-30 0001850316 acdi:PublicSharesMember 2022-06-30 0001850316 us-gaap:IPOMember 2022-06-30 0001850316 srt:MinimumMember 2022-06-30 0001850316 srt:MinimumMember acdi:PostTransactionMember 2022-06-30 0001850316 us-gaap:CommonClassBMember 2022-06-30 0001850316 us-gaap:CommonClassAMember 2022-06-30 0001850316 acdi:PromissoryNoteMember acdi:RelatedPartyLoansMember acdi:SponsorMember 2022-06-30 0001850316 acdi:WorkingCapitalLoanMember 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember 2022-06-30 0001850316 acdi:PublicWarrantsMember 2022-06-30 0001850316 acdi:PublicWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsEighteenDollarsMember us-gaap:CommonClassAMember 2022-06-30 0001850316 acdi:PublicWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember us-gaap:CommonClassAMember 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember us-gaap:CommonClassAMember 2022-06-30 0001850316 acdi:RedemptionOfWarrantsMember us-gaap:CommonClassAMember 2022-06-30 0001850316 acdi:PublicWarrantsMember us-gaap:CommonClassAMember 2022-06-30 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001850316 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-06-30 0001850316 acdi:ConversionOfClassBToClassACommonStockMember us-gaap:CommonClassBMember 2022-06-30 0001850316 us-gaap:OverAllotmentOptionMember acdi:UnderwritingAgreementMember 2022-06-30 0001850316 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 acdi:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 acdi:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 acdi:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001850316 us-gaap:CashMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001850316 acdi:PublicWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsEighteenDollarsMember 2022-06-30 0001850316 acdi:PublicWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember 2022-06-30 0001850316 us-gaap:CommonClassBMember 2021-12-31 0001850316 us-gaap:CommonClassAMember 2021-12-31 0001850316 acdi:WorkingCapitalLoanMember 2021-12-31 0001850316 acdi:PublicWarrantsMember 2021-12-31 0001850316 acdi:PrivatePlacementWarrantsMember 2021-12-31 0001850316 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001850316 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001850316 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001850316 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001850316 acdi:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001850316 acdi:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel1Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001850316 acdi:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel2Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001850316 acdi:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001850316 acdi:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001850316 acdi:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member acdi:WarrantLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001850316 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001850316 us-gaap:CashMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001850316 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001850316 us-gaap:FairValueInputsLevel3Member 2022-04-01 2022-06-30 0001850316 acdi:AdministrativeServicesMember 2022-04-01 2022-06-30 0001850316 us-gaap:CommonClassBMember 2022-04-01 2022-06-30 0001850316 us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0001850316 us-gaap:CommonClassBMember 2021-04-01 2021-06-30 0001850316 us-gaap:CommonClassAMember 2021-04-01 2021-06-30 0001850316 us-gaap:CapitalUnitsMember 2022-01-01 2022-06-30 0001850316 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001850316 acdi:SponsorMember acdi:FounderSharesMember 2022-01-01 2022-06-30 0001850316 us-gaap:IPOMember 2022-01-01 2022-06-30 0001850316 us-gaap:CommonClassAMember acdi:InitialPublicOfferAndPrivatePlacementMember 2022-01-01 2022-06-30 0001850316 acdi:PublicWarrantsMember 2022-01-01 2022-06-30 0001850316 acdi:PublicWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsEighteenDollarsMember 2022-01-01 2022-06-30 0001850316 acdi:PublicWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember 2022-01-01 2022-06-30 0001850316 acdi:PublicWarrantsMember us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001850316 acdi:PublicWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsEighteenDollarsMember us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001850316 acdi:PublicWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001850316 acdi:PrivatePlacementWarrantsMember acdi:RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001850316 acdi:RedemptionOfWarrantsMember us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001850316 us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001850316 acdi:ConversionOfClassBToClassACommonStockMember us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001850316 us-gaap:OverAllotmentOptionMember acdi:UnderwritingAgreementMember 2022-01-01 2022-06-30 0001850316 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-06-30 0001850316 acdi:AdministrativeServicesMember 2022-01-01 2022-06-30 0001850316 acdi:SponsorMember 2022-01-01 2022-06-30 0001850316 us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001850316 us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001850316 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001850316 us-gaap:CommonClassBMember 2021-02-19 2021-06-30 0001850316 us-gaap:OverAllotmentOptionMember 2021-11-15 2021-11-15 0001850316 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-11-15 2021-11-15 0001850316 acdi:PrivatePlacementWarrantsMember us-gaap:OverAllotmentOptionMember 2021-11-15 2021-11-15 0001850316 acdi:PrivatePlacementWarrantsMember us-gaap:IPOMember 2021-11-15 2021-11-15 0001850316 us-gaap:IPOMember 2021-11-15 2021-11-15 0001850316 us-gaap:CommonClassAMember 2021-11-15 2021-11-15 0001850316 acdi:PrivatePlacementWarrantsMember 2021-11-15 2021-11-15 0001850316 acdi:SponsorMember acdi:FounderSharesMember 2021-11-15 2021-11-15 0001850316 us-gaap:OverAllotmentOptionMember acdi:UnderwritingAgreementMember 2021-11-15 2021-11-15 0001850316 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-11-15 0001850316 us-gaap:IPOMember 2021-11-15 0001850316 acdi:PublicWarrantsMember 2021-11-15 0001850316 us-gaap:CommonClassAMember 2021-11-15 0001850316 acdi:PrivatePlacementWarrantsMember 2021-11-15 0001850316 us-gaap:IPOMember acdi:UnderwritingAgreementMember 2021-11-15 0001850316 us-gaap:OverAllotmentOptionMember 2021-11-15 0001850316 acdi:SponsorMember us-gaap:CommonClassBMember acdi:FounderSharesMember 2021-02-24 2021-02-24 0001850316 srt:MaximumMember acdi:SponsorMember us-gaap:CommonClassBMember acdi:FounderSharesMember 2021-02-24 0001850316 acdi:PromissoryNoteMember acdi:RelatedPartyLoansMember acdi:SponsorMember 2021-02-24 0001850316 acdi:SponsorMember us-gaap:CommonClassBMember acdi:FounderSharesMember 2021-03-23 2021-03-23 0001850316 acdi:SponsorMember us-gaap:CommonClassBMember acdi:FounderSharesMember 2021-03-23 0001850316 srt:DirectorMember acdi:SponsorMember acdi:FounderSharesMember 2021-03-31 2021-03-31 0001850316 acdi:FounderSharesMember 2021-11-09 2021-11-09 0001850316 acdi:OfficeSpaceAdministrativeAndSupportServicesMember acdi:SponsorMember 2021-11-09 2021-11-09 0001850316 srt:MaximumMember acdi:FounderSharesMember 2021-11-09 0001850316 srt:MinimumMember acdi:SponsorMember 2021-11-09 0001850316 acdi:RedemptionOfWarrantsMember us-gaap:CommonClassAMember 2021-02-19 2021-12-31 0001850316 us-gaap:FairValueInputsLevel3Member 2021-02-19 2021-12-31 0001850316 us-gaap:CommonClassAMember 2021-02-19 2021-12-31 0001850316 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001850316 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-03-31 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-02-19 2021-03-31 0001850316 us-gaap:AdditionalPaidInCapitalMember 2021-02-19 2021-03-31 0001850316 us-gaap:RetainedEarningsMember 2021-02-19 2021-03-31 0001850316 us-gaap:CommonClassAMember 2022-08-12 0001850316 us-gaap:CommonClassBMember 2022-08-12 0001850316 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001850316 us-gaap:RetainedEarningsMember 2022-06-30 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001850316 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001850316 us-gaap:RetainedEarningsMember 2021-06-30 0001850316 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001850316 us-gaap:RetainedEarningsMember 2021-12-31 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001850316 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001850316 us-gaap:RetainedEarningsMember 2022-03-31 0001850316 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-02-18 0001850316 us-gaap:AdditionalPaidInCapitalMember 2021-02-18 0001850316 us-gaap:RetainedEarningsMember 2021-02-18 0001850316 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001850316 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001850316 us-gaap:RetainedEarningsMember 2021-03-31 shares iso4217:USD utr:Day pure utr:Month utr:Year iso4217:USD shares false Q2 0001850316 00-0000000 --12-31 NY 10-Q true 2022-06-30 2022 false 001-41036 ASCENDANT DIGITAL ACQUISITION CORP. III E9 667 Madison Avenue 5th Floor New York 10065 212 209-6126 Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant ACDI.U NYSE Class A ordinary shares, par value $0.0001 per share ACDI NYSE Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share ACDI WS NYSE Yes Yes Non-accelerated Filer true true false true 30000000 7500000 516095 831432 746106 970696 1262201 1802128 306566918 306016692 307829119 307818820 195612 27416 18898 2586 119732 198198 166046 3445000 18285000 10500000 10500000 14143198 28951046 0.0001 0.0001 30000000 30000000 10.22 10.2 306466918 306000000 0.0001 0.0001 5000000 5000000 0 0 0 0 0 0 0.0001 0.0001 500000000 500000000 0 0 0 0 0 0 0.0001 0.0001 50000000 50000000 7500000 7500000 7500000 7500000 750 750 0 0 -12781747 -27132976 -12780997 -27132226 307829119 307818820 240825 10243 512116 10243 30000 60000 -270825 -10243 -572116 -10243 -7155000 -14840000 16 37 342480 550226 -7497496 -15390263 7226671 -10243 14818147 -10243 30000000 30000000 30000000 30000000 0.19 0.19 0.4 0.4 7500000 7500000 6525000 6525000 7500000 7500000 6277841 6277841 0.19 0.19 0 0 0.4 0.4 0 0 7500000 750 0 -27132976 -27132226 7591476 7591476 7500000 750 0 -19541500 -19540750 466918 466918 7226671 7226671 7500000 750 0 -12781747 -12780997 0 0 0 0 0 7503750 750 24250 25000 -10243 -10243 7503750 750 24250 -10243 14757 7503750 750 24250 -10243 14757 14818147 -10243 0 10243 550226 0 -14840000 0 -224590 0 168196 0 -18898 0 -117146 0 -315337 0 -315337 0 831432 516095 0 0 103546 0 130420 0 14757 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 1 — Description of Organization and Business Operations and Liquidity </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ascendant Digital Acquisition Corp. III (the “Company”) was incorporated in the Cayman Islands on February 19, 2021. The Company is a blank check company formed for the purpose of entering into a business combination. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is not limited to a particular industry or geographic region for purposes of consummating a business combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of June 30, 2022, the Company had not commenced any operations. All activity through June 30, 2022 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below and since the offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business combination, at the earliest. The Company <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">generates non-operating</div> interest income from the proceeds held in the Trust Account (as defined below). </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective on November 10, 2021. On November 15, 2021, the Company consummated the sale of 26,100,000 units (“Units”) with respect to the Class A ordinary shares included in the Units being offered (the “Public Shares”) at $10.00 per Unit generating gross proceeds of $261,000,000, which is discussed in Note 3. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 10,330,000 warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to the Company’s sponsor, Ascendant Sponsor LP III (the “Sponsor”) generating gross proceeds of $10,330,000. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additionally with the closing of the Initial Public Offering, the Company consummated the closing of the sale of 3,900,000 additional Units upon receiving notice of the underwriter’s election to partially exercise its overallotment option (“Overallotment Units”), generating additional gross proceeds of $39,000,000. Since the underwriters only partially exercised their over-allotment option, on November 15, 2021 the Sponsor forfeited 3,750 shares for no consideration. Simultaneously with the exercise of the overallotment, the Company consummated the Private Placement of an additional 1,170,000 Private Placement Warrants to the Sponsor, generating gross proceeds of $1,170,000. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering costs for the Initial Public Offering and the exercise of the underwriters’ over-allotment option amounted to $14,172,182, consisting of $3,000,000 of underwriting fees, $10,500,000 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $672,182 of other costs. As described in Note 6, the $10,500,000 of deferred underwriting fee payable is contingent upon the consummation of a business combination by February 15, 2023, subject to the terms of the underwriting agreement. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Following the closing of the Initial Public Offering and partial exercise of the over-allotment, $306,000,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Warrants was placed in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(d)(4) of Rule 2a-7 of the Investment</div> Company Act, as determined by the Company, until the earlier of (i) the completion of a business combination and (ii) the distribution of the Trust Account, as described below. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a business combination. There is no assurance that the Company will be able to complete a business combination successfully. The Company must complete one or more initial business combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able to successfully effect a Business Combination. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially at $10.20 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights with respect to the Company’s warrants. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">The per-share amount</div> to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s business combination. If the Company seeks shareholder approval of the business combination, the Company will proceed with a business combination if a majority of the shares voted are voted in favor of the business combination, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of incorporation (the “Charter”), conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a business combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a business combination, the Sponsor agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a business combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Notwithstanding the foregoing, the Charter provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s Sponsor, officers, directors and advisory board members (collectively, “Initial Shareholders”) agreed not to propose an amendment to the Charter that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a business combination, unless the Company provides the Public Shareholders with the opportunity to redeem their shares of Class A ordinary shares in conjunction with any such amendment. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">If the Company is unable to complete a business combination by February 15, 2023, 15 months from the closing of the Initial Public Offering (“Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Shares, at a per-share price, payable in</div> cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay for its franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a business combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a business combination within the Combination Period. The underwriters agreed to waive their rights to its deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a business combination within the Combination Period, and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.20 per shares held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Going Concern Consideration </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2022, the Company had cash of approximately $516,000 and working capital surplus of approximately $1.0 million. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s liquidity needs up prior to the consummation of the Initial Public Offering had been satisfied through the cash receipt of $25,000 from the Sponsor to cover for certain expenses on behalf of the Company in exchange for issuance of Founder Shares (as defined in Note 5), and loan from the related party of approximately $153,396 under the Note (as defined in Note 5). The Company repaid the Note in full on November 11, 2021. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering, over-allotment, and the Private Placement held outside of the Trust Account. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of June 30, 2022, there were no amounts outstanding under Working Capital Loan. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2014-15,</div> “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after February 15, 2023. The unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. </div> 26100000 10 261000000 10330000 1 10330000 3900000 39000000 3750 1170000 1170000 14172182 3000000 10500000 672182 10500000 306000000 10.2 P180D 0.80 0.50 10.2 0.15 1 100000 10.2 516000 1000000 25000 153396 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 2 — Summary of Significant Accounting Policies </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 10-Q and</div> Article 8 of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Regulation S-X and</div> pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022 or any future period. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 10-K filed</div> by the Company with the SEC on March 25, 2022. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging Growth Company </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">that apply to non-emerging growth companies but</div> any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2022 and December 31, 2021, the Company had no cash equivalents. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000.</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such accounts.</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments Held in the Trust Account </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income from investments held in the Trust Account in the accompanyin<div style="display:inline;">g unaudited<div style="display:inline;"> </div></div>condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 9). </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Financial Instruments </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">equity, is re-assessed at the end</div> of each reporting period. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">classified as non-current liabilities as</div> their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A Ordinary Shares Subject to Possible Redemption </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares sold in the Initial Public Offering and over-allotment feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of June 30, 2022 and December 31, 2021, 30,000,000 Class A ordinary shares subject to possible redemption were presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">against additional paid-in capital (to</div> the extent available) and accumulated deficit. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2022 and December 31, 2021, the shares of Class A ordinary shares reflected on the balance sheet are reconciled on the following table: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross proceeds from Initial Public Offering</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">300,000,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value of Public Warrants at issuance</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(9,180,180</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering costs allocated to Class A ordinary shares subject to possible redemption</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(13,723,591</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion on Class A ordinary shares subject to possible redemption amount</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">28,903,771</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary share subject to possible redemption - December 31, 2021</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">306,000,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Increase in redemption value of Class A ordinary shares subject to redemption</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">466,918</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption - June 30, 2022</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">306,466,918</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Offering Costs Associated with the Initial Public Offering </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company complies with the requirements of FASB <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC 340-10-S99-1. Offering</div></div></div> costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to derivative warrant liabilities were expensed as incurred and presented <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as non-operating expenses</div> in th<div style="display:inline;">e unaudited <div style="display:inline;">c</div></div>ondensed statements of operations. Offering costs allocated to the Class A ordinary shares issued were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company follows the guidance for accounting for income taxes under FASB ASC 740, “Income Taxes.” FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Income (Loss) Per Ordinary Share </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net loss by the weighted average number of ordinary shares outstanding for the respective period. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase an aggregate of 26,500,000 Class A ordinary shares in the calculation of diluted income (loss) per ordinary share since their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the three and six months ended June 30, 2022, for the six months ended June 30, 2021 and for the period from February 19, 2021 (inception) through June 30, 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per ordinary share for each class of ordinary shares: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months Ended June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,781,337</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,445,334</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,854,518</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,963,629</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average ordinary shares outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,500,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,500,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.19</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.19</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.40</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.40</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 51%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended June 30, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months Ended June 30, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net loss per ordinary share:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net loss</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,243</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,243</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average ordinary shares outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,525,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,277,841</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net loss per ordinary share</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 10-Q and</div> Article 8 of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Regulation S-X and</div> pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected through December 31, 2022 or any future period. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 10-K filed</div> by the Company with the SEC on March 25, 2022. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging Growth Company </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">that apply to non-emerging growth companies but</div> any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of June 30, 2022 and December 31, 2021, the Company had no cash equivalents. </div></div> 0 0 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000.</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such accounts.</div></div> 250000 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments Held in the Trust Account </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income from investments held in the Trust Account in the accompanyin<div style="display:inline;">g unaudited<div style="display:inline;"> </div></div>condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. </div></div> P185D <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equals or approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for the derivative warrant liabilities (see Note 9). </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Financial Instruments </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">equity, is re-assessed at the end</div> of each reporting period. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">classified as non-current liabilities as</div> their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class A Ordinary Shares Subject to Possible Redemption </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Shares of Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares sold in the Initial Public Offering and over-allotment feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of June 30, 2022 and December 31, 2021, 30,000,000 Class A ordinary shares subject to possible redemption were presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">against additional paid-in capital (to</div> the extent available) and accumulated deficit. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2022 and December 31, 2021, the shares of Class A ordinary shares reflected on the balance sheet are reconciled on the following table: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross proceeds from Initial Public Offering</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">300,000,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value of Public Warrants at issuance</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(9,180,180</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering costs allocated to Class A ordinary shares subject to possible redemption</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(13,723,591</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion on Class A ordinary shares subject to possible redemption amount</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">28,903,771</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary share subject to possible redemption - December 31, 2021</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">306,000,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Increase in redemption value of Class A ordinary shares subject to redemption</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">466,918</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption - June 30, 2022</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">306,466,918</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> 30000000 30000000 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2022 and December 31, 2021, the shares of Class A ordinary shares reflected on the balance sheet are reconciled on the following table: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross proceeds from Initial Public Offering</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">300,000,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less:</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value of Public Warrants at issuance</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(9,180,180</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering costs allocated to Class A ordinary shares subject to possible redemption</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(13,723,591</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accretion on Class A ordinary shares subject to possible redemption amount</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">28,903,771</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary share subject to possible redemption - December 31, 2021</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">306,000,000</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Plus:</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Increase in redemption value of Class A ordinary shares subject to redemption</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">466,918</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A ordinary shares subject to possible redemption - June 30, 2022</div></div></div> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">306,466,918</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> </td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> 300000000 9180180 13723591 28903771 306000000 466918 306466918 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Offering Costs Associated with the Initial Public Offering </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company complies with the requirements of FASB <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC 340-10-S99-1. Offering</div></div></div> costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Upon completion of the Initial Public Offering, offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to derivative warrant liabilities were expensed as incurred and presented <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as non-operating expenses</div> in th<div style="display:inline;">e unaudited <div style="display:inline;">c</div></div>ondensed statements of operations. Offering costs allocated to the Class A ordinary shares issued were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company follows the guidance for accounting for income taxes under FASB ASC 740, “Income Taxes.” FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div></div> 0 0 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Income (Loss) Per Ordinary Share </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per ordinary share is calculated by dividing the net loss by the weighted average number of ordinary shares outstanding for the respective period. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering and the Private Placement Warrants to purchase an aggregate of 26,500,000 Class A ordinary shares in the calculation of diluted income (loss) per ordinary share since their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the three and six months ended June 30, 2022, for the six months ended June 30, 2021 and for the period from February 19, 2021 (inception) through June 30, 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per ordinary share for each class of ordinary shares: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months Ended June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,781,337</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,445,334</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,854,518</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,963,629</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average ordinary shares outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,500,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,500,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.19</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.19</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.40</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.40</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 51%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended June 30, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months Ended June 30, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net loss per ordinary share:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net loss</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,243</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,243</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average ordinary shares outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,525,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,277,841</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net loss per ordinary share</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 26500000 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per ordinary share for each class of ordinary shares: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months Ended June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net income</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,781,337</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,445,334</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,854,518</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,963,629</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average ordinary shares outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,500,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,500,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.19</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.19</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.40</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.40</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 51%;"/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 7%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 8%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended June 30, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months Ended June 30, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class A</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class B</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net loss per ordinary share:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocation of net loss</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,243</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,243</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average ordinary shares outstanding</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,525,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,277,841</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net loss per ordinary share</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 5781337 1445334 11854518 2963629 30000000 30000000 7500000 7500000 30000000 30000000 7500000 7500000 0.19 0.19 0.19 0.19 0.4 0.4 0.4 0.4 0 -10243 0 -10243 0 0 6525000 6525000 0 0 6277841 6277841 0 0 0 0 0 0 0 0 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 3 — Initial Public Offering </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On November 15, 2021, the Company consummated its Initial Public Offering of 30,000,000 Units, including 3,900,000 units as a result of the partial exercise by the underwriters of their over-allotment option, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $14.2 million, of which approximately $10.5 million was for deferred underwriting commissions. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Each Unit consists of one Class A ordinary <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">share, and </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-half</div> of one redeemable warrant (the “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7). </div> 30000000 3900000 10 300000000 14200000 10500000 one-half of one redeemable warrant 1 1 11.5 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 4 — Private Placement Warrants </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On November 15, 2021, simultaneously with the consummation of the Initial Public Offering and the underwriters’ partial exercise of their over-allotment option, the Company consummated the issuance and sale (“Private Placement”) of 11,500,000 Private Placement Warrants in a private placement transaction at a price of $10.00 per Placement Unit, generating gross proceeds of $11,500,000. Each whole Private Placement Warrant will be exercisable to purchase one share of Class A ordinary shares at a price of $11.50 per share. A portion of the proceeds from the Private Placement Units will be added to the proceeds from the Proposed Public Offering to be held in the Trust Account. If the Company does not complete a business combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants and all underlying securities will be worthless. </div></div> 11500000 10 11500000 11.5 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 5 — Related Party Transactions </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Founder Shares </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 24, 2021, the Sponsor purchased an aggregate of 8,625,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.003 per share. On March 23, 2021, the Sponsor surrendered 1,437,500 founder shares to the Company for cancellation for no consideration creating a total of 7,187,500 founder shares to be outstanding. In March 2021, the Sponsor transferred an aggregate of 230,000 founder shares to members of the Company’s board of directors and the Company’s advisory board, resulting in the Sponsor holding 6,957,500 founder shares. On November 9, 2021, the Company effected a share capitalization of 316,250 founder shares, resulting in the Sponsor holding 7,273,750 founder shares (for an aggregate of 7,503,750 founder shares of which up to 978,750 of which were subject to forfeiture if the underwriters’ over-allotment option is not exercised in full). Since the underwriters only partially exercised their over-allotment option, on November 15, 2021 the Sponsor forfeited 3,750 shares for no consideration. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Founder Shares will automatically convert into shares of Class A ordinary shares at the time of the Company’s initial business combination and are subject to certain transfer restrictions, as described in Note 6. Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal number of shares of Class A ordinary shares, subject to adjustment, at any time. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Related Party Loans </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On February 24, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">This loan was non-interest bearing and payable</div> on the earlier of December 31, 2021, or the completion of the Initial Public Offering. The outstanding balance under the Note was repaid at the closing of the Initial Public Offering on November 15, 2021, and the Note was terminated. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a business combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">business combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a business combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into units of the post business combination entity at a price of $1.00 per warrant. The units would be identical to the Private Placement Units. As of June 30, 2022 and December 31, 2021, there were no Working Capital Loans outstanding. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Administrative Services Agreement </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On November 9, 2021, the Company entered into an agreement with the Sponsor, pursuant to which the Company agreed to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative services provided to the Company until the earlier of the consummation of a Business Combination or liquidation. The Company incurred $30,000 and $60,000 in connection with such fees during the three and six months ended June 30, 2022, respectively, included within the general and administrative fees in the accompanying unaudited condensed statements of operations. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In addition, the Sponsor, officers and directors, and any of their respective affiliates will be reimbursed for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">any out-of-pocket expenses</div></div> incurred in connection with activities on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable business combinations. The audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, officers or directors, or the Company’s or their affiliates. Any such payments prior to an initial business combination will be made from funds held outside the Trust Account. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Due to Related Party </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the period from February 19, 2021 (inception) through December 31, 2021, the Company’s Sponsor paid approximately $19,000 of expenses on behalf of the Company. As of December 31, 2021, outstanding balance for such expenses was approximately $19,000, included in due to related party in current liabilities, on the accompanying condensed balance sheet. Such fees were settled during in March 2022. </div></div> 8625000 25000 0.003 1437500 7187500 230000 6957500 316250 7273750 7503750 978750 3750 300000 0 1500000 1 0 0 10000 30000 60000 19000 19000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 6 — Commitments and Contingencies </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Registration Rights </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to shares of Class A ordinary shares) pursuant to a registration rights agreement to be signed on or before the date of the prospectus for the Initial Public Offering. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of the applicable lock-up period for the</div> securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Underwriting Agreement </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company granted the underwriters <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a 45-day option</div> from the final prospectus relating to the Initial Public Offering to purchase up to 3,915,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On November 15, 2021, the underwriters elected to partially exercise the over-allotment option purchasing 3,900,000 units and forfeited the option for the remaining 15,000 Units. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The underwriters were paid a cash underwriting discount of $0.10 per unit on the offering not including the Units issued with the underwriter’s exercise of their over-allotment option, or $3,000,000 in the aggregate at the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred underwriting commissions of $0.35 per unit, or $10,500,000 from the closing of the Initial Public Offering. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes a business combination, subject to the terms of the underwriting agreement. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risks and Uncertainties </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Management continues to evaluate the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">impact of the COVID-19 pandemic and has</div> concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements. </div></div> P45D 3915000 3900000 15000 0.1 3000000 0.35 10500000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 7 — Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preference Shares</div></div></div></div> —The Company is authorized to issue 5,000,000 shares of preference shares with a par value of $0.0001 per shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2022 and December 31, 2021, there were no preference shares issued or outstanding. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A Ordinary Shares</div></div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">—</div></div>The Company is authorized to issue 500,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. As of June 30, 2022 and December 31, 2021, there were 30,000,000 shares of Class A ordinary shares outstanding, all of which were classified as temporary equity in the accompanying unaudited condensed balance sheets. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> B Ordinary Shares</div></div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">—</div></div>The Company is authorized to issue 50,000,000 shares of Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of June 30, 2022 and December 31, 2021, there were 7,500,000 shares of Class B ordinary shares outstanding. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shareholders of the ordinary shares of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class B ordinary shares will have the right to appoint all of the Company’s directors prior to the consummation of the initial business combination. On any other matter submitted to a vote of the Company’s shareholders, holders of Class B ordinary shares and holders of Class A ordinary shares will vote together as a single class, except as required by applicable law or stock exchange rule. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The shares of Class B ordinary shares will automatically convert into shares of Class A ordinary shares at the time of the initial business <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">combination on a one-for-one basis, subject to</div></div> adjustment. In the case that additional shares of Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Proposed Public Offering and related to the closing of the initial business combination, the ratio at which shares of Class B ordinary shares shall convert into shares of Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding shares of Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A ordinary shares issuable upon conversion of all shares of Class B ordinary shares will equal, in the aggregate, on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">an as-converted basis,</div> approximately 26.0% of the sum of the total number of all shares of ordinary shares outstanding upon the completion of the Proposed Public Offering plus all shares of Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial business combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial business combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal number of shares of Class A ordinary shares, subject to adjustment as provided above, at any time. </div> 5000000 5000000 0.0001 0.0001 0 0 0 0 500000000 500000000 0.0001 0.0001 30000000 30000000 50000000 50000000 0.0001 0.0001 one vote 7500000 7500000 one-for-one 0.26 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 8 — Warrants </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2022 and December 31, 2021, the Company has 15,000,000 Public Warrants and 11,500,000 Private Placement Warrants outstanding. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) the completion of a business combination and (b) 12 months from the closing of the Proposed Public Offering. The Public Warrants will expire five years from the completion of a business combination or earlier upon redemption or liquidation. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will not be obligated to deliver any shares of ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of warrants when the price per Class A ordinary shares equals or exceeds $18.00:</div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.01 per warrant; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“30-day</div> redemption period”; and </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants— Public Shareholders’ Warrants—Anti-Dilution Adjustments”) for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading day</div> period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day redemption</div> period. If and when the warrants become redeemable by the Company, the Company may exercise their redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Except as set forth below, none of the private placement warrants will be redeemable by the Company so long as they are held by the Company’s sponsor or its permitted transferees. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of warrants when the price per Class</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A ordinary shares equals or exceeds $10.00:</div></div> Once the warrants become exercisable, the Company may call redeem the outstanding warrants: </div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities— Warrants—Public Shareholders’ Warrants” based on the redemption date and the “fair market value” of Class A ordinary shares (as defined below) except as otherwise described in “Description of Securities—Warrants—Public Shareholders’ Warrants”; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-dilution Adjustments”) for any 20 trading days within the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading day period</div> ending three trading days before the Company sends the notice of redemption to the warrant holders; and </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 5%;"> </td> <td style="width: 3%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if the closing price of the Class A ordinary shares for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading day</div> period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants—Public Shareholders’ Warrants—Anti-dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. The Company will provide warrant holders with the final fair market value no later than one business day after the 10 trading day period described above ends. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). Any redemption of the warrants for Class A ordinary shares will apply to both the public warrants and the Private Placement Warrants. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">No fractional Class A ordinary shares will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the shares of ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable for cash or on a cashless basis, at the holder’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">option, and be non-redeemable so long as</div> they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The exercise price and number of ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or the Company’s recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of shares of ordinary shares at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, if the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">volume weighted average trading price of the Company’s ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) <div style="letter-spacing: 0px; top: 0px;;display:inline;">the </div>price at which the Company issues the additional shares of ordinary shares or equity-linked securities. </div></div> 15000000 15000000 11500000 11500000 P12M P5Y 0.01 P30D 18 P20D P30D 0.1 P30D 10 P20D P30D P20D P30D 18 P10D P10D 0.361 9.2 0.60 P20D 9.2 1.15 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 9 — Fair Value Measurements </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2022 </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/> Active Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Observable Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Unobservable Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">306,566,918</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Public Warrant</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,950,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Private Placement Warrant</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,495,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2021 </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 64%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/> Active Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">306,016,692</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities—Public warrant</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,350,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities—Private warrant</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,935,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes $1,577 and $933 in cash as of June 30, 2022 and December 31, 2021, respectively. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in January 2022, as the Public Warrants were separately listed and traded in in January 2022. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1 assets include investments in money market funds that invest solely in U.S. government securities and U.S. Treasury Bills. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company utilizes a Monte Carlo simulation model to value the Private Placement Warrants and the Public Warrants prior to being separately listed and traded, with changes in fair value recognized in the accompanying unaudited condensed statements of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">U.S. Treasury zero-coupon yield curve</div> on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements inputs as of June 30, 2022 and December 31, 2021: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 69%;"/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 11%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12.80</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10.80</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock price</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10.01</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.81</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (years)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.51</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.86</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.97</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.33</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Probability of business combination</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">90.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in the fair value of the Level 3 warrant liabilities for the three and six months ended June 30, 2022 is summarized as follow: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities at December 31, 2021 - Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,285,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfer of Public Warrants from Level 3 to level 1</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,350,000</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,335,000</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities at March 31, 2022 - Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,600,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,105,000</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities at June 30, 2022 - Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,495,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2022 </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 53%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/> Active Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Observable Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant Other<br/> Unobservable Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">306,566,918</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Public Warrant</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,950,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities - Private Placement Warrant</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,495,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2021 </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 64%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/> Active Markets<br/> (Level 1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">306,016,692</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities—Public warrant</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,350,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities—Private warrant</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,935,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes $1,577 and $933 in cash as of June 30, 2022 and December 31, 2021, respectively. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> 306566918 0 0 1950000 0 0 0 0 1495000 306016692 0 0 0 0 10350000 0 0 7935000 1577 933 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements inputs as of June 30, 2022 and December 31, 2021: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 69%;"/> <td style="width: 12%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 11%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12.80</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10.80</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock price</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10.01</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.81</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected term (years)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.51</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.86</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.97</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.33</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Probability of business combination</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">90.00</td> <td style="vertical-align: bottom; white-space: nowrap;">% </td> </tr> </table> 11.5 11.5 0.128 0.108 10.01 9.81 P5Y6M3D P5Y10M9D 0.0297 0.0133 0 0 10 90 <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in the fair value of the Level 3 warrant liabilities for the three and six months ended June 30, 2022 is summarized as follow: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 83%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities at December 31, 2021 - Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,285,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfer of Public Warrants from Level 3 to level 1</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,350,000</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,335,000</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities at March 31, 2022 - Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,600,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of derivative warrant liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,105,000</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liabilities at June 30, 2022 - Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,495,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 18285000 -10350000 -3335000 4600000 -3105000 1495000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 10 — Subsequent Events </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that th<div style="letter-spacing: 0px; top: 0px;;display:inline;">e un<div style="letter-spacing: 0px; top: 0px;;display:inline;">audited</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">c</div></div>ondensed financial statements were issued. Based on this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements. </div></div> EXCEL 45 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

4,\&I3$H MC:-H;NS6LT7AL>< $53+06D42F-0&D?1W):Q<<6B7]ZYX\%=JC(B]&C%JZ]MWNO;G,'*1-7*1?^':I7WKWYJYQ2AE@U*8U :1]'C@HC4)I#$KC*)K; M,JRNB_RZ[B+71VBF,[]?[_ZF14AS1XMJ2\N:2?U*S;;FOZOH@B!NN_#8OT6= MLX5J.BB-HVANME;317Y-]XAL-R]E;3[5&NYH1ST'.[%"%1V4QJ TCJ*YL5I% M%QVX"K+])@'F8+P9U!?K0;TUR]/=+/?LJ%"U!J4Q*(VC:&ZB5JU%?K7V[O*C M?]8%M6)0&H72&)3&433W7A[6G@T'QYYU#:'&#$JC4!J#TCB*YK8,*]:&?K'F M.^N]/F/J/^W=5."<$=USGQ>H-H/2&)3&430W5*O-AO[E:5?VHN?6Q,+#S2M"<1C+!-7>$((LTFY*_R"^M&4)M%91&H336T%J& M@^T(GT-$#:V(&OJ7>U&A]SNI![WE9I8WPIPE3'^8FT"TY@AU2U :A=)80W,O M76\[...H>MT@K3<:^KW1:L9:'NY&H=IS^&#AM8' M#?T^:-,>F#/T/W=FQU])YV2AZ@A*8U :1]'<\*TZ&HZ/[AB@]@E*HU :@](X MBN;>>M3:I]B_=@MV9J>IQYV31%&+:O!O4==LH30&I7$4S73/J!70=;*(U":0Q*XRB:&[154_'PV-.P&"JS MH#0*I3$HC:-H;LO8N 7\SU_@^+A3/?&N$XK&;6=Z_%O2.5.HV(+2.(KF9FKE M5WS@&L[%GN6ZUJ?/ =:O^ M+>N<,52#06D<17,SMJ8L]ILR_W3LY]V9O]K.0S/4G4%I#$KC*)K;'*P[BX_N MSF*H.X/2*)3&H#2.HKD/>['N+/D_N;.DQ9T%HY9QWK]!7:.%TAB4QE$T-UJK MSA*_.GNB9$E:?%E[H%!K!J4Q*(VC:&Z@UIHE?FMV4<[G>A1?[;)OO..TG]2U M-X;2*)3&H#2.HKD)6XN6'/U!B0E4NT%I%$IC4!I'T=R68;5;XE\1]O3G)?HK MZ!P\U*I!:0Q*XPW-_Z!)-U6KS!*_,MO3H^OCLT,72OC!G=.$^C0HC4%I'$5S M ]]XN&)R] X>^SQ&[ ,9L4]DA%HY%,UM&=;*)0>LW)/M>;*KX,*D[=%I%_Y- MZ1PJ5,-!:1Q%W M*HU :@](XBN:V#*O+1D^Z2M%?NG.J4$4&I;&& M=N#QJJ@Z5VGUJYD0BJ8J/3^;"WDK+D2>F\=1+PN--WOWP[M$BAOSM)M7;\)> M7Y>T'S\_6Z2WXD,J;[.B(KFXT44'+T=ZAEN?H%B_4.7"(,EUJ50YKW^&ULK59MC]HX$/XKHUQU:J7M M)H2%?2D@L=#J.&EU:+F]^W#J!Y-,P*I?J.W [NE^_(T3-@4*;KMJ/H"=^)EY MGK%G/+V--I_L$M'!HQ3*]J.E] M%5O@#-W#:FIH%C=6(9H<#,>1.,_M8X0B&\)>+Q>6LT:GQZX.[XV?J'2CR)F3.+(RW^YKE;]J.K M"'(L6"G'< M8%9O'^@"9GRA>,$SIAP,LTR7RG&U@*D6/.-HX2T,\YS[X#,!$U4?(;\5K\?H M&!=O:,7#; RO7[WIQ8ZX>0]QMN5Q6_-(3_#HPIU6;FGAOY1Q:L4?KHJ%U$:3U83P9T5[:TF .0^GW_!BS MVDAGQV_:2>@YH!?TY0O2C5VQ#/L151R+9HW1X-=?6MWD72# G49))ZCD01G, M-)W@?TF)8X\P1X4%/Q[ISE=Z#J4$G;U02K>1T@U*H>0S):F@# .N')('!TSE M0+6;"4>Y>$Q3]YNG)^CUA9HN&TV704U_HI&^R-R3%L,S1_(F:DT3>2H;PO9: M5QW(V=,QY"B(?*'.JT;G53C/M914$D>"60M#^.<.Y1S-QV,"@X:^GV:M^2<9 MV]-\W6B^_L;>RI4V_A9Y3P7./9W!;,G(#4RL+0^+>:W]^JL$;"?UB.FY9SNOK@CZ) T/*OZFA\NT0IH)"Z0]N<'_# M_G]T@W^6M?UH[;0)K7!-HF8@YZ+T31=8S$K#?2$"?,Q$F?MB9;2$3,M5Z>JN M@)(=F5'40E@J7-0Y^C-Q!NSD);-EL'?+=#O'#D68ZX_&(M[IGB2:1=546J@: MH+J1:MXVC>NP:M?B+\OKKO>.F057%@06!$W.+TF,J1O)>N+TJNK%YMI19U<- ME]1\H_$+Z'NAM7N>> =-.S_X'U!+ P04 " "(@0Q5;A1;4'L$ *& M&0 'AL+W=O;H!2S:3Z\:4F]9HV-;!]?61_6PY>#6:)!=PP^I%D MK8P$/I3DB6UV#5@YP4U3?^6@O1 M JB!F@%1#8B> @8G +T:T'LIH%\#^D\!PQ. 00THA^Y78R^%B['$\REG!\1U MM&+3%Z7Z)5KI10H]41:2JU^)PLGYHIH@B*W0@JP+LB(I+B2Z2E.V*R0IUNB> M49(2$.@-.@:_7Z$'2%F1$@H9NL84%RF@13FQ;R@6 EVA]SPCA0Y>;#!7Z%6_CJR,[]C^ H6#'U$41*%)$#O\UUUQ@7I!"8],>OPW M>&*'QY J>&CJ?$>,7C,7>R5?[P3? V2@TN"2 GJG)I=2FC-*]1R\+22H2231 MI]\4!MU*R,4?A@Y?5PWTS0WHI'LIMCB%F:>RJ@"^!V_^PW?A,/C)I+U+LM@E M6>*(K.-2OW&I;V.?_\R96N!;SE* 3* 59[GRATB"*;K?+56R4/EA!5SY9G*H M(A^6Y'H7V\][0?TW]?=M^:W=.%=^EV2)([*._(-&_H%5?I69.91[K/H4ERMKGQ;[1+X,94;R4Z5R279+%+LL016<>-<>/&^%MOR&.7 M+KDDBUV2)8[(.BY-&IW$V5:Y9(N=LB4U6\>J ML#>*>H-)>,*KZ-&KZ']\@;4W?K9'+MEBIVQ)S=;V*!I/@MYH=,JBQSH\M!:0 M\]M"680%(%*T56]2W M<>V8E.:W3G;+%-5M;5^,[L*M6NQX]5N&AO0QW5FS8 MVSG;"U-];RXW7AZ:F$.-N[??.@O-@:_+0VB!RN/,ZEBT>=H<=%^5Q[O^8WAU M2GZ'^9H4 E%8*6AP,5)S@E<'S]6-9-OR9'7)I&1Y>;D!G '7 >KW%6/R>*,; M:([_YW\#4$L#!!0 ( (B!#%54JY7MP 4 *DL 9 >&PO=V]R:W-H M965TY#@C:8[EG\KUI1R]#U- MLN)FM.9\%]&:IJ2X8AN:B4^6+$\)%Z?Y:EQL\QG4[;E29S1QQP5VS0E^7]W-&&[FQ$>O5[X$J_6O+PPGDTW9$6?*/^Z M>&?M6GORZN!EI M98]H0B->(HCX\T+O:9*4)-&/?R5TU.0L P^/7^GS:O!B,,^DH/\/7- MR!VA!5V2;<*_L%U(Y8"LDA>QI*A^HYULJXU0M"TX2V6PZ$$:9_5?\EU^$06 MH]+2(YS,ICG;H;QL+6CE05405;20,,[*VGWBN?@T%G%\]E37+&)+]!2OLG@9 M1R3CZ#:*V#;C<;9"CRR)HY@6Z!-Z;?S'$MV1(HX0R1;(BY,MIPOT6=QHO[.B M0(\T1T]KDE/TP:.B@_4\;8B?BS4:B337R6[TY7 !Y)?(0/_C'1- MQWW?ASK\MVTFPK4J7.\)]X9G[POWAV?OZ_S\?>'!^\8>7IR]I:31W'Q&Q3/> MX'W>IC0GG.77?;=%'6OVQY9KVG6Q(1&]&8E%JZ#Y"QW-?OH!V]HO?34!"?,@ M83XD; X)"R!A(1"L56=F4V>FBCZ[31(6D>I90L/#9DG4'"/$B8#PF;0\("2%@(!&O5 MF=/4F0.]\BB!YQ:?<[0"6(Z+#:.S 'B02?WCI%IG_8),%QRGP]BU3 N[G55. MU:^6NFZCKJN<13R:,?%.^N8\XD)*"0GS(&$^)&P."0L@82$0K%5IDZ;2)LIY MI+8;=I4311>(O(C5:T514=H,!6);7G"2+>)LU5>&2O2Y95C#K(.;R-#JG\Z4 M IG5/\[:G5(@TP5#!QFJ^M42&FM[0TI32OWJ)UTHMII^KMJ2-D!NT+Q^3]ZN MX* )@\$##95=:VM^8$+B ;?WT>,!VM T]S#\5WA M25=NR)R^I*D>&4 3!I(V:0W2["JMZE5;:7VOM#[H[KY8:R7^;*WU05I#YO0E M3:DU9,) TDYHK>I56^N]NXF5IE;;V;A3.AMJTMFR@KJ=H#0?E#8'I06@M!"* MUJZ^O>>)S7=8'!C(\I,%!TGS0&D^*&T.2@M :2$4K5UP>Q\7JXW<"[P.-?'L M*K1Z_&[3,@RSNZ"!VK4]:7M->]"L04]6?6(;MC[IKFPGN]?6>V^A8K6'>LK] MP* V*BC- Z7YH+0Y*"T I850M';)[=U4K+93WV6#J-EGUZ-S]!KH6+TOQJ#> M:D]:V]*MH[3SOH:ZX[AFYU^3P="!A .(;5GW-BI6>F?OMCQ ?59)&R LJ(G: MD_8-87L:]@L[<"#A &);V+UKB8?8EA>_ZX(:EY)VZET7U+:4-.6[[LDF@6QR MX@56Q6GOL]I;D?HP*_)2 =7XE(F:'8G MS_X'4$L#!!0 ( (B!#%6ASG9U:@4 /PC 9 >&PO=V]R:W-H965T M[+9/VX><\D#0E-3?;@1IX&9"7^X+!3>\OZE^RQIO&+)B"J8B^\E"OQIWS#@EAR3:1 M?A"[7Z!H4#_5"T2DLO]DEY<=F,+!1FD1%\'F#F*>Y)_LI0"Q%]#M'PF@10 ] M"/ &1P*Z14#W,*!W)*!7!/0R,GE3,@X^TVPRDF)'9%K:J*4'&W"=><162V640\(/?+)4B>/)%3P]$%]\D$S M'GTV)1[G/OGTX^>1H\V-I').4%0ZS2NE1RKU7'(G$KU2Y"8)(:P+.*8%93/H M:S.NJ57Q=[$](U[_A%"7>DTW9 _W(3@C7>]HN&\/_W63F' W"Z>6UG3+A]+- M]+I']*814XJ()9EK$3R3;[^9Z^160ZS^;+BYZURLURR6)HY+M68!C#LF,RB0 M6^A,?OK!&[@_-X'"%/.1Q&H0>R7$GDU],I,B @564H1$Z[4AB4!$%YT^'7> MX471X9NXYOJ#3#_-G]M)URW^1LYV'YKU3MI"0Q*K0>N7T/I6:#X8'!)"LC$# M4^ZD866202#BV TPU\U<;)*MNU__3?0/;??P-S_CH(U!(,2P<#>;_*.\95) MR1*MR+<[B!<@&T>>5:EMRS'%?"2Q&L%A27"(F;Z&F! QQ7PDL1K$\Q+BN;4; MWKR #+@"LI;2")U7AX;K6(N^C%_;V"EJ/W._V"3Y6Q75RU>+>LZ_N;V?W M]KD!=26/JN9CJ=715:; &Z#.#:C. %7-QU*KDZS,@6==-A=S0Y[.2+C)?FU: MFZ$JPA.BLEQW0A+8Y26:YXSAFX37;?;E]EMI#>XC_(!7&0+/[@BRB2"W XU4 MSAL,\2$/5 ^ I5;G4;D SVX#]K,9^8>T60-C+OVGJ&H^EEK]9]3*25 7,\]1 M5#>!JN9CJ=5)5FZ"6M?8"'FNJ& _S]&!UY3G[+?2&MQ'F =:F0?ZCGFPY[DB MVIKG[#6TYO$1!H!6!H#:#<#_7^\6%0P:.M(;0EJ M?\. ,#,,WJZ +QJ',ZISP%*K!I5:'6;D):G<3_^E-'VWR M&$UOYZ;VVENS0G4:SMYVB1CD4[;M1)FV;Q*=[YPHORVWMEQE&SJ>*!+!TH2Z9T,S)&6^U20_T6*=;;Y8"*U%G!VN@!GB:0%S?2F$?CU)*R@W M_$S^!5!+ P04 " "(@0Q55922N90" !'!@ &0 'AL+W=OUKT@CYJ$I$#4\5XVKJE5K7 MY[ZOLA(KHD:B1FY."B$KHLU2KGQ52R2Y2R) JO!+NGN2ZGW@)"ME195YVP(*LK;D3QU==AQ&.]SB#J'R'&W@1SE-=$D3:1H0%IKHV8G+E7G M;> HMS_*0DMS2HV?3N>2;HA&F#.2H2FVAGLB)>%:P3NXR'-J:T<8P(RW-\"6 M\O@:-:'LQ)@<\'^XP6J)\F?B:P-JP_E9!W790D5[H+Z+S0C"^!2B( KA;G$- MQT]:AGA]1?4)MM@0G/0=I; MIX JM<8<\K6D? 6Z1*A14I'#\V"MVFS:>+&+9Q_O)@W#.+"?Q-\,D(Y[TO'_ MDIY"+6GF*+=60X1MG,DNX1ZVN&>+#[+-I<@04&578E>:E?D,0K=3'5Q"C^"\ ?Z-QT])T>I36P)P70NCMPG:?_K\C_0-0 M2P,$% @ B($,5:UY2&XJ"P :Y4 !D !X;"]W;W)K&ULM=UA4^)(&@?PK]+%75WM5GE"$D"=5:L=25',/G2[^=-$Q6%^FLY4HK\S3K,X+/27V7,WGV4J'"V*XFG7[?6&W3B, MDL[UY>*Q^^SZ,IT7TRA1]QG)YW$<9M\_JFGZ>M5Q.F\/?(Z>)T7Y0/?ZQWR-,^+-*Z* M]1'$4;+\&'ZK_B/6"IS^C@*W*G /+?"J N_0@GY5T#^T8% 5# XM&%8%P\V" MP8Z"LZK@[-""\ZK@_-""BZK@8K-@N.N)Z[T]<[W%"%H^Y8OQXH=%>'V9I:\D M*[?77OG)8M MZO4PB9*R/QZ*3'\WTG7%]6+D9N3 M?Y.;T2@J/P^G1"3+7BS']$^^*L)H^K/>XH\'G_STSY\ONX4^EE+L/E7[#9;[ M=7?LUR%W:5),O7MCKA_OJY9[C[UF KGX25L^$^_9,?'2M MXJ?TY90X@Q/B]ERGX8!N#RCO7>PL]^WE=V%V2CQG9SD]H-SU=I8S>SE3C[J\ MO[,\>-_!ZO+28SE47IZ(2\ MA-.Y.B&)GM0M-LB;FL3*MVT2).8C,8K$&!(+EMAP@96S_Y=K=]#K]2Z[+^NC M'[E+@<0D"#-&_V U^@?6T>_/%2E2LGZ*B%1.;N=9II*B:;A;O;;#'8GY2(PB M,8;$ B3&D9A 8G*PU=7.Q7I7&\-]N!KN0^MPWSD5.B'TVTPO\O78'V=I;*Y[ M7J-B8K3(]Z;&L.ZY;6,@,1^)423&D%B Q#@2$TA,+K'!88UQMFJ,,VMC?$FS MK^7,YS:<185>W?^:AGIY<*?B1Y4U+@VL7-O1CL1\)$:1&$-B 1+C2$P@,0G" MC*8X7S7%^9$6SN?([D!B/A*C2(PAL0")<20FD)@$849W7*RZX\*^=%"/!1%) M7F3S6*\5R&V:O"B]?'B.]AZ*",U'ZI1J,:@6@#5>*6M MC]/-W\W[-Y'63S-"L.G(U!$V&HYD,U"M48 M5 N@&H=J JI)E&;V4YT@.\-CS<:@"3%4\Z$:A6H,J@50C4,U =4D2C,;I4Z4 M'7ND;'FOQ4V7ZP>_D4UJH]6^9K5.^%V//% R:-T,U'ZI1J,:@ M6@#5.%034$VB-+.9ZN#9N3C6% R:.T,U'ZI1J,:@6@#5.%034$VB-//ZL3K) M=ELEV2>$Z7U5LZ^F]K!S;=L#JOE0C4(UYF['P%[#^QH"Z%XY5!-03:(T<^#7 MJ;>[)_7>> N'2 JE]U.0S_K$T3CRH:$W5/.A&H5J#*H%4(U76OD&C)VI]P'; M2-11F6.Y3LA=>T+.]&_KDAP3A4\Z$:A6H,J@50C4,U =4D2C,;I0[&77LP_FE>GC+* MEUOSY4EDG&9C%17U%<_%1%57/9\V]@LTY:ZT]4N8+L[.SP:;K\-"]TJA&H-J M 53C4$U -8G2S$ZHTW#7GH97U[=%_UO>N$9WQ'):U3CHH<%VI:T/>L\9NMN# M'AI90S4&U0*HQJ&:@&H2I9F#OHZL7?M5SSM6$.1OLAE+-+8!-+:&:CY4HU"- M0;4 JG&H)J":1&EFL]2QM7MVK$4%-*N&:CY4HU"-0;4 JG&H)J":1&EFH]21 MMKLGTG[OC9/L?NM^@:;64(U"-0;5 JC&H9JHM#VW=I*HG9J-4,?1KOU"Z/>O MKB^VEP9;J^%;^U&T'N#0M!FJ,:@60#4.U014DRC-O,MDG39[]K3Y\&6&?LB/ M,O54[%EZV'?8]@P!U7RH1J$:@VH!5.-034 UB=+,!JI3:\\YTM+#@\;74,V' M:A2J,:@60#4.U014DRC-;)0Z$O?LD;AMZ;&<@^U;>]AWT+IAH$EYI:U/!]V& MZ\\H=*\,J@50C4,U =4D2C-;8>W>WM;H\/V+#[O?NA.P=_GVMCIA>#'02Z.M M5L#>PAM[#V_L3;RQ=_'&WL;[&"FW5Z?X-CK4*@@3E4\Z$:A6H,J@50 MC4,U =4D2C,;I8[5/7NL#EB%0*-UJ.9#-0K5F+=]#^SS84,R$$!WRZ&:@&H2 MI9F]4*?FGOUB[W>'@7:_=2M PW.H1J$:\[8O:6]L!&@J#M4$5),HS6R$.A7W M#DG%Q;(1_&4CW%>-\%"=%'[32_*LL0F@B3A4\Z$:K33CKQCTO>V5/8/N-H!J M'*H)J"91FMD&=2;NV3/QWU4\2[,P^T[47_-(KR.J5Z?2>9$783+2;='8 -#K MLZ&:#]6HMYWYGSGG30T #<.A&H=J JI)E&;^4;DZ#._;P_"[*(GB>=SVM2:[ MVK8!H)H/U2A48U M@&H4,V':A2J,:@60#4. MU014DRC-;)0Z\>[;$^\?G$_9U=9=LAU,G[EGVV]5]*&[I5"-0;4 JG&H)J": M1&EF ]0Y=]^><]^%WS;G4RUNC&#'6_/=1UY'QJ%0S4?JE&HQJ!: -4X5!-03:(T MLU'JQ+R_)S%?GDV6D?G)\D^LEI'Y\C33V"#0F!RJ^5"-0C56:>6?<5S--'NG MO9ZW\681Z%XY5!-03:*TY=#OYA.E"C\LPNO+6&7/ZE9-ISEY*F^WK/_;.VN/ MDDR-RQN=?[AQ.UU=66]^?3D+G]5=F#U'24ZF:JQ+>Z=G>IJ81<^3U1=%.BM) M\I@611HO/IVH4,_.R@WT]\=I6KQ]4>[@-&ULM9AM M;]LV$,>_"J$-0PNDT8,M.\YL X[=;1F6Q*B7[46Q%[1TMHA(HDM2=@KTPY>D M%#TD"@M[2E[$DLS[W_V.1_K$\8&R!QX!"/28Q"F?6)$0NTO;YD$$">;G= >I M_&9#68*%O&5;F^\8X% ;);'M.<[ 3C!)K>E8/UNRZ9AF(B8I+!GB69)@]O4* M8GJ86*[U]. 3V49"/;"GXQW>P@K$_6[)Y)U=JH0D@903FB(&FXDUNO5=<#]"-=!9Q M]#$-(6S:VQ*C9/&>6*X\H^ MW9\CUS]#GN.Y;?&8S?_,TG/4<[2Y9PBG5Z:V MI_5ZK^C=B0@8JB?X\U]R"+H6D/#_6N*[RO7Z[7IJ05_R'0Y@8LD5RX'MP9K^ M\I,[<'YM@^U(K('>+]'[)O7I;+MEL,4"T!SS"-W+"68'1E1EH07A T#7GF:SI1<94-2^!$1J>H56$I<,S="M_ MCO6(UN+.]?WZJAVUU;8QCA,I1R7EZ'_4-OK67,TSN7V!'FBJ?J/'8TN@([%& MEBW0Y?KENG]<7"',JIJ%4K MYII[L7I9G]:3F!TZ>OOSJK^ MU6]RZTMTH3JJ5;MS[CXK=+/K4]&JALLS]R\_?(DV$^;B%PW"GO\T M:V=L";"M/GKD2$]'?MQ6/BV/-V?Z4,^NAN=GHS>8;8E$C&$C39WSH=R86'[< MF-\(NM,G=FLJ!$WT9018)DH-D-]O*!5/-\I!>>@[_0Y02P,$% @ B($, M572U$6YF!0 0R0 !D !X;"]W;W)K&ULM5IM M;ZLV&/TK%IOV(MT6<-[:+HG4A$WKM*Y1JVT?KO;!"4\25L"YMI/<3?OQLX% MG!(3.J\?&B#/<_ YX,?'CH=[RE[Y&D"@STF<\I&S%F)SY[I\L8:$\&NZ@51^ MLZ0L(4*>LI7+-PQ(F"4EL8L]K^\F)$J=\3"[-F/C(=V*.$IAQA#?)@EA?TT@ MION1XSN'"\_1:BW4!7<\W) 5O(#X=3-C\LPM4<(H@91'-$4,EB/GWK\+\*U* MR")^BV#/CXZ1HC*G]%6=/(0CQU,M@A@60D$0^;&#*<2Q0I+M^%2 .N4]5>+Q M\0']AXR\)#,G'*8T_CT*Q7KDW#@HA"79QN*9[G^$@E!/X2UHS+/_:%_$>@Y: M;+F@29$L6Y!$:?Y)/A="'"5T>F<2<)& 3Q+\ "#(>,KI'3$5+-'60B9EE2_I1JI[[BV#RVTCFB?$T)IRC>_3$PBB5#QZ] MK D#CEZV\S_EHT&"HAGE/)K'@)XAA&23/ZXTS"/7- Z!\:]1 ,MH$0ETA>[# M,%)!)$8/:?YFJI1O A DBK^5$5\B%_'L/D-72!*J*>ZB:/ T;S ^T^ ^>J2I M6'/T?1I"J.>[DGRI #XH,,%&P%_H[AKYO0\(>]BO:X\Y_:=M>HTZ7I:.:](# M_0@(.%_U#1NDH-UZ\%4 MS;GC&[* D2.+"@>V V?\U1=^W_NN3BB;8($E,$W$;BEBUX0^GLG: XQ!B'BF MXH8P1&6Q%$3(:SL2;P%M@.7O<)VL1OBVLN9@@PQ,E?'=V+OV/$^^+;MCP1K# M-"EZI12]5E+DW1:1K5A3%OU]V@-S^D;(MO1SL-X1KYZ7_9WP;X[3!.B7 O3? M(T#$^;:>O!&N+?G^&U*GM$T1&N%!27CP'L+2,\CW/Y6CQ*J.M1&S+>M!(VM3 MA,;ZIF1]8V0]I4DB!ZG#5M8"K7'D:8[3Q3CRIO[E8EPT\I@!6PO@ MGQM3WHP^%X7J,N!*!MQ:AH9R;$9LK0-N+,C&$)UW965]H\D[\,X*R@E. MSC345&)">%0W=9@T -(4KM8D7JHR)8_EO#4$.8U6^0^MWRR9:8 M-5[NO$W"NM.G"K:($M-%W% MRMK[-U9[I56#;Q4ML(6F*UEY?-_H?O^K.[5J^@NT9G?:&*PZA>Y M4S-@6P$*M#K+>2+!)9&Z")5%Q^TM>D.=-B.V5N&M\1[T:D5H#M0UJ/PY;N_/ M=U1(^HBIGQUJK:H9L[4*YA8JLRM;5-&"U,UN=$5A% M"VRAZ4I6,P)\T6I_BY4E,V!K,M>/_') !7DP!LG@3,@"T@ M%60%Z&FI=^R'[%&ULQ5M1;]LV M$/XKA#<,'=#9EF2[29<82*P.Z[!V0=NU#\4>&(F.M4JB2E%Q NS'CY04473E MLV6<-C\DEJ7[2'XD[^ZCR(LM%U_R#6.2/"1QFE^.-E)F+R>3/-BPA.9CGK%4 MW5ESD5"I+L7=),\$HV%IE,03=SI=3!(:I:/E1?G;C5A>\$+&4C* M>>G/YMJ@?.)CQ+9YZSO13;GE_(N^>!U>CJ:Z1BQF@=005/V[9RL6QQI)U>-K M#3IJRM2&[>]/Z+^4C5>-N:4Y6_'X4Q3*S>7H;$1"MJ9%+-_Q[:^L;E!9P8#' M>?F7;.MGIR,2%+GD26VL:I!$:?6?/M1$M P43K>!6QNXNP:+/09>;>#M&LSV M&,QJ@UG)3-64D@>?2KJ\$'Q+A'Y:H>DO)9FEM6I^E.I^?R^%NALI.[G\1(6@ MJ>>8S2:/X1_7$]V1"\@T5++^82%6XAI@$=4'7 M54'NGH(6Y U/Y28GK]*0A1WV*]C>F0( $]7JINGN4].O71#QMR(=$V_ZG+A3 MU^VJ$&SNLT"9.Z6YTV'NP^9O^?V8./,NXVO2 M=.OG-RRY9>(O\@]9\211=UE>C>'HHKY@R[A M2.DKR^7?U*'DM69)W\CG# MY!,3S$<"L_B<-WS.P2'[0= P2N](2!])QD3$0R(Y"6@<%#&5C-SSN$@8V9:^ MFX6$WC.A8A&1M5TFHH"1-8]5\-+7*9?Z!]5!HID,7;T!UTHY&E6A+@^W.M70 M!PU/9'G1L+P J_6VT--:'8+#+E#-@#$T&4EZ1MJU'=Q5A5@E/Y M,IU*W"^G8V^A_-9]FQ^P(GU')A*8Q=F+AK,7(&?;($+ZP3 ]0$@=[_F@"U[$S:$$G&,%'%@+6((*WUBH^!4 MS*99)&E,!(W*V)T50@=N$J4DX&E:KQ)N([EIA_?;0GUC:F '/+F-4KI/\=75 M.F^YK/.Q1]"S3A&SC@'](P*.BR56CPKUNX$5Y2IU"A@+%1. M(57)E.:>?2TB^=C+ HN4J_+O(-6=-UE.19G*?7!-8#\U.!L^_ M'6_.V)GOLH8D26K6AA XKA$X[@&!LS\7:BWR_M%:Y/VT829!>O6UH'&NX_NK MAVJ"ORI'KGK$YW&L,G PAX(KUS?^T4^CN,"G31SL?. M=MT%JG3"0K-I,M+)A:73\1K_ !"@\6'+WH0-H9=7!+X-.2?L/0 (^ K;L3=T0BLDSBLF#Y0U"VE^7T%Z8FHYW MLWZX&KU)&T(K>:W=<2>_8,)SK#TWV>'NLL/=9C>$1O.,1O.&>EOEH:HH5#0? M"\TFU:@H#W[)=%K"7X-:"?_NSA&XX-XT#:&+/*.+O&/?41W*60\ 0D_;-F; ML"$4DF<4DG>L0NJ3\!\ A8(YJEK"0K/),VK)@X7-C8CN]5[7FUB5D3#EZH[: M= BC]G9SJ!(*"\UFU$@H[WRHV(&J@5#1?"PT>^.[T4 S^)W4Z=L/:V!KMU"] MKW GBAS]I ]7]E0RC':9P4+CB#G[/Z:5<.5['S9 54Y8:';'&>4TBE169SV; M7YO#N%?E$=2)>;PZR?N&BKLHS4G,ULIT.GZA*BJJP['5A>19>5STEDO)D_+K MAM&0"?V NK_F7#Y=Z *:(\K+?P%02P,$% @ B($,51"F]I&! @ <@8 M !D !X;"]W;W)K&ULK57?3]LP$/Y7K&R:0.K( MKT(WED:"5K!.(%6M8 ]H#VYR;2P<.[.=EDG[XW=V0A2TENV!E\1WON_SW9?S M)=E)]:@+ $.>2B[TV"N,JFCC?7*6)K UG N:*Z+HLJ?IU"5SNQE[H/3L6;%,8Z_#3I*(;6(*Y MJ^8*+;]CR5D)0C,IB(+UV+L(SR=#&^\"[AGL=&]-;"4K*1^M,6"-/XV7)ZW9$6V%\_LU^YVK&6%=4PD?P[RTTQ]CYY)(H'^4UN8 NI\>KQ]IZ>ZXIF,/;P(FI06_#2 M#^_"L^#+/FW>B.R%4G&G5.S8XW]VRX!<4DY%!F3IALVUDG6%.@S(%1/H9]@V M2T.-TXE,:&6;1Y.'&V0D,W3KO4K%;ZG4&Y&]4&K8*35\M:=F8@O:N"89]+MG MRG3&I6V@?>4WG&>.T\[?;1J>CD:)O^V7]7?0YSCN8IIL_=Y$L-/XEJH-0_TY MK!$5G(Q./:*:"=<81E9N2*RDP9'CE@7^%$#9 -Q?2VF>#3MWNM],^@=02P,$ M% @ B($,5?&#?A!:! [QL !D !X;"]W;W)K&ULM5EKC]HX%/TK5K9:M=+N)'8@P"P@S4-5N^I(HYD^/JSV@PD&K"8Q M:SO0E?;'K_,@CH?@-N#.AR$A]Q[?\:_B@TA$GQ+DTS,O(V4VVO? M%_&&I%A/?#YEN4QH M1AXY$'F:8O[O+4G8?N9![_#%$UUO9/&%/Y]N\9H\$_EI^\C5F=^@+&E*,D%9 M!CA9S;P;>'V'QD5"&?&9DKUH'8."RH*QK\7)^^7,"XJ*2$)B64!@];$C=R1) M"B15QS\UJ->L622VCP_H;TORBLP""W+'DB]T*36TSE_/9!T0?C?*OC3\SUX_>K-U)>*:%&N']>D;BM2Z 2I M/_/L"H3!;P %"'6DW]G3[TFLTF&9#LUT7[6WZ3%J>HQ*O,$)O ]D1Q( &VI= MA*P(Q;U\+;8X)C-/W:R"\!WQYK_^ J/@CRYZCL ,LF%#-BS1PQ-D*X%<=W$, M77)T!&9P'#0L"5-.!D&ZN^%A(_C@F[ICIM2QZZE6W+3S&S2M:[==T<=@1EM MFC1MFEPDW8E+HH[ #*(PT,8E<"S>&K!;E;4QL(68A;8<%OP!Z2*K .T0?3?& M%9I)6-L=B,ZU -"ISW&%9O+43@=:3<9Y-J#&M(K0%F+6JAT+M%N6ER)T^]-O M7[SWMCI",UNE31(<7O0,A4Z-CBLTDZRV.M!J,,YYBD;?%[ MQ"Q46Q5H]RIG M"+B' ; OWGM/':&9K=)6"8XO$[!3N^,*S22K#0^TVHQS!#SYOH!M(>8,0/L5 M9/;:F._;QSEDVH,:TB= : M8M:J+0NR6Y:7(G1K ^R+]][6GS'B0=HQH<%%3U'DU/.X0C/):L^#[).A_D_1 M&M JX.,0&(3FN,"L5]L69+!HTDX/!:SWWH;4[P*>\!\33,!$K)2F<'5 M2-T0O'J[5)U(MBU?T"R8E"PM#S<$+PDO M3U%6/R<%*\\VG>\O)F1AC/=<_$BMX@*7HN?VK.EF$]YI7+*<"E 5D5! MQ.$.<[Z?>:'W=O!$-UME#OSYM"0;7*'ZNUP*O?-;EHP6R"3E# 2N9]YM>+,( M P.P%L\4][*S!A-*POF+V3QD,R\PBC#'5!D*HO]VN, \-TQ:QS\-J=?Z-,#N M^HW]HPU>!Y,0B0N>?Z69VLZ\L0<9KDF5JR>^_PN;@(:&+^6YM+^P;VP##])* M*EXT8*V@H*S^)Z]-(CJ :'@&$#6 Z&HK'9W1Z*=-)'=U)-&92$;PR)G:2OC ,LP<^$4_/@QZ"'R=UC:WT5MN M[Z)>QD\5&T <7$ 41!'\"C[(+1$H7=KZF>XQU4RA90K/,AV)C-L7(+;4\1GJ ME2&Z-%]"!@M>Z/8@Z]K>"D'8QI8/D@-T[9;D8(]O][KZ\.VSIH0'A85TEJWV M?^7V;]K4C2Q)BC-/]R&)8H?>_+=?PE'PIRM/_Q/94:JNVE1=];'//[RB2*E$ M* 5-T15JC9]8O&F@NWD8#H93?]<-X0=&1]*&K;1AK[1GGNNJY50=7+)J;!AW M7 :#,!J?"'.;!6.WM%$K;=0K;:5X^G(^935XW,U&, C"$VG_M9H,QJ%;V'4K M[/H'Y2SU7:)?9X6D<$GKAP_A@$1(&$%1MXT8,G)P?MP_1Z0;4,,T<3 =A3AN M0QSW4C]1^7*Y%H@@B'*F?^RJ>1!-KD\*X+8+X]A=@TDK<-(K\)[N:(8L@P/% MW-6T[VJ\GA,ZCD^T]9H*%[:^2#A2D\;=KG5 R$*8Z"?KSE7;QOCH!TQY_\" M4$L#!!0 ( (B!#%7"6 (H P0 (43 9 >&PO=V]R:W-H965T;U9N98PI33;V2AUB-K8*$%+'%*U1/?_0[%AGJ&+^94 M9K]H5ZQU+!2G4O&D &L/$L+R?_RC$*("T#S- *\ >*\!P1& 7P#\4RT$!2 X M%= K -G6[7SOF7 A5G@\%'R'A%FMV@K MIBF@!\ R%:"S0$GT$N!,K26*V (6#?BP'1^\ MA8_:\?T6O*TE+G7V]CI/O%;"/U)VB7SG GF.YS7X,VV'/V"AX>Y1>'BZ=;=) MC7_M?$T,OTPZ/^/SWTRZ"S3E+-89)W!6-W1Z/1'Y?(%N"<,L)IBBF<(J2THT MQ1NS2*+O]YH0W>EI^6=3;N76@V;KIO3>R V.863IVBI!;,$:__J+VW=^:PI, MEV1AEV111V2U$ 9E"(,V]O$$5H0QPE9H@JF.%#3%H97BW#CD9/V,S+2_[=@= M>(.>XSA#>UO5N$NKT0E6:_KU2OUZK?I-UYBM !&&EN9AV.Z+ZP($V6+3/-&N MJ*WTI;8VB=P[\/#CE=L[U&7:ZM"YB7QH]96Y*%_1J_KE!H/ .2I=OY2NWRJ= M+LDF[^;'\ZY_8-H/@@9%6NV[*#O.(>UZ7#=D7;7ZM.Y\IU@M2:-Z[Q\9SBMXGS6O4PN09AT M?DSGE,3[CX?&KM;.=FZ^%FSU9N3XO4/=PTX-1UVQU46O?-RY_]%;1F&HIJ#O M.@U-M7&E[S=D;KOS9TO=$5M=:N]%:N\GWTH*@MJ[9'#=I.#APL8:$;:[=+: M;_N7:V-7CAL2$*OLG$>BF*=,Y5_$Y6QYEO0I.T%Y-3]Q;Z;YB= +37Y I;]W M=2V5B,)24SJ75SJ=1'[FDP\4WV2'&G.N%$^RRS5@G==F@;Z_Y%SM!\9 >?(V M_@=02P,$% @ B($,51;[.&U/ P +A4 T !X;"]S='EL97,N>&UL MW5A=3]LP%/TK41@32!-I&DB3T5;:*B%-VB8D>-@;0XF>.R=K]^OG:: M?N#;%1X&72J(?8_/NY-R+M3 3]J09V]? MLH$?QI>^9^5&948'_L/9^Y_S4EV_\^S]Y,/)2>?A_'HW?F: J;%!,/CY,?I\X)MT[2'J/,B:<; N;T:=:Q_).,5IZX$KN74A$O-=Q>&K$ M_DX.W>333;*=5M!4XK"?EV)=D)%O UJ=%-1[)'S@CPAG8\F E9."\:4-=R$P M*7DI/:6?!)TNA$C]V\*A[<%#TN@43)32Y+89[.]Q,WP'6/7 (..\-=CU;6#8 MKXA25(H;W3? )Y#7M^V6E'4XE68;=*W]-,#>=9%S*C,HV3>BO0L,^ISG8 MD6PZ@[LJJP! IA5[+-7GN9Z.,'VH4WHK:HBKDZKB MRT^<345![>0/3CCLDQ7/FY62_=;9H%0F.D"E[SU2J=AD,_)+DNJ>+M2JG!8Y M[KE[A)[_[3I/J:"2\$W3NO;?\BJ_V''4>RW+YJVR:]CIL3D6O'635\=@,CX& MDT=1D\DQF$R/P&3OU=Z:SS$9ODF307,4VCAO;9VVVJ@'I]J!_QW.R'R=U!O/ M&5=,-+T9RS(JGARZM+PB8_W'X):^'I_1G,RYNF_!@;]N?Z,9FQ=I.^H6%J(9 MM6Y_A>F%<7NDUKF8R.B"9J.F*Z=CT_1T0V=M+B#L(C?F2#3\]8:WVV\0O;7 ;:G^RH$FRE>B=A,\;4&Q+UNP$A3 M]VYC>8"![0)6.Y#?G0=JRLV)(MA5S!OV!.-(FF((U**[1N,869T8/N[]P9Z2 M*$I3-P*8VT$480@\C3B".0 /&!)%YGMPY_LH6'U/!>O_D [_ %!+ P04 M" "(@0Q5EXJ[', 3 @ "P %]R96QS+RYR96QSG9*Y;L,P#$!_Q="> M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C] M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA< MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X M4$L#!!0 ( (B!#%4SI>3@6 , *\6 / >&PO=V]R:V)O;VLN>&UL MQ9A;;]HP%(#_BI6GOG20A-*+2B4&Z8K4 FIH]SB9Q(&S.C:S';KVU\\)0G76 M<;07BZ?@"\[GZW?BZU>I7I92OI#?)1=Z$*R-V5QU.CI;LY+J+W+#A"TII"JI ML4FUZNB-8C37:\9,R3M1M]OOE!1$<'.];VNN.FY"&I89D,)FUAG/P%[U1WF= M)%O0L 0.YFT0-+\Y"T@) DIX9_D@Z 9$K^7KG53P+H6A/,V4Y'P0A+N"9Z8, M9)^RTQIR09>ZR3%T^4@MR"#H=VV#!2AMFAI-^]0R;IFMO$M51MX"-TR-J6'? ME*PV(%9U,[87':<;S3CLG[M!O%+_,XRR*"!C8YE5)1-F-XZ*\1I0Z#5L=$ $ M+=D@&,DM4V1.5ZSNE'W+)-]UT%@R9[C4%=@"-% Q@AD[!?R:3I\&D\6%O(#-UT,%\E#,K6H M#F0/@>P=$?)'Y$">(9!GQX2,'<@^ MGW"SEF.E.PJ?.)+,A,K:B ]Z8>H2)W M(,\1R'._D&E5EE2]U8 IK 38OU%AR##+9"4,.) 7".2%7\B) .4DWFUY)"1 M65$P9<]E!^X2@;OT"S=7L+5O)G-.,U;7)=^I4G80M7MP=[&3N^N7\+'.9+F5 MB3)O9&'9-&W4W")$W>);+K(LP=25=+TUR,C:WDXP$QFP%B2FF-"W8SC5F@SM M1LY!U'LF75NW:))6RY\VU'$Q,M\GV;S#,'J%G?: G:/\)@"::DXQ P2>E;( M@55(3FSHS]MG#.:2T+-,T)BA->D19I3(LU'P2>^YF)A6(L]:P3'/7$STV\6S M6'#,OHN)B27R+)8#41@Y)<,\!]=_$>:;R+-O#L=C#:F+B7DG\NR=PT'9)TS, M0I%G"Z&1&3EU,3$+19XMA,9F[7,3LU#DV4*ME6CWC"VW&VHB=HVY7UL19J'( MLX4.R?+S3H\Q"\6>+708LSE174S,0K%G"Z&8K;498Q:*/5L(QW0#N1B]0VLL MU-E?D.:L ,'RJ7V%MOD9Y=E]Q]:N[RR3>96 M76_;\4G1#4WFQ^50ZC[+;UEI-<=QHH?7&>IX>)T9G1^]_<_$KBBNN?WL\N_& MMOZ/P?JG&VZNLM:KZ)P-I?6ITO=ZONWT=*'5.%E%ITNJAM.%E X=Q!#$X8,, M!)GP06L(6HC-J#<+T)L7/]L"]&;4FP7HS:@W"]";46\6H#>CWBQ ;T:]68#>C'JS +T9 M]68!>AO4VPC0VZ#>1H#>!O4V O0VB\.2=^KM_*.V;NYYKG'_=U+MQW?MO/VT M?-Y/C+FLI%JZ M1!MJPDZA;2U]>+4+9F2VE MB8C0:LTPWGAH_]*U&/)L\4R%7E8]>-N&S4[J9 MQI8J%T=/N\+6:QI+8RJ521_VV;K)?[@,]PY)Z.QJ7*F,&X2"F)UT:'=^-]CW MO:W)6I53-)?6O\HZ5+%-Q9S?5N22?HD3&751J(QRG:WJT)(X8TGFKB3R=97L M1 ?]SC[<,.V>_&K_3J;/,%3.K38N3,S2Y7:'D;3=0Q.$R'K5?\2C8Y"^^GS4 M3CNG_$SO<+V?VBZ[>3C6+=??\?<9'_4OS"% &UL4$L! A0#% @ B($,53>0;4[N M *P( !$ ( !KP &1O8U!R;W!S+V-O&UL4$L! M A0#% @ B($,59E&PO=V]R:W-H965T&UL4$L! M A0#% @ B($,59P&PO=V]R:W-H965T&UL4$L! A0#% @ B($,50]W MLSUY!P WCX !@ ("!^A\ 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0#% @ B($,51$(:YK6$P &PO=V]R:W-H965TA: !X M;"]W;W)K&UL4$L! A0#% @ B($,5?5!W-ZP M!0 B0T !D ("!AF, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ B($,5?4,^T3@!@ $A( !D M ("!V7@ 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ B($,5<_G6!J*! ;0P !D ("!BY< M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MB($,5&PO=V]R:W-H965T&UL4$L! A0#% @ B($,5:'.=G5J!0 M_", !D ("!)[T 'AL+W=O&PO=V]R:W-H965T4AN*@L &N5 9 " @9/% !X;"]W;W)K&UL4$L! A0#% @ B($,556N6_Y;! !8 !D M ("!]- 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ B($,51"F]I&! @ <@8 !D ("! ^, 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ B($, M5<)8 B@#! A1, !D ("! NX 'AL+W=O&PO3@6 , *\6 / " 9_V !X;"]W;W)K M8F]O:RYX;6Q02P$"% ,4 " "(@0Q5X#T)5V@! !*% &@ M @ $D^@ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 M" "(@0Q5')H)78P! #G% $P @ '$^P 6T-O;G1E;G1? @5'EP97-=+GAM;%!+!08 *0 I !8+ "!_0 ! end XML 46 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 47 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 148 196 1 false 35 0 false 7 false false R1.htm 1001 - Document - Cover Page Sheet http://www.ascendant.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - CONDENSED BALANCE SHEETS Sheet http://www.ascendant.com/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 1003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Sheet http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 1005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT Sheet http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT Statements 5 false false R6.htm 1006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS Sheet http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 1007 - Disclosure - Description of Organization and Business Operations and Liquidity Sheet http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidity Description of Organization and Business Operations and Liquidity Notes 7 false false R8.htm 1008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.ascendant.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Initial Public Offering Sheet http://www.ascendant.com/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 1010 - Disclosure - Private Placement Warrants Sheet http://www.ascendant.com/role/PrivatePlacementWarrants Private Placement Warrants Notes 10 false false R11.htm 1011 - Disclosure - Related Party Transactions Sheet http://www.ascendant.com/role/RelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 1012 - Disclosure - Commitments and Contingencies Sheet http://www.ascendant.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 1013 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit Sheet http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficit Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit Notes 13 false false R14.htm 1014 - Disclosure - Warrants Sheet http://www.ascendant.com/role/Warrants Warrants Notes 14 false false R15.htm 1015 - Disclosure - Fair Value Measurements Sheet http://www.ascendant.com/role/FairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 1016 - Disclosure - Subsequent Events Sheet http://www.ascendant.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 1017 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.ascendant.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 1018 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.ascendant.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 1019 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.ascendant.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.ascendant.com/role/FairValueMeasurements 19 false false R20.htm 1020 - Disclosure - Description of Organization and Business Operations and Liquidity - Additional Information (Detail) Sheet http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail Description of Organization and Business Operations and Liquidity - Additional Information (Detail) Details 20 false false R21.htm 1021 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 21 false false R22.htm 1022 - Disclosure - Summary of Significant Accounting Policies - Summary Of Reconciled Balance Sheet Class A Ordinary Shares (Detail) Sheet http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail Summary of Significant Accounting Policies - Summary Of Reconciled Balance Sheet Class A Ordinary Shares (Detail) Details 22 false false R23.htm 1023 - Disclosure - Summary of Significant Accounting Policies - Summary Of Basic and Diluted Net Loss Per Share (Details) Sheet http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails Summary of Significant Accounting Policies - Summary Of Basic and Diluted Net Loss Per Share (Details) Details 23 false false R24.htm 1024 - Disclosure - Initial Public Offering - Additional Information (Detail) Sheet http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail Initial Public Offering - Additional Information (Detail) Details 24 false false R25.htm 1025 - Disclosure - Private Placement Warrants - Additional Information (Detail) Sheet http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail Private Placement Warrants - Additional Information (Detail) Details 25 false false R26.htm 1026 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 26 false false R27.htm 1027 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 27 false false R28.htm 1028 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit - Additional Information (Detail) Sheet http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit - Additional Information (Detail) Details 28 false false R29.htm 1029 - Disclosure - Warrants - Additional Information (Detail) Sheet http://www.ascendant.com/role/WarrantsAdditionalInformationDetail Warrants - Additional Information (Detail) Details 29 false false R30.htm 1030 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 30 false false R31.htm 1031 - Disclosure - Fair Value Measurements - Summary of Fair Value Assets and Liabilities Measured on Recurring Basis (Details) Sheet http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails Fair Value Measurements - Summary of Fair Value Assets and Liabilities Measured on Recurring Basis (Details) Details 31 false false R32.htm 1032 - Disclosure - Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements (Details) Sheet http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements (Details) Details 32 false false R33.htm 1033 - Disclosure - Fair Value Measurements - Summary of Fair Value of the Level 3 Warrant Liabilities (Detail) Sheet http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueOfTheLevel3WarrantLiabilitiesDetail Fair Value Measurements - Summary of Fair Value of the Level 3 Warrant Liabilities (Detail) Details 33 false false All Reports Book All Reports d324890d10q.htm acdi-20220630.xsd acdi-20220630_cal.xml acdi-20220630_def.xml acdi-20220630_lab.xml acdi-20220630_pre.xml d324890dex311.htm d324890dex312.htm d324890dex321.htm d324890dex322.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 51 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d324890d10q.htm": { "axisCustom": 1, "axisStandard": 17, "contextCount": 148, "dts": { "calculationLink": { "local": [ "acdi-20220630_cal.xml" ] }, "definitionLink": { "local": [ "acdi-20220630_def.xml" ] }, "inline": { "local": [ "d324890d10q.htm" ] }, "labelLink": { "local": [ "acdi-20220630_lab.xml" ] }, "presentationLink": { "local": [ "acdi-20220630_pre.xml" ] }, "schema": { "local": [ "acdi-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 330, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 6, "total": 6 }, "keyCustom": 43, "keyStandard": 153, "memberCustom": 18, "memberStandard": 17, "nsprefix": "acdi", "nsuri": "http://www.ascendant.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://www.ascendant.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "acdi:PrivatePlacementWarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Private Placement Warrants", "role": "http://www.ascendant.com/role/PrivatePlacementWarrants", "shortName": "Private Placement Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "acdi:PrivatePlacementWarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Related Party Transactions", "role": "http://www.ascendant.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Commitments and Contingencies", "role": "http://www.ascendant.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "acdi:TemporaryEquityAndStockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit", "role": "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficit", "shortName": "Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "acdi:TemporaryEquityAndStockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "acdi:DisclosureOfWarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Warrants", "role": "http://www.ascendant.com/role/Warrants", "shortName": "Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "acdi:DisclosureOfWarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Fair Value Measurements", "role": "http://www.ascendant.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Subsequent Events", "role": "http://www.ascendant.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "acdi:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "acdi:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.ascendant.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - CONDENSED BALANCE SHEETS", "role": "http://www.ascendant.com/role/CondensedBalanceSheets", "shortName": "CONDENSED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "acdi:InitialPublicOfferingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P11_15_2021To11_15_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Description of Organization and Business Operations and Liquidity - Additional Information (Detail)", "role": "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "shortName": "Description of Organization and Business Operations and Liquidity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "2", "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)", "role": "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "acdi:InitialPublicOfferingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P11_15_2021To11_15_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Summary of Significant Accounting Policies - Summary Of Reconciled Balance Sheet Class A Ordinary Shares (Detail)", "role": "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail", "shortName": "Summary of Significant Accounting Policies - Summary Of Reconciled Balance Sheet Class A Ordinary Shares (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:TemporaryEquityTableTextBlock", "acdi:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P02_19_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P02_19_2021To03_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Summary of Significant Accounting Policies - Summary Of Basic and Diluted Net Loss Per Share (Details)", "role": "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails", "shortName": "Summary of Significant Accounting Policies - Summary Of Basic and Diluted Net Loss Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2021To06_30_2021_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "0", "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "acdi:InitialPublicOfferingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P11_15_2021To11_15_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Initial Public Offering - Additional Information (Detail)", "role": "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "shortName": "Initial Public Offering - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "acdi:InitialPublicOfferingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn11_15_2021_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "acdi:PrivatePlacementWarrantsTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P11_15_2021To11_15_2021_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "0", "first": true, "lang": null, "name": "acdi:ClassOfWarrantsAndRightsIssuedDuringThePeriod", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Private Placement Warrants - Additional Information (Detail)", "role": "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "shortName": "Private Placement Warrants - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "acdi:PrivatePlacementWarrantsTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn11_15_2021_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P02_19_2021To03_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Related Party Transactions - Additional Information (Detail)", "role": "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P02_19_2021To12_31_2021", "decimals": "0", "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn11_15_2021", "decimals": "0", "first": true, "lang": null, "name": "acdi:AggregateCashUnderwritingDiscount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "role": "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn11_15_2021", "decimals": "0", "first": true, "lang": null, "name": "acdi:AggregateCashUnderwritingDiscount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "acdi:TemporaryEquityAndStockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit - Additional Information (Detail)", "role": "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "shortName": "Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockSharesOutstanding", "div", "acdi:TemporaryEquityAndStockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RedemptionOfWarrantsMemberusgaapScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis", "decimals": null, "first": true, "lang": "en-US", "name": "acdi:TradingDayPeriodToCalculateVolumeWeightedAverageTradingPriceFollowingNoticeOfRedemption", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Warrants - Additional Information (Detail)", "role": "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail", "shortName": "Warrants - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RedemptionOfWarrantsMemberusgaapScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis", "decimals": null, "first": true, "lang": "en-US", "name": "acdi:TradingDayPeriodToCalculateVolumeWeightedAverageTradingPriceFollowingNoticeOfRedemption", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "acdi:TemporaryEquityAndStockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical)", "role": "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical", "shortName": "CONDENSED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockSharesOutstanding", "us-gaap:CommonStockSharesOutstanding", "us-gaap:CommonStockSharesIssued", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022_CashMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Fair Value Measurements - Additional Information (Detail)", "role": "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail", "shortName": "Fair Value Measurements - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022_CashMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Fair Value Measurements - Summary of Fair Value Assets and Liabilities Measured on Recurring Basis (Details)", "role": "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "shortName": "Fair Value Measurements - Summary of Fair Value Assets and Liabilities Measured on Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements (Details)", "role": "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails", "shortName": "Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn06_30_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilitiesNoncurrent", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Fair Value Measurements - Summary of Fair Value of the Level 3 Warrant Liabilities (Detail)", "role": "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueOfTheLevel3WarrantLiabilitiesDetail", "shortName": "Fair Value Measurements - Summary of Fair Value of the Level 3 Warrant Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To03_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "0", "lang": null, "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P04_01_2022To06_30_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS", "role": "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations", "shortName": "UNAUDITED CONDENSED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P04_01_2022To06_30_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "PAsOn02_18_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT", "role": "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "shortName": "UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P02_19_2021To03_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P04_01_2022To06_30_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS", "role": "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows", "shortName": "UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P02_19_2021To06_30_2021", "decimals": "0", "lang": null, "name": "acdi:GeneralAndAdministrativeExpensesPaidByRelatedPartyInExchangeForIssuanceOfClassBOrdinaryShares", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - Description of Organization and Business Operations and Liquidity", "role": "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidity", "shortName": "Description of Organization and Business Operations and Liquidity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.ascendant.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "acdi:InitialPublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Initial Public Offering", "role": "http://www.ascendant.com/role/InitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "d324890d10q.htm", "contextRef": "P01_01_2022To06_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "acdi:InitialPublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 35, "tag": { "acdi_AdjustedExercisePriceOfWarrantsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adjusted exercise price of warrants percentage.", "label": "Adjusted Exercise Price Of Warrants Percentage", "verboseLabel": "Adjusted exercise price of warrants percentage" } } }, "localname": "AdjustedExercisePriceOfWarrantsPercentage", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "acdi_AdministrativeServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Administrative services.", "label": "Administrative Services [Member]" } } }, "localname": "AdministrativeServicesMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_AggregateCashUnderwritingDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate cash underwriting discount.", "label": "Aggregate Cash Underwriting Discount" } } }, "localname": "AggregateCashUnderwritingDiscount", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "acdi_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "acdi_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement.", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_BasicAndDilutedNetLossPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic And Diluted Net loss Per Share [Abstract]", "terseLabel": "Basic and diluted net income per ordinary share:" } } }, "localname": "BasicAndDilutedNetLossPerShareAbstract", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "acdi_CapitalizationOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capitalization of shares.", "label": "Capitalization of Shares", "terseLabel": "Capitalization of Shares" } } }, "localname": "CapitalizationOfShares", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "acdi_CashUnderwritingDiscountPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash underwriting discount per unit.", "label": "Cash Underwriting Discount Per Unit" } } }, "localname": "CashUnderwritingDiscountPerUnit", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "acdi_ClassOfWarrantOrRightRedemptionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant redemption price.", "label": "Class Of Warrant Or Right Redemption Price", "terseLabel": "Warrant redemption price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightRedemptionPrice", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "acdi_ClassOfWarrantsAndRightsIssuedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants and rights issued during the period.", "label": "Class Of Warrants and Rights Issued During the Period", "terseLabel": "Class of warrants and rights issued during the period" } } }, "localname": "ClassOfWarrantsAndRightsIssuedDuringThePeriod", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "acdi_ClassOfWarrantsAndRightsIssuedPricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants and rights issued, price per warrant.", "label": "Class Of Warrants and Rights Issued, Price Per Warrant", "terseLabel": "Class of warrants and rights issued, price per warrant" } } }, "localname": "ClassOfWarrantsAndRightsIssuedPricePerWarrant", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "acdi_ClassificationOfCommonStockBasedOnRedeemabilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of Common Stock Based on Redeemability.", "label": "Classification of Common Stock Based on Redeemability [Axis]" } } }, "localname": "ClassificationOfCommonStockBasedOnRedeemabilityAxis", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "acdi_ClassificationOfCommonStockBasedOnRedeemabilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of Common Stock Based on Redeemability.", "label": "Classification of Common Stock Based on Redeemability [Domain]" } } }, "localname": "ClassificationOfCommonStockBasedOnRedeemabilityDomain", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "acdi_ConversionOfClassBToClassACommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion of class B to class A common stock.", "label": "Conversion of Class B to Class A Common Stock [Member]" } } }, "localname": "ConversionOfClassBToClassACommonStockMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_DeferredOfferingCostsIncludedInAccruedOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs included in accrued offering costs.", "label": "Deferred Offering Costs Included In Accrued Offering Costs", "verboseLabel": "Deferred offering costs included in accrued expenses" } } }, "localname": "DeferredOfferingCostsIncludedInAccruedOfferingCosts", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "acdi_DeferredUnderwritingCommissions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commissions.", "label": "Deferred Underwriting Commissions" } } }, "localname": "DeferredUnderwritingCommissions", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "acdi_DeferredUnderwritingCommissionsPayableNonCurrent": { "auth_ref": [], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commissions payable non current.", "label": "Deferred Underwriting Commissions Payable Non Current", "terseLabel": "Deferred underwriting commissions" } } }, "localname": "DeferredUnderwritingCommissionsPayableNonCurrent", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "acdi_DeferredUnderwritingCommissionsPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commissions per unit.", "label": "Deferred Underwriting Commissions Per Unit" } } }, "localname": "DeferredUnderwritingCommissionsPerUnit", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "acdi_DeferredUnderwritingFeesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting fees payable.", "label": "Deferred Underwriting Fees Payable", "terseLabel": "Deferred underwriting fees payable" } } }, "localname": "DeferredUnderwritingFeesPayable", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "acdi_DenominatorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Denominator.", "label": "Denominator [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "DenominatorAbstract", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "acdi_DisclosureOfWarrantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of warrants.", "label": "Disclosure Of Warrants [Text Block]", "verboseLabel": "Warrants" } } }, "localname": "DisclosureOfWarrantsTextBlock", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/Warrants" ], "xbrltype": "textBlockItemType" }, "acdi_DissolutionExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dissolution expense.", "label": "Dissolution Expense", "terseLabel": "Dissolution expense" } } }, "localname": "DissolutionExpense", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "acdi_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Emerging growth company.", "label": "Emerging Growth Company [Policy Text Block]", "terseLabel": "Emerging Growth Company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "acdi_FounderSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder shares.", "label": "Founder Shares [Member]" } } }, "localname": "FounderSharesMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_GeneralAndAdministrativeExpensesPaidByRelatedPartyInExchangeForIssuanceOfClassBOrdinaryShares": { "auth_ref": [], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "General And Administrative Expenses Paid By Related Party In Exchange For Issuance Of Class B Ordinary Shares.", "label": "General And Administrative Expenses Paid By Related Party In Exchange For Issuance Of Class B Ordinary Shares", "terseLabel": "General and administrative expenses paid by related party in exchange for issuance of Class B ordinary shares" } } }, "localname": "GeneralAndAdministrativeExpensesPaidByRelatedPartyInExchangeForIssuanceOfClassBOrdinaryShares", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "acdi_InitialPublicOfferAndPrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offer and private placement.", "label": "Initial Public Offer And Private Placement [Member]" } } }, "localname": "InitialPublicOfferAndPrivatePlacementMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_InitialPublicOfferingDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offering disclosure.", "label": "Initial Public Offering Disclosure [Text Block]", "verboseLabel": "Initial Public Offering" } } }, "localname": "InitialPublicOfferingDisclosureTextBlock", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "acdi_MinimumSharePriceOfTheResidualAssetsRemainingAvailableForDistribution": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum share price of the residual assets remaining available for distribution.", "label": "Minimum Share Price Of The Residual Assets Remaining Available For Distribution", "terseLabel": "Minimum share price of the residual assets remaining available for distribution" } } }, "localname": "MinimumSharePriceOfTheResidualAssetsRemainingAvailableForDistribution", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "acdi_NetWorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net working capital.", "label": "Net Working Capital", "terseLabel": "Net Working Capital" } } }, "localname": "NetWorkingCapital", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "acdi_NoticePeriodToRedeemWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notice period to redeem warrants.", "label": "Notice Period To Redeem Warrants", "verboseLabel": "Notice period to redeem warrants" } } }, "localname": "NoticePeriodToRedeemWarrants", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "acdi_NumberOfDaysGrantedForExercisingTheOption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "number of days granted for exercising the option.", "label": "Number Of Days Granted For Exercising The Option" } } }, "localname": "NumberOfDaysGrantedForExercisingTheOption", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "acdi_NumeratorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Numerator.", "label": "Numerator [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "NumeratorAbstract", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "acdi_OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Offering costs associated with the initial public offering.", "label": "Offering Costs Associated With The Initial Public Offering [Policy Text Block]", "terseLabel": "Offering Costs Associated with the Initial Public Offering" } } }, "localname": "OfferingCostsAssociatedWithTheInitialPublicOfferingPolicyTextBlock", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "acdi_OfficeSpaceAdministrativeAndSupportServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Office space, administrative and support services.", "label": "Office Space, Administrative and Support Services [Member]" } } }, "localname": "OfficeSpaceAdministrativeAndSupportServicesMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ordinary shares subject to possible redemption.", "label": "Ordinary Shares Subject To Possible Redemption [Policy Text Block]", "verboseLabel": "Class A Ordinary shares subject to Possible Redemption" } } }, "localname": "OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "acdi_OtherOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other offering cost.", "label": "Other Offering Costs", "terseLabel": "Other offering costs" } } }, "localname": "OtherOfferingCosts", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "acdi_PaymentOfDeferredOfferingCostsByNotePayableRelatedPartyOne": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of deferred offering costs by note payable related party one.", "label": "Payment of Deferred Offering Costs by Note Payable Related Party One", "terseLabel": "Payment of deferred offering costs by note payable - related party" } } }, "localname": "PaymentOfDeferredOfferingCostsByNotePayableRelatedPartyOne", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "acdi_PaymentOfDeferredOfferingCostsByNotesPayableRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of deferred offering costs by notes payable \u2013 related party.", "label": "Payment Of Deferred Offering Costs By Notes Payable, Related Party", "terseLabel": "Payment of deferred offering costs by the Sponsor in exchange for the issuance of Class B ordinary shares" } } }, "localname": "PaymentOfDeferredOfferingCostsByNotesPayableRelatedParty", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "acdi_PercentageOfCommonStockIssuedAndOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of common stock issued and outstanding.", "label": "Percentage Of Common Stock Issued And Outstanding" } } }, "localname": "PercentageOfCommonStockIssuedAndOutstanding", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "acdi_PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of fair market value of target business to asset held in trust account.", "label": "Percentage Of Fair Market Value Of Target Business To Asset Held In Trust Account", "terseLabel": "Percentage of fair market value of target business to asset held in trust account" } } }, "localname": "PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "acdi_PercentageOfGrossProceedsOnTotalEquityProceeds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of gross proceeds on total equity proceeds.", "label": "Percentage Of Gross Proceeds On Total Equity Proceeds", "verboseLabel": "Percentage of gross proceeds on total equity proceeds" } } }, "localname": "PercentageOfGrossProceedsOnTotalEquityProceeds", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "acdi_PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of public shares to be redeemed on non completion of business combination.", "label": "Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination", "terseLabel": "Percentage of public shares to be redeemed on non completion of business combination" } } }, "localname": "PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "acdi_PercentageOfRedeemingSharesOfPublicSharesWithoutTheCompaniesPriorWrittenConsent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of redeeming shares of public shares without the companies prior written consent.", "label": "Percentage Of Redeeming Shares Of Public Shares Without The Companies Prior Written Consent", "terseLabel": "Percentage of redeeming shares of public shares without the companies prior written consent" } } }, "localname": "PercentageOfRedeemingSharesOfPublicSharesWithoutTheCompaniesPriorWrittenConsent", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "acdi_PeriodToExerciseWarrantsAfterClosingOfProposedPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period to exercise warrants after closing of proposed Public Offering.", "label": "Period To Exercise Warrants After Closing Of Proposed Public Offering", "verboseLabel": "Period to exercise warrants after closing of proposed public offering" } } }, "localname": "PeriodToExerciseWarrantsAfterClosingOfProposedPublicOffering", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "acdi_PostTransactionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Post Transaction [Member]" } } }, "localname": "PostTransactionMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement warrants.", "label": "Private Placement Warrants [Member]", "terseLabel": "Private warrant [Member]" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_PrivatePlacementWarrantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement warrants.", "label": "Private Placement Warrants [Text Block]", "terseLabel": "Private Placement Warrants" } } }, "localname": "PrivatePlacementWarrantsTextBlock", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/PrivatePlacementWarrants" ], "xbrltype": "textBlockItemType" }, "acdi_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note.", "label": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_PublicSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public shares.", "label": "Public Shares [Member]" } } }, "localname": "PublicSharesMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public warrants.", "label": "Public Warrants [Member]" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_RedemptionOfWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption of warrants.", "label": "Redemption of Warrants [Member]" } } }, "localname": "RedemptionOfWarrantsMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_RedemptionOfWarrantsWhenClassAEqualsOrExceedsEighteenDollarsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption of warrants when class A equals or exceeds eighteen dollars.", "label": "Redemption Of Warrants When Class A Equals or Exceeds Eighteen Dollars [Member]" } } }, "localname": "RedemptionOfWarrantsWhenClassAEqualsOrExceedsEighteenDollarsMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption of warrants when class A equals or exceeds ten dollars.", "label": "Redemption Of Warrants When Class A Equals or Exceeds Ten Dollars [Member]" } } }, "localname": "RedemptionOfWarrantsWhenClassAEqualsOrExceedsTenDollarsMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_RelatedPartyLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related party loans.", "label": "Related Party Loans [Member]" } } }, "localname": "RelatedPartyLoansMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_RestrictedInvestmentsTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted investments term.", "label": "Restricted Investments Term" } } }, "localname": "RestrictedInvestmentsTerm", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "acdi_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor.", "label": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_StockForfeitedDuringThePeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock forfeited during the period shares.", "label": "Stock Forfeited During The Period Shares" } } }, "localname": "StockForfeitedDuringThePeriodShares", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "acdi_TemporaryEquityAndStockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity and stockholders equity note.", "label": "Temporary Equity And Stockholders Equity Note [Abstract]" } } }, "localname": "TemporaryEquityAndStockholdersEquityNoteAbstract", "nsuri": "http://www.ascendant.com/20220630", "xbrltype": "stringItemType" }, "acdi_TemporaryEquityAndStockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity and stockholders equity note disclosure.", "label": "Temporary Equity And Stockholders Equity Note Disclosure [Text Block]", "terseLabel": "Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit" } } }, "localname": "TemporaryEquityAndStockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficit" ], "xbrltype": "textBlockItemType" }, "acdi_TemporaryEquityIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Temporary equity issuance costs.", "label": "Temporary Equity Issuance Costs", "negatedLabel": "Offering costs allocated to Class A ordinary shares subject to possible redemption" } } }, "localname": "TemporaryEquityIssuanceCosts", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail" ], "xbrltype": "monetaryItemType" }, "acdi_TermOfRestrictedInvestments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of restricted investments.", "label": "Term Of Restricted Investments", "terseLabel": "Term of Restricted Investments" } } }, "localname": "TermOfRestrictedInvestments", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "acdi_ThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold consecutive trading days.", "label": "Threshold Consecutive Trading Days", "verboseLabel": "Threshold consecutive trading days" } } }, "localname": "ThresholdConsecutiveTradingDays", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "acdi_ThresholdIssuePriceForCapitalRaisingPurposeInConnectionWithClosingOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold issue price for capital raising purpose in connection with closing of business combination.", "label": "Threshold Issue Price For Capital Raising Purpose In Connection With Closing Of Business Combination", "verboseLabel": "Threshold issue price for capital raising purpose in connection with closing of business combination" } } }, "localname": "ThresholdIssuePriceForCapitalRaisingPurposeInConnectionWithClosingOfBusinessCombination", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "acdi_ThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold trading days.", "label": "Threshold Trading Days", "verboseLabel": "Threshold trading days" } } }, "localname": "ThresholdTradingDays", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "acdi_TradingDayPeriodToCalculateVolumeWeightedAverageTradingPriceFollowingNoticeOfRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading day period to calculate volume weighted average trading price following notice of redemption.", "label": "Trading Day Period To Calculate Volume Weighted Average Trading Price Following Notice Of Redemption", "verboseLabel": "Trading day period to calculate volume weighted average trading price following notice of redemption" } } }, "localname": "TradingDayPeriodToCalculateVolumeWeightedAverageTradingPriceFollowingNoticeOfRedemption", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "acdi_UnderwritingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting agreement.", "label": "Underwriting Agreement [Member]" } } }, "localname": "UnderwritingAgreementMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "acdi_VolumeWeightedAveragePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Volume weighted average price per share.", "label": "Volume Weighted Average Price Per Share", "verboseLabel": "Volume weighted average price per share" } } }, "localname": "VolumeWeightedAveragePricePerShare", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "acdi_WarrantLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant liabilities.", "label": "Warrant Liabilities [Member]" } } }, "localname": "WarrantLiabilitiesMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "acdi_WorkingCapitalLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working capital loan.", "label": "Working Capital Loan [Member]" } } }, "localname": "WorkingCapitalLoanMember", "nsuri": "http://www.ascendant.com/20220630", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r391" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_DirectorMember": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r141", "r142", "r143", "r144", "r163", "r194", "r219", "r222", "r311", "r312", "r313", "r314", "r315", "r316", "r335", "r366", "r367", "r377", "r378" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r141", "r142", "r143", "r144", "r163", "r194", "r219", "r222", "r311", "r312", "r313", "r314", "r315", "r316", "r335", "r366", "r367", "r377", "r378" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r136", "r141", "r142", "r143", "r144", "r163", "r194", "r208", "r219", "r222", "r225", "r226", "r227", "r311", "r312", "r313", "r314", "r315", "r316", "r335", "r366", "r367", "r377", "r378" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r136", "r141", "r142", "r143", "r144", "r163", "r194", "r208", "r219", "r222", "r225", "r226", "r227", "r311", "r312", "r313", "r314", "r315", "r316", "r335", "r366", "r367", "r377", "r378" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r74", "r79", "r140", "r220" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r74", "r79", "r140", "r220", "r303" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r115", "r294" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r22", "r300" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrent": { "auth_ref": [ "r22", "r62", "r293", "r295" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Related Parties, Current", "terseLabel": "Accounts payable - related party" } } }, "localname": "AccountsPayableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "verboseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r15", "r300" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r66", "r67", "r68", "r228", "r229", "r230", "r258" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive securities excluded from computation of earnings per share, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r8", "r61", "r107", "r109", "r113", "r123", "r147", "r148", "r149", "r151", "r152", "r153", "r154", "r155", "r156", "r158", "r159", "r247", "r249", "r276", "r298", "r300", "r350", "r360" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r21", "r61", "r123", "r147", "r148", "r149", "r151", "r152", "r153", "r154", "r155", "r156", "r158", "r159", "r247", "r249", "r276", "r298", "r300" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r261" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Investments held in Trust Account" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r58" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Investments held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r218", "r221", "r245" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r218", "r221", "r243", "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of voting interests acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_CapitalUnitsMember": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "Type of ownership interest in a corporation. Class of capital units or capital shares.", "label": "Capital Units [Member]", "terseLabel": "Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant [Member]" } } }, "localname": "CapitalUnitsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_Cash": { "auth_ref": [ "r7", "r300", "r373", "r374" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r7", "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash - end of the period", "periodStartLabel": "Cash - beginning of the period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r53", "r349" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Investments Held in the Trust Account" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r46", "r277" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r7" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "FDIC Insured Amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "verboseLabel": "Supplemental disclosure of noncash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashMember": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.", "label": "Cash [Member]" } } }, "localname": "CashMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r12", "r13", "r14", "r59", "r61", "r83", "r84", "r85", "r87", "r89", "r95", "r96", "r97", "r123", "r147", "r152", "r153", "r154", "r158", "r159", "r192", "r193", "r196", "r197", "r199", "r276", "r384" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.ascendant.com/role/CondensedBalanceSheets", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical", "http://www.ascendant.com/role/CoverPage", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations", "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r207", "r223" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price of warrant" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "warrants issuable", "verboseLabel": "Number of shares issued upon exercise of warrant" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Class of warrant or right, outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r207", "r223" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r28", "r354", "r363" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r137", "r138", "r139", "r145", "r376" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CondensedBalanceSheets", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical", "http://www.ascendant.com/role/CoverPage", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations", "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CondensedBalanceSheets", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical", "http://www.ascendant.com/role/CoverPage", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockConversionBasis": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Description of basis for conversion of convertible common stock.", "label": "Common Stock, Conversion Basis", "terseLabel": "Stock conversion basis", "verboseLabel": "Common Stock, Conversion Basis" } } }, "localname": "CommonStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r66", "r67", "r258" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par or stated value per share", "verboseLabel": "Common stock par or stated value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock shares authorized", "verboseLabel": "Common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r14", "r199" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock shares outstanding", "verboseLabel": "Common stock shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common Stock, Shares Subscribed but Unissued" } } }, "localname": "CommonStockSharesSubscribedButUnissued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r14", "r300" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common Stock, Value, Issued" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock, Voting Rights", "verboseLabel": "Common stock shares voting rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r100", "r358" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConversionOfStockByUniqueDescriptionAxis": { "auth_ref": [ "r54", "r55", "r56" ], "lang": { "en-us": { "role": { "documentation": "Information by description of stock conversions.", "label": "Stock Conversion Description [Axis]" } } }, "localname": "ConversionOfStockByUniqueDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConversionOfStockNameDomain": { "auth_ref": [ "r54", "r55", "r56" ], "lang": { "en-us": { "role": { "documentation": "The unique name of a noncash or part noncash stock conversion.", "label": "Conversion of Stock, Name [Domain]" } } }, "localname": "ConversionOfStockNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpensesRelatedParty": { "auth_ref": [ "r39" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties.", "label": "Costs and Expenses, Related Party", "terseLabel": "Administrative expenses - related party" } } }, "localname": "CostsAndExpensesRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r9", "r10", "r11", "r60", "r64", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r180", "r181", "r182", "r183", "r286", "r351", "r352", "r359" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r178" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Debt Instrument Convertible Into Warrants" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r162", "r179" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt Instrument Conversion Price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r160", "r180", "r181", "r285", "r286", "r287" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r26", "r161" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt Instrument Interest Rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r27", "r60", "r64", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r180", "r181", "r182", "r183", "r286" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r30" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Derivative warrant liabilities" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueOfTheLevel3WarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r63", "r252", "r253", "r254", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r22", "r62", "r150", "r152", "r153", "r157", "r158", "r159", "r292" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Due to Related Parties Current", "verboseLabel": "Due To Related Parties, Current" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r38", "r71", "r72", "r73", "r74", "r75", "r81", "r83", "r87", "r88", "r89", "r92", "r93", "r259", "r260", "r356", "r365" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic net income per ordinary share", "verboseLabel": "Basic net income (loss) per ordinary share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r38", "r71", "r72", "r73", "r74", "r75", "r83", "r87", "r88", "r89", "r92", "r93", "r259", "r260", "r356", "r365" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net income per ordinary share", "verboseLabel": "Diluted net income (loss) per ordinary share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r90", "r91" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "verboseLabel": "Net Income (Loss) Per Ordinary Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r34", "r35", "r36", "r66", "r67", "r68", "r70", "r76", "r78", "r94", "r124", "r199", "r206", "r228", "r229", "r230", "r240", "r241", "r258", "r278", "r279", "r280", "r281", "r282", "r283", "r288", "r368", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CoverPage", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_ExpenseRelatedToDistributionOrServicingAndUnderwritingFees": { "auth_ref": [ "r357" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expense related to distribution, servicing and underwriting fees.", "label": "Expense Related to Distribution or Servicing and Underwriting Fees", "terseLabel": "Expense Related to Distribution or Servicing and Underwriting Fees" } } }, "localname": "ExpenseRelatedToDistributionOrServicingAndUnderwritingFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r50", "r184" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of derivative warrant liabilities", "terseLabel": "Change in fair value of derivative warrant liabilities", "verboseLabel": "Change in fair value of derivative warrant liabilities" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueOfTheLevel3WarrantLiabilitiesDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r261", "r262", "r270" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueOfTheLevel3WarrantLiabilitiesDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of Quantitative Information Regarding Level 3 Fair Value Measurements" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r261", "r274", "r275" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r169", "r180", "r181", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r217", "r262", "r308", "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueOfTheLevel3WarrantLiabilitiesDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r268", "r270" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r261", "r262", "r264", "r265", "r271" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueOfTheLevel3WarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r169", "r209", "r210", "r215", "r217", "r262", "r308" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r169", "r180", "r181", "r209", "r210", "r215", "r217", "r262", "r309" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r169", "r180", "r181", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r217", "r262", "r310" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueOfTheLevel3WarrantLiabilitiesDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r266", "r270" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Fair Value of the Level 3 Warrant Liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r169", "r180", "r181", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r217", "r308", "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueOfTheLevel3WarrantLiabilitiesDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r268", "r271" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value Measurements Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3": { "auth_ref": [ "r267", "r269" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset) out of level 3 of the fair value hierarchy.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3", "terseLabel": "Transfer of Public Warrants" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueOfTheLevel3WarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r272", "r273" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r118", "r119", "r120", "r121", "r122", "r125", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r133", "r177", "r198", "r257", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r384", "r385", "r386", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.", "label": "Financial Liabilities Fair Value Disclosure", "terseLabel": "Derivative warrant liabilities" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r41", "r50", "r117" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "negatedLabel": "Income from investments held in Trust Account", "terseLabel": "Income from investments held in Trust Account" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r40" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r33", "r232", "r233", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r49" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r49" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r49" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due to Related Parties", "terseLabel": "Accounts payable - related party" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r49" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "terseLabel": "Interest income from operating account" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r261" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Investments, Fair Value Disclosure" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r23", "r61", "r110", "r123", "r147", "r148", "r149", "r152", "r153", "r154", "r155", "r156", "r158", "r159", "r248", "r249", "r250", "r276", "r298", "r299" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r19", "r61", "r123", "r276", "r300", "r353", "r362" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities, Redeemable Class A Ordinary Shares and Shareholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities, Redeemable Class A Ordinary Shares and Shareholders' Deficit:" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r5", "r25", "r61", "r123", "r147", "r148", "r149", "r152", "r153", "r154", "r155", "r156", "r158", "r159", "r248", "r249", "r250", "r276", "r298", "r299", "r300" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r27", "r146" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r46", "r48", "r51" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r31", "r32", "r36", "r37", "r51", "r61", "r69", "r71", "r72", "r73", "r74", "r77", "r78", "r86", "r107", "r108", "r111", "r112", "r114", "r123", "r147", "r148", "r149", "r152", "r153", "r154", "r155", "r156", "r158", "r159", "r260", "r276", "r355", "r364" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Allocation of net income (loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfCashFlows", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "negatedTotalLabel": "Total other income" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r107", "r108", "r111", "r112", "r114" ], "calculation": { "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r65", "r80", "r106", "r251" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "verboseLabel": "Description of Organization and Business Operations and Liquidity" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidity" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income:" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForUnderwritingExpense": { "auth_ref": [ "r47" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.", "label": "Payments for Underwriting Expense", "terseLabel": "Underwriting expense paid | $" } } }, "localname": "PaymentsForUnderwritingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "terseLabel": "Offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRestrictedInvestments": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.", "label": "Payments to Acquire Restricted Investments", "terseLabel": "Payments to acquire restricted investments" } } }, "localname": "PaymentsToAcquireRestrictedInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r13", "r192" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock par or stated value per share", "verboseLabel": "Preferred stock par or stated value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r13", "r192" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued", "verboseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "verboseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r13", "r300" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r3", "r20", "r134", "r135" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from issuance initial public offering", "verboseLabel": "Gross proceeds from Initial Public Offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from issuance of private placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "negatedLabel": "Fair value of Public Warrants at issuance" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.", "label": "Redeemable Noncontrolling Interest, by Legal Entity [Table]" } } }, "localname": "RedeemableNoncontrollingInterestByLegalEntityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RedeemableNoncontrollingInterestLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Redeemable Noncontrolling Interest [Line Items]" } } }, "localname": "RedeemableNoncontrollingInterestLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r216", "r291", "r292" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r291", "r295" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Related Party Transaction, Amounts of Transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r216", "r291", "r292", "r295" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r291" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Related Party Transaction, Expenses from Transactions with Related Party" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.", "label": "Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party", "terseLabel": "RelatedPartyTransaction, SellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" } } }, "localname": "RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r216", "r291", "r295", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r289", "r290", "r292", "r296", "r297" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r44" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r16", "r206", "r300", "r361", "r371", "r372" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r66", "r67", "r68", "r70", "r76", "r78", "r124", "r228", "r229", "r230", "r240", "r241", "r258", "r368", "r370" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of stock, price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary Of Basic and Diluted Net Loss Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r261", "r262" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Summary of Fair Value Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r293", "r295" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis": { "auth_ref": [ "r185", "r186", "r187" ], "lang": { "en-us": { "role": { "documentation": "Represents settlement terms for the group of mandatorily redeemable securities, including the description and the details of all terms for each outstanding financial instrument and each settlement option.", "label": "Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]" } } }, "localname": "ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r12", "r13", "r14", "r59", "r95", "r96", "r188", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Stock price", "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price", "verboseLabel": "Share price (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected team" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Shares issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Shares Issued, Price Per Share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance Ending, shares", "periodStartLabel": "Beginning Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain": { "auth_ref": [ "r186", "r187" ], "lang": { "en-us": { "role": { "documentation": "Identifying description of each financial instrument that embodies an unconditional obligation requiring the issuer to redeem the securities by transferring the assets at a specified or determinable date (or dates) or upon an event that is certain to occur. Examples are preferred stock or trust preferred securities, each of which has redemption rights beyond the control of the issuer on a specified date or upon an event that is certain to occur.", "label": "Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]" } } }, "localname": "SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r57", "r65" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r12", "r13", "r14", "r59", "r61", "r83", "r84", "r85", "r87", "r89", "r95", "r96", "r97", "r123", "r147", "r152", "r153", "r154", "r158", "r159", "r192", "r193", "r196", "r197", "r199", "r276", "r384" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.ascendant.com/role/CondensedBalanceSheets", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical", "http://www.ascendant.com/role/CoverPage", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations", "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r29", "r34", "r35", "r36", "r66", "r67", "r68", "r70", "r76", "r78", "r94", "r124", "r199", "r206", "r228", "r229", "r230", "r240", "r241", "r258", "r278", "r279", "r280", "r281", "r282", "r283", "r288", "r368", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionAndShareholdersDeficitAdditionalInformationDetail", "http://www.ascendant.com/role/CoverPage", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r66", "r67", "r68", "r94", "r336" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets", "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r13", "r14", "r199", "r206" ], "lang": { "en-us": { "role": { "definitionGuidance": "Stock issued during period, shares, new issues", "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock issued during period, shares, new issues", "verboseLabel": "Issuance of Class\u00a0B ordinary shares to Sponsor, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Stock Issued During Period, Shares, Other" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited", "terseLabel": "Number of shares forfeited during the period.", "verboseLabel": "Shares issued, shares, share-based payment arrangement, forfeited" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r13", "r14", "r199", "r206" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Stock issued during period, value, new issues", "verboseLabel": "Issuance of Class\u00a0B ordinary shares to Sponsor" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r14", "r17", "r18", "r61", "r116", "r123", "r276", "r300" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance Ending", "periodStartLabel": "Beginning Balance", "totalLabel": "Total shareholders' deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' Deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r284", "r302" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r284", "r302" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/PrivatePlacementWarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r301", "r304" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "verboseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "http://www.ascendant.com/role/DescriptionOfOrganizationAndBusinessOperationsAndLiquidityAdditionalInformationDetail", "http://www.ascendant.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "negatedLabel": "Accretion of Class A ordinary shares subject to possible redemption amount", "verboseLabel": "Accretion on Class A ordinary shares subject to possible redemption amount" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r147", "r152", "r153", "r154", "r158", "r159" ], "calculation": { "http://www.ascendant.com/role/CondensedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Class A ordinary shares subject to possible redemption, $0.0001 par value, 30,000,000 shares at redemption value of approximately $10.22 and $10.20 per share as of June 30, 2022 and December 31, 2021, respectively", "verboseLabel": "Class A ordinary share subject to possible redemption" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheets", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Temporary Equity Disclosure [Abstract]" } } }, "localname": "TemporaryEquityDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease": { "auth_ref": [ "r6", "r189" ], "lang": { "en-us": { "role": { "documentation": "Change in the value of each type or class of stock classified as temporary equity during the period. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.", "label": "Temporary Equity, Carrying Amount, Period Increase (Decrease)", "terseLabel": "Increase in redemption value of Class A ordinary shares subject to redemption" } } }, "localname": "TemporaryEquityIssuePeriodIncreaseOrDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfReconciledBalanceSheetClassAOrdinarySharesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r6", "r189" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Temporary equity, par or stated value per share" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r6", "r189" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Temporary equity, redemption price per share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary equity, shares issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CondensedBalanceSheetsParenthetical", "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Temporary equity shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquityTableTextBlock": { "auth_ref": [ "r6", "r189" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity [Table Text Block]", "terseLabel": "Summary Of Reconciled Balance Sheet Class A Ordinary Shares" } } }, "localname": "TemporaryEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r118", "r119", "r120", "r121", "r122", "r177", "r198", "r257", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r384", "r385", "r386", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r231", "r235" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r234" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Accrued for interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r98", "r99", "r101", "r102", "r103", "r104", "r105" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "verboseLabel": "Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants and Rights Note Disclosure [Abstract]" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input", "terseLabel": "Probability of business combination" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/FairValueMeasurementsSummaryOfQuantitativeInformationRegardingLevel3FairValueMeasurementsDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "verboseLabel": "Warrants and rights outstanding term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r82", "r89" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r81", "r89" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.ascendant.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareDetails", "http://www.ascendant.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r139": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r145": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=118255708&loc=SL5909891-110878" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22026-110879" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r251": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r297": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r304": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.14)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r379": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r380": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r381": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r382": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r383": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r384": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r385": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r386": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r387": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r388": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r389": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r390": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r391": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r392": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r65": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" } }, "version": "2.1" } ZIP 52 0001193125-22-219950-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-219950-xbrl.zip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end